Finex logo
Finex Intelligence

Market Signal Briefing

Real-time pulse of financial headlines curated from 2 premium feeds.

Last news saved at Mar 13, 04:41 53m ago Cron last ran Mar 13, 04:41 53m ago 2 sources live
Switch language
83,076 Stories ingested Auto-fetched market intel nonstop.
424 Distinct tickers Symbols referenced across the feed
stockne... Trending sources stocknewsapi • cryptonews
Hot tickers
BTC XRP ETH SOL DOGE USO
Surfacing from current coverage
Details Saved Published Title Source Tickers
2025-10-14 12:22 4mo ago
2025-10-14 08:17 4mo ago
Lulus Appoints Heidi Crane as Fractional Chief Financial Officer stocknewsapi
LVLU
October 14, 2025 08:17 ET

 | Source:

Lulu's Fashion Lounge Holdings, Inc.

CHICO, Calif., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Lulu’s Fashion Lounge Holdings, Inc. (“Lulus” or the “Company”) (Nasdaq: LVLU) today announced the appointment of Heidi Crane as its fractional Chief Financial Officer (“Fractional CFO”), effective yesterday, October 13, 2025. Ms. Crane will lead the Company's financial strategy with a focus on accelerating growth momentum, improving operational efficiencies and driving long-term shareholder value.

“We’re thrilled to welcome Heidi to the Lulus team. Heidi’s extensive experience and knowledge leading financial strategy for high-growth, consumer-focused companies will be instrumental as we continue to execute against our financial and strategic initiatives, and work towards achieving long-term, sustainable growth,” said Crystal Landsem, CEO of Lulus.

“I’m excited to join Lulus at a pivotal moment in its journey,” said Ms. Crane, Fractional CFO of Lulus. “Lulus is an incredible brand with significant runway ahead, and I look forward to working alongside the leadership team to position the business for long-term growth and value-creation.”

With over 17 years of CFO experience across private equity and venture-backed consumer brands, Ms. Crane brings deep financial expertise in scaling direct-to-consumer businesses. She has led finance teams at FightCamp, BH Cosmetics, and Techstyle Fashion Group, and previously held roles at Diageo PLC, Dole Food Company, and Ernst & Young, where she earned her C.P.A. License. Ms. Crane holds an M.B.A. from University of California, Los Angeles Anderson School of Management and a B.S. in Business Administration from California State University, Long Beach.

About Lulus
Headquartered in California and serving millions of customers worldwide, Lulus is an attainable luxury fashion brand for women, offering modern, unapologetically feminine designs at accessible prices for every occasion. Our aim is to make every woman feel confident and celebrated, supporting her for all of life’s occasions, big or small – from work desk to dream date, cozying up on the couch to the spotlight of her wedding day. Founded in 1996, Lulus delivers fresh styles to consumers daily, using direct consumer feedback and insights to refine product offerings and elevate the customer experience. Lulus’ world class personal stylists, bridal concierge, and customer care team share an unwavering commitment to elevating style and quality and bring exceptional customer service and personalized shopping to customers around the world. Follow @lulus on Instagram and @lulus on TikTok. Lulus is a registered trademark of Lulu’s Fashion Lounge, LLC. All rights reserved.

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including without limitation statements regarding the Company’s financial strategy. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause Lulus’ actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to, the risk factors discussed in Part I, Item 1A, “Risk Factors” in Lulus’ Annual Report on Form 10-K for the fiscal year ended December 29, 2024, Part II, Item IA, “Risk Factors” in Lulus’ Quarterly Reports on Form 10-Q for the fiscal quarters ended March 30, 2025 and June 29, 2025, and our other filings with the Securities and Exchange Commission which could cause actual results to differ materially from those indicated by the forward-looking statements made in this press release. Any such forward-looking statements represent management’s estimates as of the date of this press release. While Lulus may elect to update such forward-looking statements at some point in the future, it disclaims any obligation to do so, except as required by law, even if subsequent events cause its views to change.

Contact
[email protected] 
2025-10-14 12:22 4mo ago
2025-10-14 08:17 4mo ago
Vodafone's network of hope meets a wall of worry stocknewsapi
VOD
Vodafone Group PLC's (LSE:VOD) turnaround story has split the market. Deutsche Bank is doubling down on optimism, while Citi is keeping its hand firmly on the handbrake.

Deutsche’s Robert Grindle has lifted his target price from 135p to 140p and kept his “Buy” rating, pointing to a company that looks “distinctly un-Lemony”, in other words, fewer mishaps and a bit more sunshine.

The shares, last seen at 84.38p, have already risen 27% in sterling terms this year, outpacing European peers.

The German operation, long a drag on sentiment, is now showing signs of life, with organic service revenue growth “back to growth or close to it” in the second quarter.

Emerging markets, especially Africa, are improving in euro terms, and the integration of Three UK is underway. Deutsche sees £700 million of annual cost savings by year five from the merger.

Grindle highlights Vodafone’s “hidden assets”, including stakes in Zegona, Oak Holdings and VodafoneZiggo, that could be monetised to fund further share buybacks.

With the balance sheet strengthening and buyback accretion in play, the dividend could start rising again from 2026, he says.

Citi, by contrast, is not convinced the worst is behind the group. It has kept a 'neutral' rating and raised its price target only slightly, from 75p to 85p, while adding a “90-day negative catalyst watch”. The concern is that too many things remain outside Vodafone’s control.

The bank flags a still-tough German and UK telecoms market, the risk that Deutsche Telekom could accelerate its fibre build, and uncertainty around Germany’s mobile network consolidation.

It also notes a pattern investors know too well: heavy share price falls on the day of interim results in each of the past three years.

Both banks agree the shares look cheap and that synergies from the Three deal should eventually bolster free cash flow. The debate is whether Vodafone can finally stop dropping the call.
2025-10-14 12:22 4mo ago
2025-10-14 08:17 4mo ago
M&S boost as Norman stays at the helm stocknewsapi
MAKSY
Marks and Spencer Group PLC (LSE:MKS) shareholders can relax: Archie Norman is not going anywhere just yet.

The retailer has decided to extend the chairman’s tenure for another three years beyond 2026, a move that Shore Capital calls “good news for all stakeholders”.

The decision, led by senior independent director Fiona Dawson after consultation with shareholders, means Norman will stay in post until at least 2029, subject to annual review.

It breaks with the usual nine-year guideline for listed company chairs, but the board said it was “unanimous in its conviction” that his continuation was in the company’s best interests.

ShoreCap's analysts, led by Clive Black, welcomed the decision, describing Norman as “hugely well-respected” and praising his role in transforming M&S since taking over in 2017.

They argue that stepping down purely to “tick a governance box” would have been unhelpful given the progress under chief executive Stuart Machin and the close working relationship between the two.

Norman’s tenure has spanned Brexit disruption, the pandemic and more recent cyberattacks, but the group has emerged leaner and stronger.

ShoreCap points to a “genuine transformation in reputation, operating performance and financial output” during his leadership.

M&S is in its close period ahead of half-year results on 5 November, followed by a capital markets day a week later.

Forecasts suggest adjusted pre-tax profit of about £600 million this year, rising towards £1 billion by 2027. 

The shares were flat at 399p.
2025-10-14 12:22 4mo ago
2025-10-14 08:18 4mo ago
Oracle and AMD Expand Partnership to Help Customers Achieve Next-Generation AI Scale stocknewsapi
AMD ORCL
Beginning in calendar Q3 2026, Oracle will be the first hyperscaler to offer a publicly available AI supercluster powered by 50,000 AMD Instinct MI450 Series GPUs

, /PRNewswire/ -- Oracle AI World -- Oracle and AMD (NASDAQ: AMD) today announced a major expansion of their long-standing, multi-generation collaboration to help customers significantly scale their AI capabilities and initiatives. Building on years of co-innovation, Oracle Cloud Infrastructure (OCI) will be a launch partner for the first publicly available AI supercluster powered by AMD Instinct™ MI450 Series GPUs—with an initial deployment of 50,000 GPUs starting in calendar Q3 2026 and expanding in 2027 and beyond.

This announcement builds upon the joint work of Oracle and AMD to deliver AMD Instinct GPU platforms on OCI to end customers, beginning with the launch of AMD Instinct MI300X powered shapes in 2024 and extending to the general availability of OCI Compute with AMD Instinct MI355X GPUs. These will be available in the zettascale OCI Supercluster.

Demand for large-scale AI capacity is accelerating as next-generation AI models outgrow the limits of current AI clusters. To train and run these workloads, customers need flexible, open compute solutions engineered for extreme scale and efficiency. OCI's planned new AI superclusters will be powered by the AMD "Helios" rack design, which includes AMD Instinct MI450 Series GPUs, next- generation AMD EPYC™ CPUs codenamed "Venice," and next-generation AMD Pensando™ advanced networking codenamed "Vulcano." This vertically-optimized, rack-scale architecture is designed to deliver maximum performance, scalability, and energy efficiency for large-scale AI training and inference.

"Our customers are building some of the world's most ambitious AI applications, and that requires robust, scalable, and high-performance infrastructure," said Mahesh Thiagarajan, executive vice president, Oracle Cloud Infrastructure. "By bringing together the latest AMD processor innovations with OCI's secure, flexible platform and advanced networking powered by Oracle Acceleron, customers can push the boundaries with confidence. Through our decade-long collaboration with AMD—from EPYC to AMD Instinct accelerators—we're continuing to deliver the best price-performance, open, secure, and scalable cloud foundation in partnership with AMD to meet customer needs for this next era of AI."

"AMD and Oracle continue to set the pace for AI innovation in the cloud," said Forrest Norrod, executive vice president and general manager, Data Center Solutions Business Group, AMD. "With our AMD Instinct GPUs, EPYC CPUs, and advanced AMD Pensando networking, Oracle customers gain powerful new capabilities for training, fine-tuning, and deploying the next generation of AI. Together, AMD and Oracle are accelerating AI with open, optimized, and secure systems built for massive AI data centers."

AMD Instinct MI450 Series GPUs Coming to OCI
AMD Instinct MI450 Series GPU-powered shapes are designed to deliver high-performance, flexible cloud deployment options and provide extensive open-source support. This provides the ideal foundation for customers running today's most advanced language models, generative AI, and high-performance computing workloads. With AMD Instinct MI450 Series GPUs on OCI, customers will be able to benefit from:

Breakthrough compute and memory: Helps customers achieve faster results, tackle more complex workloads, and reduce the need for model partitioning by increasing memory bandwidth for AI training models. Each AMD Instinct MI450 Series GPU will provide up to 432 GB of HBM4 and 20 TB/s of memory bandwidth, enabling customers to train and infer models that are 50 percent larger than previous generations entirely in-memory.
AMD optimized "Helios" rack design: Enables customers to operate at scale while optimizing performance density, cost, and energy efficiency via dense, liquid-cooled, 72-GPU racks. The AMD "Helios" rack design integrates UALoE scale-up connectivity and Ethernet-based Ultra Ethernet Consortium (UEC)-aligned scale-out networking to minimize latency and maximize throughput across pods and racks.
Powerful head node: Helps customers maximize cluster utilization and streamline large-scale workflows by accelerating job orchestration and data processing on an architecture consisting of next-generation AMD EPYC CPUs, code named "Venice." In addition, these EPYC CPUs will offer confidential computing capabilities and built-in security features to help safeguard sensitive AI workloads end to end.
DPU-accelerated converged networking: Powers line-rate data ingestion to improve performance and enhance security posture for large-scale AI and cloud infrastructure. Built on the fully programmable AMD Pensando DPU technology, the DPU-accelerated converged networking offers the security and performance required for data centers to run the next era of AI training, inferencing, and cloud workloads.
Scale -out networking for AI: Enables customers to leverage ultra-fast distributed training and optimized collective communication with a future-ready open networking fabric. Each GPU can be equipped with up to three 800 Gbps AMD Pensando "Vulcano" AI-NICs, providing customers with lossless, high-speed, and programmable connectivity that supports advanced RoCE and UEC standards.
Innovative UALink and UALoE fabric: Helps customers efficiently expand workloads, reduce memory bottlenecks, and orchestrate large multi-trillion-parameter models. The scalable architecture minimizes hops and latency without routing through CPUs and enables direct, hardware-coherent networking and memory sharing among GPUs within a rack via UALink protocol transported over a UALoE fabric. UALink is an open, high-speed interconnect standard purpose built for AI accelerators and supported by a broad industry ecosystem. As a result, customers gain the flexibility, scalability, and reliability needed to run their most demanding AI workloads on open standards-based infrastructure.
Open-source AMD ROCm™ software stack: Enables rapid innovation, offers freedom of vendor choice, and simplifies the migration of existing AI and HPC workloads by providing customers with an open, flexible programming environment, including popular frameworks, libraries, compilers, and runtimes.
Advanced partitioning and virtualization: Enables customers to safely share clusters and allocate GPUs based on workload needs by facilitating the secure and efficient use of resources via fine-grained GPU and pod partitioning, SR-IOV virtualization, and robust multi-tenancy.

To give customers that build, train, and inference AI at scale more choice, OCI also announced the general availability of OCI Compute with AMD Instinct MI355X GPUs. These will be available in the zettascale OCI Supercluster that can scale to 131,072 GPUs. AMD Instinct MI355X-powered shapes are designed with superior value, cloud flexibility, and open-source compatibility. Learn more here and here.

Additional Resources

Learn more about Oracle Cloud Infrastructure
Learn more about OCI Compute 

About Oracle
Oracle offers integrated suites of applications plus secure, autonomous infrastructure in the Oracle Cloud. For more information about Oracle (NYSE: ORCL), please visit us at www.oracle.com.

About Oracle AI World
Oracle AI World is where customers and partners discover the latest product and technology innovations, see how AI is being applied across industries, and connect with experts and peers. Attendees will gain practical tips and insights to drive immediate impact within their organizations and explore how Oracle is helping unlock the full potential of cloud and AI. Join the event to see new capabilities in action and hear from thought leaders and industry movers. Register now at oracle.com/ai-world or follow the news and conversation at oracle.com/news and linkedin.com/company/oracle.

About AMD
For more than 55 years AMD has driven innovation in high-performance computing, graphics and visualization technologies. Billions of people, leading Fortune 500 businesses and cutting-edge scientific research institutions around the world rely on AMD technology daily to improve how they live, work and play. AMD employees are focused on building leadership high-performance and adaptive products that push the boundaries of what is possible. For more information about how AMD is enabling today and inspiring tomorrow, visit the AMD (NASDAQ: AMD) website, blog, LinkedIn, Facebook and X pages.

Future Product Disclaimer
The preceding is intended to outline our general product direction. It is intended for information purposes only, and may not be incorporated into any contract. It is not a commitment to deliver any material, code, or functionality, and should not be relied upon in making purchasing decisions. The development, release, timing, and pricing of any features or functionality described for Oracle's products may change and remains at the sole discretion of Oracle Corporation.

Forward-Looking Statements Disclaimer
Statements in this press release relating to Oracle's and AMD's future plans, expectations, beliefs, and intentions are "forward-looking statements" and are subject to material risks and uncertainties. Many factors could affect Oracle's and AMD's current expectations and actual results, and could cause actual results to differ materially. A discussion of such factors and other risks that affect Oracle's and AMD's business is contained in Oracle's and AMD's Securities and Exchange Commission (SEC) filings, including Oracle's and AMD's most recent reports on Form 10-K and Form 10-Q under the heading "Risk Factors." These filings are available on the SEC's website or on Oracle's website at http://www.oracle.com/investor and AMD's website at https://ir.amd.com. All information in this article is current as of October 14, 2025 and Oracle and AMD undertakes no duty to update any statement in light of new information or future events.

Trademarks
Oracle, Java, MySQL and NetSuite are registered trademarks of Oracle Corporation. NetSuite was the first cloud company—ushering in the new era of cloud computing.

SOURCE Oracle

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+

Newsrooms &

Influencers

9k+

Digital Media

Outlets

270k+

Journalists

Opted In
2025-10-14 12:22 4mo ago
2025-10-14 08:19 4mo ago
BP guidance 'vague' as concerns around debt suggest more share buyback cuts stocknewsapi
BP
BP PLC's (LSE:BP.) updated guidance ahead of its third-quarter results was not entirely clear but debt continues to be a "large concern", said analysts, and suggests share buybacks may need to be cut back.

The new guidance, given ahead of 4 November results, suggests production will be higher than the second quarter's 2.27 million barrels of oil equivalent per day (mmboepd) but it was not said whether it would be higher than the first quarter's 2.38mmboepd.

"It will still be lower y-o-y due to declines impacting the wider portfolio," analysts at Panmure Liberum said, noting that price realisations were broadly flat, but refining margins will be stronger and that no guidance was given on refinery uptime.

With net debt set to be unchanged at $26 billion, the analysts said: "this is a large concern given BP is targeting reducing this to $18 billion by 2027.

"This remains a fanciful goal given falling output, softer commodity prices and ongoing need to sell off more valuable assets – of which there are less in the portfolio after the push into low margin renewables.

"If this is to be achieved, the scale of buybacks may need to be trimmed further."

The oil trading business was reported to be performing poorly on oil trading with gas trading average.

"Investors will not be much clearer on what to expect as the statement is vague and woolly – BP should follow Shell's lead and provide clear granular guidance – but being vague does help BP if its going to miss expectations (again)."
2025-10-14 12:22 4mo ago
2025-10-14 08:20 4mo ago
aTyr Pharma, Inc.'s (ATYR) Failed Drug Trial Spurs Securities Lawsuit -- Hagens Berman stocknewsapi
ATYR
ATYR Investors with Losses Encouraged to Contact Hagens Berman

, /PRNewswire/ -- A federal class-action lawsuit has been filed against aTyr Pharma, Inc. (NASDAQ: ATYR) following a devastating 83% drop in the biotech company's stock price after its lead drug candidate failed to meet its primary endpoint in a critical Phase 3 trial.

Prominent shareholders rights firm Hagens Berman has been investigating the alleged claims.

Blog: www.hbsslaw.com/blog

The firm urges investors in aTyr who suffered significant losses to submit your losses now. The firm also encourages persons with knowledge who may be able to assist in the investigation to contact its attorneys.

Class Period: Jan. 16, 2025 – Sep. 12, 2025
Lead Plaintiff Deadline: Dec. 8, 2025
Visit:www.hbsslaw.com/investor-fraud/atyr
Contact the Firm Now: [email protected]
844-916-0895

aTyr Pharma, Inc. (AYTR) Securities Litigation:

The suit, Munguia v. aTyr Pharma Inc., filed in the U.S. District Court for the Southern District of California, alleges that aTyr and its top executives made false and misleading statements about the efficacy of its drug, Efzofitimod, leading investors to purchase stock at artificially inflated prices.

The proposed class covers all investors who acquired aTyr common stock between January 16, 2025, and September 12, 2025, inclusive.

At the heart of the allegations is aTyr's Phase 3, randomized, double-blind, placebo-controlled study, known as EFZO-FIT, which evaluated intravenous Efzofitimod in patients with pulmonary sarcoidosis. The drug was intended to help patients reduce their dependency on steroids.

According to the complaint, throughout the Class Period, aTyr executives expressed overwhelmingly positive statements and confidence in the study's design, particularly its forced taper approach intended to gauge the drug's ability to allow patients to completely wean themselves off steroids.

However, the lawsuit claims that concurrently with these optimistic pronouncements, the company was allegedly concealing material adverse facts concerning Efzofitimod's capability to allow a patient to completely taper their steroid usage—a key measure of efficacy.  The lawsuit asserts that aTyr's statements crossed the line into securities law violations by allegedly misrepresenting the drug's true prospects.

The truth, as alleged in the complaint, came to light on Monday, September 15, 2025. Pre-market, aTyr hosted an investor call announcing that the EFZO-FIT study did not meet its primary endpoint: the change from baseline in mean daily oral corticosteroid (OSC) dose at week 48.

The disappointing topline results prompted a swift and brutal market reaction. aTyr's common stock, which had closed at $6.03 per share on the preceding Friday, September 12, cratered to close at just $1.02 per share on September 15—a catastrophic one-day decline of 83.2%.

In its post-announcement comments, the company stated that it would engage with the Food and Drug Administration (FDA) to determine a path forward, acknowledging the setback.

Hagens Berman's Investigation

Hagens Berman is investigating whether aTyr may have misled investors about its data and trial design while emphasizing Efzofitimod's multi-billion-dollar market opportunity.  "We're scrutinizing whether aTyr's previous representations about the drug's efficacy were materially misleading to investors," said Reed Kathrein, the Hagens Berman partner leading the firm's investigation.

If you invested in aTyr and have substantial losses, or have knowledge that may assist the firm's investigation, submit your losses now »

If you'd like more information and answers to frequently asked questions about the aTyr case and our investigation, read more »

Whistleblowers: Persons with non-public information regarding aTyr should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email [email protected].

About Hagens Berman
Hagens Berman is a global plaintiffs' rights complex litigation firm focusing on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings. Hagens Berman's team has secured more than $2.9 billion in this area of law. More about the firm and its successes can be found at hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw. 

SOURCE Hagens Berman Sobol Shapiro LLP

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+

Newsrooms &

Influencers

9k+

Digital Media

Outlets

270k+

Journalists

Opted In
2025-10-14 12:22 4mo ago
2025-10-14 08:20 4mo ago
Oracle Introduces Multicloud Universal Credits stocknewsapi
ORCL
First cross-cloud consumption model  will enable customers to quickly and easily buy Oracle AI Database and OCI services in the cloud of their choice

Customers will be able to streamline procurement with flexible terms and consistent contracts across AWS, Google Cloud, Microsoft Azure, and OCI

, /PRNewswire/ -- Oracle AI World -- Oracle today introduced Oracle Multicloud Universal Credits, a new licensing option that will enable customers to procure Oracle AI Database and Oracle Cloud Infrastructure (OCI) services more quickly and easily in the cloud of their choice. The new Multicloud Universal Credits will be usable across Oracle Database@AWS, Oracle Database@Azure, Oracle Database@Google Cloud, and OCI, enabling customers to streamline procurement, benefit from consistent contracts across clouds, and operate Oracle databases in their preferred region, subject to the cloud service provider's marketplace policies.

"Procurement and governance are often roadblocks for innovation," said Dave McCarthy, research vice president, IDC. "Oracle has already done the technical work to create multicloud offerings in AWS, Google Cloud, and Microsoft Azure, and now they've taken it a step further and simplified procurement, contracting, and governance to provide even more flexibility to customers. Oracle Multicloud Universal Credits could be the jet fuel that accelerates widespread adoption of Oracle's multicloud services."

Unified Cross-Cloud Experience
Oracle Multicloud Universal Credits will provide customers with unique capabilities including:

A single consumption model across clouds: Provides seamless administration and governance for procuring and operating Oracle databases across multiple clouds. In addition, customers can apply this program to procure any OCI service.
Expanded access to regions across clouds: Gives customers more options for running applications by enabling them to deploy Oracle AI Database workloads on OCI across any available AWS, Google Cloud, Microsoft Azure, or OCI region.
Workload portability and flexibility: Provides commercial freedom to run Oracle AI Database workloads across multiple clouds and facilitates a consistent database management experience.

"Oracle's industry-leading multicloud solution is designed to help customers accelerate application modernization and cloud migrations," said Karan Batta, senior vice president, Oracle Cloud Infrastructure. "With multiple regions now live across AWS, Google Cloud, and Microsoft Azure and the coming launch of Oracle Multicloud Universal Credits, we're giving customers more choices and flexibility than ever by simplifying contracts and introducing the industry's first flexible, cross-cloud consumption model."

Customers can request early access for Oracle Multicloud Universal Credits.

Additional Resources

Learn more about Oracle Multicloud Solutions
Learn more about new capabilities for Oracle Database@AWS, Oracle Database@Azure, and Oracle Database@Google Cloud

About Oracle Distributed Cloud
Oracle's distributed cloud delivers the benefits of cloud with greater control and flexibility. Oracle's distributed cloud lineup includes:

Public cloud: Hyperscale public cloud regions serve any size of organization, including those requiring strict EU sovereignty controls. See the full list of regions here.
Dedicated cloud: Customers can run all OCI cloud services in their own data centers with OCI Dedicated Region, while partners can resell OCI cloud services and customize the experience using Oracle Alloy. Oracle also operates separate U.S., UK, and Australian Government Clouds, and Isolated Cloud Regions for national security purposes. Each of these products provide a full cloud and AI stack that customers can deploy as a Sovereign Cloud.
Hybrid cloud: OCI delivers key cloud services on-premises via Oracle Exadata Cloud@Customer and Compute Cloud@Customer and is already managing deployments in over 60 countries. Additionally, OCI Roving Edge Infrastructure, which consists of multiple configurations of ruggedized and portable high-performance devices, helps customers leverage remote AI inferencing at the edge.
Multicloud: OCI is physically deployed within all the hyperscale cloud providers, including AWS, Google Cloud, and Microsoft Azure, providing low latency, natively integrated Oracle AI Database services, including Oracle Database@AWS, Oracle Database@Azure, Oracle Database@Google Cloud; and Oracle HeatWave on AWS and Microsoft Azure. Oracle Interconnect for Microsoft Azure and Oracle Interconnect for Google Cloud allows customers to combine key capabilities from across clouds.

About Oracle
Oracle offers integrated suites of applications plus secure, autonomous infrastructure in the Oracle Cloud. For more information about Oracle (NYSE: ORCL), please visit us at www.oracle.com.

About Oracle AI World
Oracle AI World is where customers and partners discover the latest product and technology innovations, see how AI is being applied across industries, and connect with experts and peers. Attendees will gain practical tips and insights to drive immediate impact within their organizations and explore how Oracle is helping unlock the full potential of cloud and AI. Join the event to see new capabilities in action and hear from thought leaders and industry movers. Register now at oracle.com/ai-world or follow the news and conversation at oracle.com/news and linkedin.com/company/oracle.

Future Product Disclaimer
The preceding is intended to outline our general product direction. It is intended for information purposes only, and may not be incorporated into any contract. It is not a commitment to deliver any material, code, or functionality, and should not be relied upon in making purchasing decisions. The development, release, timing, and pricing of any features or functionality described for Oracle's products may change and remains at the sole discretion of Oracle Corporation.

Trademarks
Oracle, Java, MySQL and NetSuite are registered trademarks of Oracle Corporation. NetSuite was the first cloud company—ushering in the new era of cloud computing.

SOURCE Oracle

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+

Newsrooms &

Influencers

9k+

Digital Media

Outlets

270k+

Journalists

Opted In
2025-10-14 12:22 4mo ago
2025-10-14 08:20 4mo ago
IMUNON to Present Phase 3 Ovarian Cancer Study of IMNN-001 at ESMO Congress stocknewsapi
IMNN
Prestigious European Society for Medical Oncology Conference “trials-in-progress” session

Pivotal OVATION 3 trial of its DNA-mediated immunotherapy in newly diagnosed patients underway

Company on track with established plans to accelerate patient recruitment

LAWRENCEVILLE, N.J., Oct. 14, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (Nasdaq: IMNN), a clinical-stage company in Phase 3 development with its DNA-mediated immunotherapy, today announced that a trials-in-progress abstract on the ongoing Phase 3 OVATION 3 clinical trial of IMNN-001, its investigational therapy for the treatment of women with newly diagnosed advanced ovarian cancer, was accepted for poster presentation at the European Society for Medical Oncology (ESMO) Congress 2025, being held October 17-21, 2025 in Berlin, Germany.

IMNN-001, based on IMUNON’s proprietary TheraPlas® technology platform, is an interleukin-12 (IL-12) DNA plasmid vector incorporated in a nanoparticle delivery system, enabling cell transfection followed by persistent, local production and secretion of the IL-12 protein in the tumor microenvironment. IL-12 is a powerful pluripotent cytokine known for inducing strong anti-cancer immunity by promoting T-lymphocyte and natural killer cell proliferation while inhibiting tumor-mediated immune suppression. IMNN-001 is the first therapy to achieve a clinically effective response in advanced (stage IIIC/IV) ovarian cancer including benefits in both progression-free survival and overall survival in a first-line treatment setting when used with standard of care chemotherapy.

In July 2025, the Company announced treatment of the first patient in the pivotal Phase 3 OVATION 3 Study and is working with trial investigators to expand clinical sites and accelerate enrollment. Four sites have been activated to date and are open for patient enrollment, with up to 46 additional sites being considered for activation.

Details of the ESMO virtual poster presentation are as follows:

Abstract Title: OVATION-3: A randomized phase III trial evaluating the safety and efficacy of intraperitoneal IL-12 gene therapy administered in combination with standard neoadjuvant and adjuvant chemotherapy (N/ACT) in newly-diagnosed patients with advanced epithelial ovarian cancer (EOC)

Presenting Author: Premal H. Thaker, M.D., Chief of Gynecologic Oncology, David & Lynn Mutch Distinguished Professor of Obstetrics & Gynecology, Director of Gynecologic Oncology Clinical Research at Washington University School of Medicine, Study Chair of OVATION 2 and Phase 3 OVATION 3 trials

Poster Number: 1234eTiP

Following the conference, the poster presentation will be available on the “Scientific Presentations” page of the IMUNON website at https://investors.imunon.com/scientific-presentations.

About the OVATION 3 Study

OVATION 3 is IMUNON’s pivotal Phase 3 study of IMMN-001, an IL-12 gene-mediated immunotherapy, in women with advanced stage epithelial ovarian cancer. The study is supported with unprecedented overall survival (OS) data from a large, 112-patient, randomized Phase 2 OVATION 2 study showing the following:

Median 13-month increase in OS (HR 0.70) and median 3-month increase in PFS (HR 0.79) in IMNN-001 treatment arm compared to standard of care alone.Better therapeutic effect observed with IMNN-001 treatment compared to the control arm (p=0.0375), as shown by mean 6.5-month extension of time free of progression or death (PFS + OS) captured in totality of treatment effect.Use of poly ADP-ribose polymerase (PARP) inhibitors as part of maintenance therapy further enhanced outcomes, with median OS not yet reached in the IMNN-001 treatment arm as patients surpass 5 years since randomization in the trial compared to median OS of 37 months on standard of care (HR 0.42). The results from the OVATION 2 Study have resulted in invitations to present data from the Phase 2 Study at both the ASCO and ESMO annual meetings and in the peer-reviewed journal Gynecologic Oncology.

The OVATION-3 trial is a robustly designed clinical study with at least 95% statistical power on the primary endpoint of overall survival. The trial design includes two planned interim analyses of the primary endpoint, designed to allow for an accelerated timeline for FDA submission of an IMNN-001 BLA if the primary endpoint reaches statistical significance. OVATION 3 is currently enrolling patients at four clinical sites with up to 46 additional sites being considered for activation.

About the Phase 2 OVATION 2 Study

OVATION 2 evaluated the dosing, safety, efficacy and biological activity of intraperitoneal administration of IMNN-001 in combination with neoadjuvant and adjuvant chemotherapy (N/ACT) of paclitaxel and carboplatin in patients newly diagnosed with advanced epithelial ovarian, fallopian tube or primary peritoneal cancer. Treatment in the neoadjuvant period is designed to shrink the tumors as much as possible for optimal surgical removal after three cycles of chemotherapy. Following N/ACT, patients undergo interval debulking surgery, followed by three additional cycles of adjuvant chemotherapy to treat any residual tumor. This open-label study enrolled 112 patients who were randomized 1:1 and evaluated for safety and efficacy to compare N/ACT plus IMNN-001 versus standard-of-care N/ACT. In accordance with the study protocol, patients randomized to the IMNN-001 treatment arm could receive up to 17 weekly doses of 100 mg/m2 in addition to N/ACT. As a Phase 2 study, OVATION 2 was not powered for statistical significance. Additional endpoints included objective response rate, chemotherapy response score and surgical response score.

About IMNN-001 Immunotherapy

Designed using IMUNON's proprietary TheraPlas® platform technology, IMNN-001 is an IL-12 DNA plasmid vector encased in a nanoparticle delivery system that enables cell transfection followed by persistent, local secretion of the IL-12 protein. IL-12 is one of the most active cytokines for the induction of potent anticancer immunity acting through the induction of T-lymphocyte and natural killer cell proliferation. IMUNON previously reported positive safety and encouraging Phase 1 results with IMNN-001 administered as monotherapy or as combination therapy in patients with advanced peritoneally metastasized primary or recurrent ovarian cancer and completed a Phase 1b dose-escalation trial (the OVATION 1 Study) of IMNN-001 in combination with carboplatin and paclitaxel neoadjuvantly in patients with newly diagnosed ovarian cancer. IMUNON previously reported positive results from the recently completed Phase 2 OVATION 2 Study, which assessed IMNN-001 (100 mg/m2 administered intraperitoneally weekly) plus neoadjuvant and adjuvant chemotherapy (N/ACT) of paclitaxel and carboplatin compared to standard-of-care N/ACT alone in 112 patients with newly diagnosed advanced ovarian cancer.

About Epithelial Ovarian Cancer

Epithelial ovarian cancer is the sixth deadliest malignancy among women in the U.S. There are approximately 20,000 new cases of ovarian cancer every year and approximately 70% are diagnosed in advanced stage III/IV. Epithelial ovarian cancer is characterized by dissemination of tumors in the peritoneal cavity with a high risk of recurrence (75%, stage III/IV) after surgery and chemotherapy. Since the five-year survival rates of patients with stage III/IV disease at diagnosis are poor (41% and 20%, respectively), there remains a need for a therapy that not only reduces the recurrence rate but also improves overall survival. The peritoneal cavity of advanced ovarian cancer patients contains the primary tumor environment and is an attractive target for a regional approach to immune modulation.

About IMUNON

IMUNON is a clinical-stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the body’s natural mechanisms to generate safe, effective and durable responses across a broad array of human diseases, constituting a differentiating approach from conventional therapies. IMUNON is developing its non-viral DNA technology across its modalities. The first modality, TheraPlas®, is developed for the gene-based delivery of cytokines and other therapeutic proteins in the treatment of solid tumors where an immunological approach is deemed promising. The second modality, PlaCCine®, is developed for the gene delivery of viral antigens that can elicit a strong immunological response.

The Company’s lead clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer that has completed multiple clinical trials including one Phase 2 clinical trial (OVATION 2) and is currently conducting a Phase 3 clinical trial (OVATION 3). IMNN-001 works by instructing the body to produce safe and durable levels of powerful cancer-fighting molecules, such as interleukin-12 and interferon gamma, at the tumor site. Additionally, the Company has completed dosing in a first-in-human study of its COVID-19 booster vaccine (IMNN-101). The Company will continue to leverage these modalities and to advance, either directly or through partnership, the technological frontier of plasmid DNA to better serve patients with difficult-to-treat conditions. For more information, please visit www.imunon.com.

Forward-Looking Statements

IMUNON wishes to inform readers that forward-looking statements in this news release are made pursuant to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact, including, but not limited to, statements regarding the timing of enrollment of the Company’s clinical trials, the potential of any therapies developed by the Company to fulfill unmet medical needs, the market potential for the Company’s products, if approved, the potential efficacy and safety profile of our product candidates, and the Company’s plans and expectations with respect to its development programs more generally, are forward-looking statements. We generally identify forward-looking statements by using words such as “may,” “will,” “expect,” “plan,” “anticipate,” “estimate,” “intend” and similar expressions (as well as other words or expressions referencing future events, conditions or circumstances). Readers are cautioned that such forward-looking statements involve risks and uncertainties including, without limitation, uncertainties relating to unforeseen changes in the course of research and development activities and in clinical trials, including the fact that interim results are not necessarily indicative of final results; the uncertainties of and difficulties in analyzing interim clinical data; the significant expense, time and risk of failure in conducting clinical trials; the need for IMUNON to evaluate its future development plans; possible actions by customers, suppliers, competitors or regulatory authorities; and other risks detailed from time to time in IMUNON’s filings with the Securities and Exchange Commission. IMUNON assumes no obligation, except to the extent required by law, to update or supplement forward-looking statements that become untrue because of subsequent events, new information or otherwise.

Contacts:  Media Investors Jenna UrbanPeter VozzoCG lifeICR [email protected]@icrhealthcare.com
2025-10-14 12:22 4mo ago
2025-10-14 08:21 4mo ago
Fastenal Stock Pulls Back in October—Is It Time to Buy FAST? stocknewsapi
FAST
Fastenal Today

$42.33 -3.45 (-7.54%)

As of 10/13/2025 04:00 PM Eastern

52-Week Range$35.31▼

$50.63Dividend Yield2.08%

P/E Ratio40.70

Price Target$47.05

Fastenal Company NASDAQ: FAST stock is pulling back in October, and the Q3 results aren’t helping with support. However, the problem isn’t with growth, profitability, or capital returns so much as valuation and analysts' sentiment, which are likely to be passing issues.

With shares trading at 42x this year’s earnings and recent results falling short of consensus, there’s little immediate incentive for the market to buy in mid-October. However, that dynamic is likely to shift as catalysts play out and sentiment improves over time.

Not only is this company growing in the face of macroeconomic headwinds, but it is also widening its margin, set up to improve its valuation and sustain its stock price uptrend over the long term. 

Fastenal’s High-Valuation Isn’t Undeserved
Fastenal’s Q3 results failed to impress the market but still highlight the quality of its operations. The company grew revenue by 11.5%, which is in line with MarketBeat’s consensus analyst estimate and is driven by an increase in client count and location penetration.

The company reported increased unit sales, with strength across client sizes, particularly in larger businesses. Segmentally, the core fastener segment was strongest, gaining 14.4%, while Safety and Other grew by 9.8% and 10.7%, respectively.

Breaking it down by end-market, manufacturing was strongest, up 12.7%, followed by 7.5% and 8.9% increases in non-residential construction and Other, with no reason to expect weaknesses to emerge in Q4.

The margin news is also bullish. The company experienced margin pressures, but price increases, product mix, sales leverage, and operational improvement offset them, leaving the gross and operating margins up by 40 basis points each.

The net result is that operating and net income grew at leveraged rates, with net up 12.6% and GAAP EPS up 12.3%. A higher share count impacted GAAP EPS. Fastenal has an existing repurchase authorization but did not buy shares in Q3. 

Fastenal’s cash flow and balance sheet also reflect its high-quality operations. Balance sheet highlights at the end of Q3 include increased cash, receivables, and inventory, as well as current and total assets sufficient to offset liabilities and improve shareholder equity.

The quarterly cash flow was positive, long-term debt declined, and leverage remains ultra-low. The company’s total liabilities are less than 0.35x its equity, leaving it in a fortress-like condition capable of sustaining its growth while paying dividends. 

Fastenal Is Growing Its Dividend Quickly
Fastenal Dividend PaymentsDividend Yield2.08%

Annual Dividend$0.88

Dividend Increase Track Record26 Years

Dividend Payout Ratio84.62%

Next Dividend PaymentNov. 25

FAST Dividend History

Fastenal’s dividend is attractive for numerous reasons, including its yield, safety, and distribution growth. The stock yields approximately 2.0% after its October price plunge and has been increasing its annual distribution at a double-digit CAGR for years.

The payout ratio is on the high side at nearly 80%, but this isn’t a red flag given the earnings growth outlook and balance sheet health. The company has virtually no long-term debt, leaving its cash flow unimpeded and available for distribution.

While the dividend growth CAGR may slow in the coming years, it is unlikely that Fastenal will stop increasing its dividend and give up its recently acquired Dividend Aristocrat status. 

Analysts and institutional trends suggest that these groups will buy Fastenal stock on the dip. The analyst trends include increased coverage, a solid support base with 15 tracked by MarketBeat, and a rising price target. Institutional trends are likely bullish, with them owning about 80% and buying on balance in 2025.

The caveat is that the Q3 release may not inspire bullish revisions to analysts' forecasts, including the stock price target, which may cap the market until better news emerges. That could begin as soon as the upcoming quarter, when FOMC interest rate cuts are expected to start impacting industrial activity globally. 

Should You Invest $1,000 in Fastenal Right Now?Before you consider Fastenal, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Fastenal wasn't on the list.

While Fastenal currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
2025-10-14 11:21 4mo ago
2025-10-14 07:01 4mo ago
St-Georges annonce des progres importants dans son usine pilote de lithium et ses initiatives metallurgiques stocknewsapi
SXOOF
  

Montréal – TheNewswire - le 14 octobre 2025 – La Corporation Éco-Minière St-Georges (CSE: SX) (OTCQB: SXOOF) (FSE: 85G1) et sa filiale en propriété exclusive, Métallurgie St-Georges, annoncent une mise à jour concernant leur usine pilote de production de lithium ainsi que d’autres initiatives métallurgiques.

Au cours des derniers mois, la Corporation et ses partenaires ont soigneusement évalué plusieurs fournisseurs potentiels de spodumène à travers le Canada. Plusieurs candidats ont manifesté leur intérêt à fournir du concentré. Le consortium de partenaires — Coalia, LiOH Corp. et Métallurgie St-Georges (SXM) — a maintenant reçu un premier envoi d’environ cinq tonnes de concentré de spodumène d’origine canadienne. Les travaux initiaux et les essais sont en cours, et le matériel reçu a déjà été traité à l’étape de transformation alpha-bêta. Des mises à jour régulières sur les résultats du programme seront communiquées lorsqu’elles seront disponibles.

« (…) La technologie au lithium de SX apportera des avancées majeures à la métallurgie du lithium grâce à plusieurs améliorations clés par rapport aux procédés traditionnels. Elle permet d’obtenir une grande pureté et un taux de récupération élevé du lithium, tout en réduisant la quantité de résidus générés, la consommation d’eau, d’acide et de réactifs, et en produisant des sous-produits de valeur tels que l’alumine et des engrais à base d’azote. Ensemble, ces améliorations procurent un fort potentiel économique, permettant au procédé de fonctionner à des coûts inférieurs aux alternatives chinoises. Le projet pilote en cours fournira les données nécessaires à la réalisation d’une étude de faisabilité qui sera lancée d’ici mars 2027, laquelle inclura une analyse détaillée des coûts d’investissement (CAPEX) et d’exploitation (OPEX) afin de confirmer la position de cette technologie comme l’une des solutions les plus durables et économiques de l’industrie (…) », a commenté Mathieu Boudreau, chef de projet chez Coalia.

Autres initiatives métallurgiques

SXM continue de faire progresser deux projets axés sur le nickel, soutenus par des demandes de subvention soumises en collaboration avec plusieurs partenaires, dont un fournisseur de procédés métallurgiques de premier rang. Parmi les principaux contributeurs à ces initiatives figurent Coalia et l’entreprise montréalaise IGS.

Parallèlement, des préparatifs sont en cours pour l’extraction complète de minéraux de valeur grâce au traitement métallurgique d’échantillons en vrac préalablement recueillis sur les projets de minéraux critiques Julie et Manicouagan. Ces travaux devraient débuter avant la fin de l’année.

De plus, par l’entremise de sa filiale en propriété exclusive Iceland Resources ehf, la Corporation collabore avec un producteur d’énergie géothermique en Islande. Les premiers essais sur le matériel fourni ont révélé des teneurs variant d’environ ~67 g/t Au-équivalent. à ~437 g/t Au-équivalent., soit plus de 14 onces d’or équivalent par tonne. Plus de 200 kilogrammes de ce matériel ont été importés avec succès au Canada pour des tests d’extraction et de séparation, lesquels alimenteront les initiatives en cours visant à établir une opération régulière.

Pour plus d’informations sur les résultats précédents, veuillez consulter le communiqué suivant :

https://webfiles.thecse.com/SX_Communique_-_24_avril_2023_-_St-Georges_recoit_dimpressionants_resultats_preleves_in_situ_dans_une_installation_geothermique_en_Islande.pdf?q1qdc3OHZoSMmiaNm6vVzqo.K2ajuBwT

Prolongation de la validité de bons de souscription

La Corporation annonce également la prolongation de la durée de certains bons de souscription, dont les dates d’expiration initiales étaient prévues en novembre et décembre 2025 :

Bons émis le 1er novembre 2022 (2 850 000) :

Modalités initiales: Prix d’exercice de 0,29 $ pour une période de 36 mois suivant la date de clôture. 

Nouvelles modalités: Prix d’exercice de 0,29 $ pour une période de 60 mois suivant la date de clôture. Nouvelle date d’expiration : 1er novembre 2027. 

Bons émis le 18 novembre 2022 (3 600 000) :

Modalités initiales: Prix d’exercice de 0,29 $ pour une période de 36 mois suivant la date de clôture. 

Nouvelles modalités: Prix d’exercice de 0,29 $ pour une période de 60 mois suivant la date de clôture. Nouvelle date d’expiration : 18 novembre 2027. 

Bons émis le 30 décembre 2022 (5 000 000) :

Modalités initiales: Prix d’exercice de 0,50 $ pour une période de 36 mois suivant la date de clôture. 

Nouvelles modalités: Prix d’exercice de 0,50 $ pour une période de 60 mois suivant la date de clôture. Nouvelle date d’expiration : 30 décembre 2027. 

Bons émis le 23 novembre 2023 (14 259 260) :

Modalités initiales: Prix d’exercice de 0,175 $ pour une période de 24 mois suivant la date de clôture. 

Nouvelles modalités: Prix d’exercice de 0,175 $ pour une période de 60 mois suivant la date de clôture. Nouvelle date d’expiration : 23 novembre 2028. 

Bons émis le 20 décembre 2023 (7 703 700) :

Modalités initiales: Prix d’exercice de 0,175 $ pour une période de 24 mois suivant la date de clôture. 

Nouvelles modalités: Prix d’exercice de 0,175 $ pour une période de 60 mois suivant la date de clôture. Nouvelle date d’expiration : 20 décembre 2028. 

AU NOM DU CONSEIL D'ADMINISTRATION

Neha Edah Tally

Secrétaire corporative

À propos du partenariat de l’usine pilote de lithium

L’usine pilote de lithium est conçue pour produire du nitrate de lithium et potentiellement de l’hydroxyde de lithium, ainsi que divers sous-produits générés par la technologie de traitement exclusive de St-Georges. L’installation est exploitée dans les locaux de Coalia, un centre de recherche de premier plan basé au Québec.

En vertu de l’entente actuelle, LiOH Corp., en contribuant financièrement à l’initiative, détient en contrepartie un droit d’exclusivité limité de cinq ans sur la technologie, lui permettant de collaborer aux essais et de partager l’ensemble des données générées durant les opérations pilotes.

Toute la propriété intellectuelle et les données résultantes demeurent la propriété de Métallurgie St-Georges (SXM) et peuvent être utilisées par la Corporation et ses filiales pour construire leurs propres installations commerciales. Toutefois, aucune autre licence ne sera accordée à des tiers tant que la phase pilote sera active.

Une étude de faisabilité, s’appuyant sur les résultats du projet pilote, devrait être amorcée avant le 31 mars 2027. À son achèvement, LiOH Corp. aura la possibilité de prolonger son exclusivité limitée pour une période supplémentaire de cinq ans si elle entreprend la construction d’une usine commerciale. Les résultats de cette étude permettront à SXM de concevoir et de construire une installation à l’échelle commerciale, après quoi de nouvelles licences technologiques pourront être envisagées pour d’autres partenaires.

À propos de LiOH Corp.

LiOH Corp. est une société canadienne axée sur le développement et la commercialisation de technologies avancées de raffinage du lithium.

Sa mission est de renforcer la chaîne d’approvisionnement canadienne en lithium par l’innovation et des partenariats stratégiques avec des institutions de recherche et des développeurs miniers de premier plan.

En collaborant avec SXM et Coalia, LiOH vise à accélérer le déploiement de procédés de conversion du lithium durables et à haut rendement, soutenant la croissance des marchés émergents des véhicules électriques et du stockage d’énergie.

À propos de Iceland Resources ehf

Iceland Resources est une filiale en propriété exclusive de St-Georges Eco-Mining Corp.

Axée sur l’or, l’argent et les métaux énergétiques, la société détient la licence du projet Thormodsdalur, situé près de la capitale islandaise Reykjavik, et a conclu des ententes avec les propriétaires du projet aurifère Elbow Creek. Plusieurs autres licences sont actuellement en phase de demande.

Iceland Resources possède également une vaste base de données regroupant des échantillonnages géochimiques, des cartographies géologiques et des programmes détaillés de forage. Ces travaux historiques offrent un potentiel considérable pour une exploitation minière écologique, avec des perspectives additionnelles dans les opérations géothermiques pour la production in situ, le traitement des résidus et les effluents hydrothermaux.

À propos de la Corporation Éco-Minière St-Georges

St-Georges développe de nouvelles technologies et détient un portefeuille diversifié d'actifs et de propriété intellectuelle en instance de brevet au sein de plusieurs filiales très prometteuses, notamment : EVSX, une initiative de premier plan en Amérique du Nord dans le traitement avancés des batteries usagées ; Métallurgie St-Georges, avec de la recherche et développement métallurgique et la propriété intellectuelle connexe, y compris le traitement et la récupération de lithium à haute teneur à partir du spodumène ; Iceland Resources, avec des projets d'exploration à haute teneur en or et en argent, y compris l'actif aurifère phare Thor ; H2SX, qui développe une technologie pour convertir le méthane en carbone solide et en hydrogène turquoise ; et des projets d'exploration au Québec, notamment les projets de minéraux critiques Manicouagan et Julie sur la Côte-Nord du Québec et le projet de niobium Notre-Dame au Lac St-Jean.

Consultez le site Web de la corporation : https://stgeorgesecomining.com/fr/  

Pour toute information supplémentaire ou questions : [email protected]  

La Bourse des valeurs canadiennes (CSE) n'a pas examiné ce communiqué et n'accepte aucune responsabilité quant à la pertinence ou à l'exactitude de son contenu.

  
2025-10-14 11:21 4mo ago
2025-10-14 07:01 4mo ago
Iridium and Qualcomm Join Forces to Enable Satellite Connectivity in Snapdragon Mission Tactical Radio stocknewsapi
IRDM
Multiple Iridium data services integrated into the powerful Snapdragon platform for U.S. government and allied users

, /PRNewswire/ -- Iridium Communications Inc. (NASDAQ: IRDM), a leading provider of global voice, data, and PNT satellite services, and Qualcomm Technologies, Inc. (QTI) today announced that they have successfully integrated Iridium® data services into the Snapdragon® Mission Tactical Radio (MTR) and intend to make these services available for adoption and use by U.S. government customers and approved allied partners.

Iridium Satellite Network

By integrating Iridium data services, Snapdragon MTR-equipped devices, ranging from handheld and mounted radios to autonomous vehicles, stand to benefit from flexible, highly reliable, and secure L-band satellite communications in environments where terrestrial networks are congested, compromised, or unavailable.

To meet diverse mission needs, the Snapdragon MTR can integrate multiple Iridium services into a single chipset: Short Burst Data® (SBD®), for proven low-latency messaging and telemetry, and Iridium Burst®, for receipt of simultaneous broadcasts to an unlimited number of enabled devices. The Iridium waveform, coupled with QTI's leadership in commercial wireless capabilities such as cellular, Wi-Fi, Bluetooth, and GNSS, will enable powerful global connectivity in devices with strict size, weight, power, and cost (SWaP-C) requirements.

Iridium Executive Vice President of Government Programs Scott Scheimreif said, "The Snapdragon MTR positions Iridium and QTI at the forefront of next-generation communications architectures while equipping warfighters and coalition partners with scalable solutions."

QTI-powered devices with integrated Iridium data services, which will be eligible for activation through the Enhanced Mobile Satellite Services (EMSS) program, are expected to be available following finalization of commercial arrangements among QTI, Iridium and original equipment manufacturers (OEMs). Iridium EMSS connectivity provides trusted and protected access to satellite communications for an unlimited number of approved government users. This latest innovation marks another advancement in Iridium's commitment to the EMSS program, a longstanding partnership that delivers truly global standard and secure voice, broadcast, push-to-talk (PTT), and other services to approved government subscribers anywhere on Earth.

Iridium and QTI are working to make Iridium data services available via the Snapdragon® X75 5G Modem-RF System in the form of an M.2 modem module for government partners who wish to create unique satellite connectivity solutions.

Iridium and QTI are highlighting Snapdragon MTR capabilities at the Association of the U.S. Army's (AUSA) annual convention October 13-15, 2025, in Washington, D.C., with demonstrations planned alongside industry partners.

For more information about the Iridium EMSS program, visit www.iridium.com/enhanced-mobile-satellite-services.

About Iridium Communications Inc.

Iridium® is the only mobile voice and data satellite communications network that spans the entire globe. Iridium enables connections between people, organizations, and assets to and from anywhere, in real time. Together with its ecosystem of partner companies, Iridium delivers an innovative and rich portfolio of reliable solutions for markets that require truly global communications. In 2024, Iridium acquired Satelles and its positioning, navigation, and timing (PNT) service. Iridium Communications Inc. is headquartered in McLean, Va., U.S.A., and its common stock trades on the Nasdaq Global Select Market under the ticker symbol IRDM. For more information about Iridium products, services, and partner solutions, visit www.iridium.com.

Snapdragon is a product of Qualcomm Technologies, Inc. and/or its subsidiaries. Snapdragon is a trademark or registered trademark of Qualcomm Incorporated.

Press Contact: 

Investor Contact:

Jordan Hassin

Kenneth Levy

Iridium Communications Inc. 

Iridium Communications Inc.

[email protected]

[email protected]

+1 (703) 287-7421

+1 (703) 287-7570

SOURCE Iridium Communications Inc.

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+

Newsrooms &

Influencers

9k+

Digital Media

Outlets

270k+

Journalists

Opted In
2025-10-14 11:21 4mo ago
2025-10-14 07:01 4mo ago
Exclusive: Broadcom to launch new networking chip, as battle with Nvidia intensifies stocknewsapi
AVGO NVDA
A smartphone with a displayed Broadcom logo is placed on a computer motherboard in this illustration taken March 6, 2023. REUTERS/Dado Ruvic/Illustration Purchase Licensing Rights, opens new tab

SummaryCompaniesThor Ultra networking chip aims to scale up AI networksChip launch to represent hardening of AI battle with NvidiaBroadcom sees its AI market as a $60 billion to $90 billion opportunity in 2027SAN FRANCISCO, Oct 14 (Reuters) - Broadcom

(AVGO.O), opens new tab is launching a new networking chip on Tuesday that will help companies build artificial intelligence computing systems by stringing together hundreds of thousands of chips that crunch data, deepening its rivalry with Nvidia

(NVDA.O), opens new tab.

The chip, called the Thor Ultra, enables computing infrastructure operators to deploy far more chips than they otherwise could, allowing them to build and run the large models used to power AI apps such as ChatGPT.

Sign up here.

The Thor Ultra will battle Nvidia's networking interface chips and aim to further entrench Broadcom's control of network communications inside data centers designed for AI applications.

It comes after Broadcom on Monday unveiled a deal to roll out 10 gigawatts worth of custom chips for ChatGPT maker OpenAI beginning in the second half of 2026, challenging Nvidia's grip on the AI accelerator market.

AI represents a big opportunity for Broadcom. Chief executive Hock Tan said late last year the market the company is going after for its various AI chips is in the range of $60 billion to $90 billion in 2027, divided between its networking chips and the data center processors it helps Alphabet's

(GOOGL.O), opens new tab Google and OpenAI make.

Broadcom reported AI revenue of $12.2 billion in fiscal 2024. In September, it announced a new, unnamed $10 billion customer for its custom data center AI chips.

The Thor Ultra chip, part of Broadcom's growing catalog of networking chips, operates as a critical link between an AI system and the rest of the data center. The networking chips help data center operators move information around inside a facility.

"In the distributed computing system, network plays an extremely important role in building these large clusters," Ram Velaga, a Broadcom senior vice president, told Reuters. "So I'm not surprised that anybody who's in the GPU business wants to make sure that they are participating in the networking."

FOCUSING ON CHIP DESIGNWhile networking chips are crucial to the company's plans, the AI chips Broadcom helps design for large cloud computing companies such as Google are lucrative.

Broadcom has worked on multiple generations of Google's Tensor processor, which Google began designing more than a decade ago. The Tensor chips have generated billions of dollars in revenue for Broadcom, according to analyst estimates.

During a tour in September of Broadcom's San Jose network chip-testing labs where engineers work on current and forthcoming designs of its networking chips, company executives detailed measures taken to construct and test new networking processors.

Towards that end, Broadcom's engineers doubled the bandwidth on Thor Ultra compared with the prior version. They put the chips through rigorous testing and evaluation from the earliest stages of production.

To make a chip like the Thor Ultra or flagship series of Tomahawk networking switches, the engineers build an entire system around the chip. With the hardware system team, the engineers will discuss what kind of package the chip uses, how much power it will need and how much heat it will emit, Velaga said.

Broadcom does not sell servers itself but offers the designs for components and systems it creates for testing to its customers in order to give them a reference point to construct the networking infrastructure around it.

"For every dollar we invest in our silicon, there is at least $6 to $10 that our ecosystem partners are investing," Velaga said. "So a lot of our focus is on design, as if we are almost ready to take it to production."

Reporting by Max A. Cherney in San Francisco; Editing by Muralikumar Anantharaman

Our Standards: The Thomson Reuters Trust Principles., opens new tab

Max A. Cherney is a correspondent for Reuters based in San Francisco, where he reports on the semiconductor industry and artificial intelligence. He joined Reuters in 2023 and has previously worked for Barron’s magazine and its sister publication, MarketWatch. Cherney graduated from Trent University with a degree in history.
2025-10-14 11:21 4mo ago
2025-10-14 07:05 4mo ago
NeoGenomics to Highlight RaDaR ST MRD Assay at ESMO Congress 2025 stocknewsapi
NEO
FORT MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced the presentation of assay-relevant data, including interventional therapy trials in progress, to showcase how its molecular residual disease (MRD) assay may benefit pharmaceutical partners at the European Society for Medical Oncology (ESMO) Congress 2025, October 17–21, in Berlin, Germany. RaDaR ST, the company’s circulating tumor DNA (ctDNA) assay, is designed to accelerate and optimize oncology drug development.

Building on NeoGenomics’ established molecular capabilities, the RaDaR ST assay uses whole-exome sequencing data from tumor samples and advanced bioinformatics to create patient-specific MRD panels. By leveraging high-depth sequencing and personalized panel design, the assay delivers highly sensitive and specific detection of ctDNA from plasma samples, providing real-time insights into tumor dynamics and treatment response.

“We stand by our commitment to clinical validation and interventional studies utilizing NeoGenomics’ MRD technology, as reflected in three new posters from our European collaborators presented at this year’s ESMO congress,” said Tony Zook, Chief Executive Officer. “We are excited to continue our long-standing support of drug development and interventional clinical trials, now with our RaDaR ST assay. Pharmaceutical sponsors are seeking partners who can deliver both innovation and operational excellence across every stage of oncology trials. NeoGenomics meets that need with RaDaR ST, providing patient-specific insights in real time to help drive faster, more informed decisions and advance cancer research more effectively.”

As MRD gains traction as a preferred solution to monitor responses to next-generation therapies, NeoGenomics’ launch of RaDaR ST strengthens its position as a partner to biopharma organizations seeking to advance precision oncology. The company will feature RaDaR ST and its broader oncology testing and research capabilities at booth #4012.

About NeoGenomics

NeoGenomics, Inc. is a premier cancer diagnostics company specializing in cancer genetics testing and information services. We offer one of the most comprehensive oncology-focused testing menus across the cancer continuum, serving oncologists, pathologists, hospital systems, academic centers, and pharmaceutical firms with innovative diagnostic and predictive testing to help them diagnose and treat cancer. Headquartered in Fort Myers, FL, NeoGenomics operates a network of CAP-accredited and CLIA-certified laboratories for full-service sample processing and analysis services throughout the US and a CAP-accredited full-service sample-processing laboratory in Cambridge, United Kingdom.

Forward Looking Statements

This press release includes forward-looking statements. These forward-looking statements generally can be identified by the use of words such as “anticipate,” “expect,” “plan,” “can,” “could,” “would,” “may,” “will,” “believe,” “estimate,” “forecast,” “goal,” “project,” “guidance,” “potential” and other words of similar meaning, although not all forward-looking statements include these words. Each forward-looking statement contained in this press release is subject to a number of risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Applicable risks and uncertainties include, among others, the risks identified under the heading "Risk Factors" contained in the Company's Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and the Company's other filings with the Securities and Exchange Commission.

We caution investors not to place undue reliance on the forward-looking statements contained in this press release. You are encouraged to read our filings with the SEC, available at www.sec.gov and in the “Investors” section of our website at ir.neogenomics.com, for a discussion of these and other risks and uncertainties. The forward-looking statements in this press release speak only as of the date of this document (unless another date is indicated), and we undertake no obligation to update or revise any of these statements. Our business is subject to substantial risks and uncertainties, including those referenced above. Investors, potential investors, and others should give careful consideration to these risks and uncertainties.

More News From NeoGenomics, Inc.
2025-10-14 11:21 4mo ago
2025-10-14 07:05 4mo ago
PepsiCo: Delivers On Earnings, But The Real Upside Is In The Execution stocknewsapi
PEP
PepsiCo remains a long-term favorite, but current headwinds and macro uncertainty justify maintaining a Hold rating for now. PepsiCo's recent earnings beat estimates, yet declining gross and operating profits signal ongoing challenges in its turnaround strategy. Strategic moves—like acquiring Walmart's CFO, increasing its Celsius stake, and cost-saving initiatives—position PepsiCo for future growth.
2025-10-14 11:21 4mo ago
2025-10-14 07:05 4mo ago
GM Stock Falls After $1.6 Billion EV Write-down. How Trump Policies Are Biting. stocknewsapi
GM
As electric vehicle adoption slows in the U.S., GM announced a $1.6 billion write down related to its EV investments.
2025-10-14 11:21 4mo ago
2025-10-14 07:05 4mo ago
OKLO Stock To $75? stocknewsapi
OKLO
CHONGQING, CHINA - AUGUST 08: In this photo illustration, a smartphone displays the logo of Oklo Inc. (NYSE: OKLO), a nuclear energy company developing advanced fission power plants, in front of a screen showing the company's latest stock market chart on August 8, 2025 in Chongqing, China. (Photo illustration by Cheng Xin/Getty Images)

Getty Images

Oklo Inc. (NYSE: OKLO), the advanced nuclear technology firm developing small modular reactors (SMRs), has emerged as one of the most remarkable stock market narratives of 2025. Shares are currently trading at approximately $168, having increased more than seven times year-to-date, as investors speculate on nuclear's capability to power AI data centers, industrial sites, and the overall transition to clean energy.

However, following such an incredible surge, the pivotal question has evolved: is Oklo valued for perfection — or for potential disappointment? Additionally, see: Oklo Stock To Increase 50% More?

For those looking for an upside with reduced volatility compared to holding an individual stock, consider the High Quality Portfolio. It has significantly outperformed its benchmark, which includes a mix of the S&P 500, Russell, and S&P MidCap indexes, achieving returns that have exceeded 105% since its inception. Collectively, HQ Portfolio stocks have demonstrated better returns with lower risk compared to the benchmark index; delivering a smoother ride, as illustrated in HQ Portfolio performance metrics. Furthermore, see Can PayPal Stock Fall To $50?

The Core Concern: Too Much Future, Too Little PresentOklo continues to be a pre-revenue entity, and while its aspirations are commendable, revenue generation is still quite a few years away. The firm has indicated about 14 GW of customer interest — a pipeline potentially translating to $5 billion or more in yearly revenue by 2028 if projects come to fruition.

Nonetheless, at the current share price of $167, Oklo holds a market capitalization of about $25 billion, despite not having produced or sold a single reactor yet. This valuation is generally associated with established industrial or energy companies that have billions in current revenue, rather than pre-commercial ventures still navigating licensing and prototype phases.

Even if Oklo reaches $5 billion in annual revenue by 2028, the stock is presently trading at nearly five times potential sales for 2028. Should execution falter or timelines extend — which is a plausible scenario in the nuclear industry — a reassessment toward two times sales would suggest a share price closer to $70–75, representing a 50% decline from current prices.

Key Downside RisksRegulatory Delays: Oklo’s reactor design is still pending full approval from the U.S. Nuclear Regulatory Commission (NRC), a process that traditionally takes many years. Any holdup could delay commercialization into the next decade.Capital Requirements: The construction and deployment of SMRs is extremely capital-intensive. Oklo will likely need to secure billions in the coming years — potentially through share dilution — to finance development, construction, and fuel procurement.Execution Hurdles: Transitioning from engineering concepts to large-scale commercial deployment involves significant technical and operational challenges. Cost overruns or supply chain issues could impair early projects.Valuation Stretch: With shares rising over 600% in 2025, Oklo trades well ahead of its fundamentals. Any slowdown in regulatory updates or sector rotation could prompt sharp corrections.The Structural RealityNuclear energy — particularly SMRs — constitutes one of the most complex and sluggish sectors of energy infrastructure. Each phase, from licensing to construction and operation, demands years and billions of dollars. Even with robust customer interest, Oklo’s capacity to transform those commitments into operational reactors remains unproven.

In contrast to software or solar initiatives that can expand rapidly, SMRs necessitate patience, capital, and impeccable execution — three elements that markets seldom reward simultaneously.

The VerdictAt $167 per share, Oklo’s market capitalization reflects substantial expectations — not only for regulatory success but also for perfect execution and swift commercialization. The firm could ultimately validate these expectations if it achieves multi-gigawatt deployment by 2028, but the journey is protracted and uncertain.

If timeframes extend or investor enthusiasm wanes, a retreat toward the $70–80 range would be entirely plausible — and perhaps even beneficial.

Oklo stands as one of the most audacious bets in clean energy today: high potential, high visibility, and equally high risk. For investors with long-term perspectives and a strong tolerance for volatility, it continues to be a captivating narrative. For others, the existing valuation likely presumes too much, too quickly.

Now, we apply a risk assessment framework while constructing the Trefis High Quality (HQ) Portfolio, which, with a collection of 30 stocks, has a record of comfortably outperforming the S&P 500 over the last four-year timeframe —and has achieved returns surpassing 105% since its inception. Why is that? As a collective, HQ Portfolio stocks have yielded better returns with lower risk compared to the benchmark index; offering a steadier experience as demonstrated in HQ Portfolio performance metrics.
2025-10-14 11:21 4mo ago
2025-10-14 07:05 4mo ago
What's Next After The 6x Surge In TMC Stock? stocknewsapi
TMC
Construction materials are on a building site in Montreal, Quebec, Canada, on October 8, 2025. (Photo by Graham Hughes/NurPhoto via Getty Images)

NurPhoto via Getty Images

Few stocks have stirred interest in 2025 quite like TMC The Metals Company (NASDAQ: TMC). Shares have skyrocketed to around $10.00, rising over 800% year-to-date, as the previously speculative deep-sea mining pioneer approaches commercial viability. What was once regarded as a far-off idea now appears feasible, supported by concrete advancements in project development, clearer regulatory frameworks, and a surge in demand for battery metals. The current question is whether this impressive trend has the potential to persist—or if investors should prepare for forthcoming volatility.

If you’re looking for an upside with less volatility than holding a single stock, consider the High Quality Portfolio. It has comfortably outperformed its benchmark—an amalgamation of the S&P 500, Russell, and S&P MidCap indexes—and has achieved returns exceeding 105% since its inception. Separately, see Can PayPal Stock Fall To $50?

Core Thesis: From Speculation to ExecutionCommercial Launch Nearing & Re-Rating in ProgressTMC’s ascent has been fueled by an increasing belief that its long-anticipated Clarion-Clipperton Zone (CCZ) project could commence production by 2026, following successful pilot initiatives and environmental assessments. The company has transitioned from concept to credible operations—completing pilot collection campaigns (utilizing a robotic vehicle to gather battery metals from the ocean floor), enhancing processing technology, and securing strategic funding to support the next phase.

In 2023 and 2024, TMC reported minimal revenue, concentrating mainly on research and pilot collection. However, current projections indicate potential annual revenues of $1–1.5 billion once full-scale production kicks off. Investors have swiftly factored in this transformation, propelling valuation multiples significantly higher.

At current prices, TMC is trading at approximately 8–9x forward sales, marking a substantial re-rating from early 2025 when the stock was valued at under 1x. This momentum mirrors not just optimism regarding commercialization but also the scarcity of scalable, ESG-aligned metal sources beyond traditional mining.

Nevertheless, maintaining this surge will hinge on impeccable execution, regulatory clarity, and steady advancements toward initial metal production.

Key Growth CatalystsExploding Demand for EV Metals – The global demand for electric vehicles (EVs) and energy storage is prompting a rush for nickel, cobalt, copper, and manganese—the very metals that TMC’s seabed nodules are rich in. As automakers strive to secure low-carbon supply chains, TMC is positioned to gain from its anticipated lower environmental footprint compared to land mining.Regulatory Progress with the ISA – Following years of ambiguity, the International Seabed Authority (ISA) is now nearing the finalization of the mining code. This framework could officially approve TMC’s commercial license, paving the way for production.Environmental and Economic Edge – TMC argues that collecting seabed nodules results in up to 70% lower carbon emissions and land disruption compared to terrestrial mining, granting both an ESG benefit and a cost advantage.Strategic Partnerships – TMC is actively pursuing discussions with battery and EV manufacturers for long-term supply contracts, which would ensure revenue visibility as production commences.Robust Balance Sheet – Recent capital raises and debt financing have extended the company's cash runway, supporting its efforts to enhance mining systems and processing capacity through 2026.Risks: Can the Momentum Hold?Regulatory Delays: The ISA might still defer commercial approvals, delaying production timelines.Environmental Pushback: Resistance from NGOs and environmental organizations persists, which could result in reputational threats or political backlash.Valuation Stretch: Following an 800% increase, expectations are elevated. Any operational hiccup or market correction might lead to sharp declines.Capital Requirements: Scaling to complete commercial operations is still capital-intensive, and additional funding rounds will likely be necessary before reaching breakeven.Commodity Price Risk: A decline in nickel or cobalt prices could reduce margins once operations start.The VerdictAt around $10, The Metals Company has evolved from a speculative penny stock into a high-stakes wager on the commercialization of an innovative resource frontier. The fundamentals are rapidly improving, but the current valuation assumes a smooth path in both regulatory and operational respects.

If TMC manages to initiate production by 2026 and grows revenues to the $1–1.5 billion range, the present price could be justified—or even seen as conservative in the long term. However, considering the 800% year-to-date surge, short-term fluctuations and profit-taking are probable as the market adjusts its expectations.

For long-term advocates of the deep-sea mining and clean energy metals narrative, TMC continues to represent one of the most asymmetric opportunities in the market—a potential blueprint for the next phase of the energy transition.

At $19, TMC stands as evidence that the company’s formerly controversial vision is beginning to resemble the future of sustainable mining.

Investors should brace themselves for significant volatility and the risk of substantial losses if market conditions worsen or if the company is unable to deliver on its ambitious growth targets. While the potential upside is mathematically robust based on anticipated revenues, it hinges on perfect execution in a rapidly changing and competitive environment. Now, we apply a risk assessment framework while constructing the Trefis High Quality (HQ) Portfolio, which, with a collection of 30 stocks, has a track record of comfortably outperforming the S&P 500 over the last 4-year period. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk compared to the benchmark index; less of a volatile experience as demonstrated in HQ Portfolio performance metrics.
2025-10-14 11:21 4mo ago
2025-10-14 07:05 4mo ago
Rare-Earth Moves In China Pushes MP Materials Stock Higher stocknewsapi
MP
CANADA - 2025/09/28: In this photo illustration, the MP Materials logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

SOPA Images/LightRocket via Getty Images

MP Materials (NYSE:MP), an American company specializing in rare-earth materials and based in Las Vegas, Nevada, experienced a stock increase of approximately 8% on Friday after China revealed new export restrictions on rare-earth elements. The updated regulations will necessitate that foreign purchasers secure licenses, heightening concerns over supply shortages. In reaction, President Donald Trump threatened more substantial tariffs on Chinese imports and indicated the possibility of canceling his meeting with President Xi, rekindling U.S.-China trade frictions. This situation could provide a significant advantage for MP Materials. With Washington already investing $400 million in the firm and ensuring future purchases, MP stands to gain from any initiative that encourages the U.S. to reduce reliance on Chinese supplies. Investors are currently wagering on increased demand, improved pricing, and ongoing policy support for U.S.-based manufacturers.

MP stock has recently made substantial gains, yet we presently find it unappealing. This could be seen as a warning, and there exists considerable risk in depending on a single stock. Nonetheless, there is immense value to the broader diversified strategy we adopt with Trefis High Quality Portfolio. Additionally, contemplate what the long-term performance of your portfolio could resemble if you integrated 10% commodities, 10% gold, and 2% crypto along with equities.

Geopolitical changes have only heightened the significance of this role. Earlier this year, after Washington enacted higher tariffs on Chinese goods, Beijing implemented export controls on rare earths. China's rare earth exports have been severely impacted: in September 2025, exports fell by 31% from August to reach 4,000.3 tonnes, marking the lowest monthly figure since February 2025. Now, China has broadened its rare earth export restrictions to encompass 12 of the 17 rare earth elements, with new regulations set to take effect from December 1. These regulations will mandate licenses for the export of rare earth magnets and related products, including those for foreign companies that utilize Chinese-origin rare earth materials or technologies. These events underscore the necessity for a secure domestic supply.

This positions MP Materials as one of the most strategic companies in America's endeavor to establish its critical minerals supply chain. The firm owns and operates the Mountain Pass Mine in California – currently the only operational rare-earth mine and processing facility in the United States. Its primary focus is on producing Neodymium-Praseodymium (NdPr), critical for high-strength permanent magnets used in EV motors, wind turbines, drones, and defense apparatus. In July, the U.S. Department of Defense became MP’s largest shareholder following a $400 million equity investment aimed at boosting the company’s magnet production capacity. MP also entered into a $500 million supply agreement with Apple, using prepayments to finance much of its new Independence facility in Texas, which will manufacture finished rare-earth magnets.

Operational AdvancementsMP’s operational advancements have been robust. In Q2 2025, the company announced record NdPr oxide production, up 119% year-on-year, with sales volumes tripling to 443 metric tons. Revenue soared 84% to $57.4 million, surpassing expectations. Management anticipates another sequential production increase of 10%–20% in Q3. The company is also progressing downstream — shifting from raw oxide production to high-value magnet alloys and finished magnets, a segment where sales have already reached $20 million last quarter. MP aims to scale this to 10,000 metric tons annually by 2028, which could significantly enhance margins. Financially, MP remains well-capitalized, holding nearly $2 billion in cash, which provides it with the flexibility for expansion and R&D.

What Are The Risks?Despite its strong fundamentals and policy backing, valuation is a significant concern. MP trades at approximately 50x forward revenue, comparing more closely with high-growth tech companies than with miners. The business is still unprofitable, reporting a $53.5 million net loss and consuming $126 million in cash year-to-date. Although geopolitical tailwinds have driven its rise — the stock has increased over 500% year-to-date — this reliance could work against it. Any easing in trade tensions or normalization in Chinese exports might weaken the bullish perspective. With China producing 90% of the world’s rare-earth magnets, MP’s advantage remains particularly sensitive to policy changes.

The Trefis High Quality (HQ) Portfolio, comprising a selection of 30 stocks, has a proven history of comfortably surpassing its benchmark that encompasses all three – S&P 500, Russell, and S&P midcap – achieving returns in excess of 105% since its inception. Why is this the case? Collectively, HQ Portfolio stocks have delivered superior returns with lower risk compared to the benchmark index, resulting in a less volatile experience, as evident in HQ Portfolio performance metrics.
2025-10-14 11:21 4mo ago
2025-10-14 07:06 4mo ago
Charlotte's Web™ Expands its Brightside Line with Launch of Knockout Hemp THC Sleep Gummies stocknewsapi
CWBHF
The fourth addition to its  hemp-derived  THC product lineup, Knockout expands Charlotte's Web's Brightside collection into the sleep market by combining cannabinoids, clean ingredients, and fast-acting delivery technology to support quality sleep.

, /PRNewswire/ - (TSX: CWEB) (OTCQB: CWBHF) Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company"), the pioneer and market leader in hemp-derived wellness, today announced the launch of Knockout, the newest addition to its Brightside collection of hemp-derived THC gummies. Each blackberry-flavored gummy is precisely infused with a balanced ratio of hemp-derived THC and CBN, delivering dual-action support - THC to help you fall asleep, while CBN promotes restful, uninterrupted sleep throughout the night. Leveraging proprietary AZUCA TiME INFUSION™ delivery system, Knockout offers rapid onset, with effects typically beginning within 5 to 15 minutes—setting the stage for a fast-acting, dependable experience. 

The launch builds on the success of Charlotte's Web's Brightside Hemp THC Gummies, which introduced a new standard of precision wellness earlier this year with its Unwind, Focus, and Recover formulations. With sleep continuing to rank among the top wellness priorities for consumers, Knockout represents the next phase of the company's investment in fast-acting, hemp-derived THC innovation.

Key Benefits of Knockout:

Rapid-onset formulation with effects in 5–15 minutes
Balanced hemp-derived THC + CBN ratio for falling and staying asleep
Natural blackberry flavor
Vegan, gluten-free, and made in the USA with U.S.-grown hemp

"Sleep remains one of the fastest-growing segments in wellness, and Charlotte's Web is positioned to lead the hemp wellness category," said Bill Morachnick, CEO of Charlotte's Web. "Knockout offers consumers a controlled, predictable experience—combining our trusted ingredient integrity with innovative, fast-acting delivery technology. This approach not only meets the growing demand for safe, reliable sleep solutions but also strengthens our portfolio and reinforces our commitment to science-backed formulations."

Knockout is designed for people who want better sleep without compromise. As more consumers look for natural alternatives to alcohol and traditional sleep aids, Knockout combines trusted quality, clean formulations, and precise delivery for a controlled experience—helping you rest easy with confidence.

Knockout retails for $39.99 (20-count) and is available through Charlotte's Web online and at select retailers nationwide starting on October 14, 2025. Shop the full sleep collection here.

To learn more about Charlotte's Web, please visit www.charlottesweb.com.

About Brightside Hemp-Derived THC Gummies
Brightside is a new line of fast-acting hemp-derived THC gummies from Charlotte's Web, designed to elevate your wellness journey with precision and care. Featuring four unique formulations - Unwind, Focus, Recover, and Knockout - Brightside gummies combine micro- to moderate doses of hemp-derived THC with synergistic cannabinoids, offering targeted benefits in just 5-15 minutes. Brightside embodies a commitment to innovation and wellness, empowering individuals to enhance their daily experiences with curated cannabinoid formulations. Crafted for both the THC-curious and seasoned users, these gummies are made with US-grown hemp and are compliant with the 2018 Farm Bill. All products are marketed as dietary supplements and are not intended for sale to persons under the age of 21.

About Charlotte's Web Holdings, Inc.
About Charlotte's Web Holdings, Inc.Charlotte's Web Holdings, Inc., a Certified B Corporation headquartered in Louisville, Colorado, is a botanical wellness innovation company and market leader in hemp extract wellness. The Company's product categories include CBD oil tinctures (liquid products), CBD gummies (sleep, calming, exercise recovery, immunity), CBN gummies, hemp-derived THC microdose gummies, functional mushroom gummies, CBD capsules, CBD topical creams and lotions, as well as CBD pet products for dogs. Through its substantially vertically integrated business model, Charlotte's Web maintains stringent control over product quality and consistency with analytic testing for quality assurance. Charlotte's Web products are distributed to retailers and healthcare practitioners throughout the U.S.A. and are available online through the Company's website at www.charlottesweb.com.

SOURCE Charlotte's Web Holdings, Inc.

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+

Newsrooms &

Influencers

9k+

Digital Media

Outlets

270k+

Journalists

Opted In
2025-10-14 11:21 4mo ago
2025-10-14 07:06 4mo ago
Wells Fargo Third-Quarter Profit Rises stocknewsapi
WFC
Wells Fargo said its profit increased 9% in the third quarter.
2025-10-14 11:21 4mo ago
2025-10-14 07:07 4mo ago
Wells Fargo profit rises on higher interest income stocknewsapi
WFC
CNBC's Leslie Picker joins 'Squawk Box' to break down the company's quarterly earnings results.
2025-10-14 11:21 4mo ago
2025-10-14 07:08 4mo ago
GM Faces $1.6 Billion Charge on EV Pullback stocknewsapi
GM
Automaker cites end of government-funded subsidies and regulatory mandates that fueled electric-vehicle growth.
2025-10-14 11:21 4mo ago
2025-10-14 07:08 4mo ago
Already Up 322%, Can CoreWeave Hit $400 by 2028? stocknewsapi
CRWV
CoreWeave‘ (CRWV) 322% surge stems from AI demand, turning its crypto roots into a $5 billion revenue machine.
2025-10-14 11:21 4mo ago
2025-10-14 07:08 4mo ago
Why Congress Is Buying Intuitive Surgical Ahead of Earnings stocknewsapi
ISRG
Intuitive Surgical Today

ISRG

Intuitive Surgical

$435.73 +6.14 (+1.43%)

As of 10/13/2025 04:00 PM Eastern

52-Week Range$425.00▼

$616.00P/E Ratio60.77

Price Target$584.76

Intuitive Surgical Inc. NASDAQ: ISRG is entering a potential breakout window as it heads into its next earnings report on October 21, 2025. A wave of recent developments has improved the outlook and set the stage for a possible rally leading into—or following—the announcement.

With new FDA approvals and a green light for European expansion, Intuitive Surgical now has access to a much larger, more actionable customer base. These developments have meaningfully expanded its addressable market and could drive increased adoption of its systems across both the United States and abroad.

Get Intuitive Surgical alerts:

That broader reach should begin to show up in improved earnings results over the coming quarters. As is often the case in the healthcare sector, regulatory developments play a pivotal role in shaping investor sentiment.

Notably, there’s growing speculation that key regulations could soon clear, especially given recent buying activity from several U.S. Congress members—a signal that hasn't gone unnoticed by the market. As a result, investors are now assigning a premium valuation to the company, reflecting heightened expectations for future growth. For retail investors, this is an opportunity worth serious consideration.

Why Intuitive Surgical Can Win
Intuitive Surgical develops artificial intelligence-driven robotics for surgical procedures, enabling medical professionals to perform these procedures remotely with precision and accuracy. Given the nature of this company's industry, it is inherently surrounded by moats that neither competition nor the adoption of artificial intelligence can breach.

That could be why markets view this as the premium company, but there is much more behind it. One of these drivers is the recent FDA approval for Intuitive Surgical’s da Vinci 5 software features, which will facilitate further adoption of this technology and enable remote surgical procedures aided by robotics and artificial intelligence.

Secondly, the Ion endoluminal system trials have now been cleared across Europe and the United States, involving over 2,000 subjects. These studies increase the likelihood that this company will begin to report more diversified and rapidly growing revenue streams, enhancing its valuation.

Despite these bullish factors, the stock trades at only 70% of its 52-week high (well into bear market territory), creating a more attractive risk-to-reward ratio for new and existing shareholders. Some of these new shareholders include congressional members who may or may not possess valuable information regarding future FDA approvals and developments.

Markwayne Mullin bought up to $100,000 at an average price of $443.99 per share, or Ro Khanna, who bought up to $15,000 at an average of $466.66. These purchases were made in September 2025, just a month before the company releases its quarterly results, likely to include some positive guidance given the recent FDA approvals and European expansion.

What Markets Think of Intuitive Surgical Stock
Intuitive Surgical Stock Forecast Today12-Month Stock Price Forecast:
$584.76
34.20% Upside

Moderate Buy
Based on 22 Analyst Ratings

Current Price$435.73High Forecast$700.00Average Forecast$584.76Low Forecast$440.00Intuitive Surgical Stock Forecast Details

The most clear-cut way investors can gauge sentiment is through valuation multiples. In the case of Intuitive Surgical, a price-to-earnings ratio of 59.9x indicates a significant preference for this stock. This multiple commands a steep premium for the medical instruments industry, at only 26.3x, and there must be a reason why markets are willing to overpay here.

The Wall Street analyst consensus price target on the stock is $589.43 per share, which implies a 37.2% upside potential from its current trading price, not accounting for the potential financial benefits that could arise from recent developments.

Despite these tailwinds, the company reported net earnings per share (EPS) of $2.19 in its latest quarterly results, 13% above the MarketBeat consensus of $1.93. This trade can work for many fundamental reasons, but it also goes beyond Intuitive Surgical’s business.

The Healthcare Select Sector SPDR Fund NYSEARCA: XLV has underperformed the broader S&P 500 index by approximately 22% over the past 12 months, marking the widest spread in over a decade. This means that healthcare stocks, overall, are compressed in terms of valuations and price action.

Should a recovery extend to the entire sector, Intuitive Surgical can amplify its bullish fundamentals and accelerate its rally higher alongside its other peers in the space, thereby creating a fantastic risk-to-reward setup.

Should You Invest $1,000 in Intuitive Surgical Right Now?Before you consider Intuitive Surgical, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.

While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
2025-10-14 11:21 4mo ago
2025-10-14 07:09 4mo ago
JPMorgan Chase tops estimates on better-than-expected trading, investment banking results stocknewsapi
JPM
CNBC's Joe Kernen reports on the company's quarterly earnings results.
2025-10-14 11:21 4mo ago
2025-10-14 07:10 4mo ago
Sono-Tek Reports Fiscal Second Quarter Financial Results and Record First Half 2026 Revenue stocknewsapi
SOTK
- Reports Sixth Consecutive Quarter of Revenue over $5 million Highlighted by 150% Annual Increase in Medical Market Sales-

-Fiscal First Half Net Income Increases 35%-

-Backlog Increased 50% Sequentially Reflecting New Order Momentum-

-Updates FY26 Guidance Reflecting Improved Outlook, Anticipating Modest Revenue Growth with Increasing Demand in the Medical Device Market-

-Conference Call Today at 10:30 am ET-

MILTON, N.Y., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Sono-Tek Corporation (Nasdaq: SOTK), the leading developer and manufacturer of ultrasonic coating systems, today reported financial results for the second quarter and first half of fiscal year 2026, ended August 31, 2025.

Second Quarter Fiscal 2026 Highlights

Net Sales for the quarter increased to $5.163 million compared to $5.162 million year over year and increased sequentially compared to $5.13 million in the first quarter of fiscal 2026.Gross profit for the quarter increased 3% year over year to $2.6 million compared with $2.5 million.Net income for the quarter increased 24% to $424 thousand, or $0.03 per share, compared with $341 thousand, or $0.02 per share. First Half Fiscal 2026 Highlights

Record first half fiscal 2026 revenue increased year over year to $10.30 million compared to $10.19 million.Gross profit increased 6% year over year to $5.3 million compared with $5.0 million, primarily due to product mix and favorable warranty expenses in the current period.Net income increased 35% year over year to $909 thousand, or $0.06 per share, compared with $672 thousand, or $0.04 per share. Balance Sheet, Backlog and Guidance for Fiscal Year 2026

As of August 31, 2025, cash, cash equivalents and marketable securities totaled $10.6 million with no outstanding debt.Total equipment and service-related backlog remains strong at $11.21 million compared to $11.6 million at the end of Q2 FY2025 and increased 50% compared to $7.48 million at the end of Q1 FY2026, reflecting new order momentum from the medical market. For the full fiscal year, the Company is updating its guidance reflecting an improved outlook anticipating modest revenue growth, balancing a cautious view as the market adjusts to recent shifts in governmental clean energy and tariff policies with a positive offset from growing demand in the medical device market. Dr. Christopher L. Coccio, Executive Chairman, stated, “We are pleased to report continued growth and profitability in line with our guidance with the continuing trend of over $5 million in quarterly revenue for the past six quarters. Importantly, we remain solidly profitable with strong margins and effective cost controls. Based on projected shipments for the second half of our fiscal year 2026, we are raising guidance slightly, now anticipating modest revenue growth, taking into consideration evolving governmental clean energy incentives and tariff policies which each may affect the initiation and timing of customer orders. Despite the evolving landscape in the clean energy industry, we have successfully offset it with our diversification strategy into other sectors such as the medical device industry. It is gratifying to see the promising demand in the medical device industry that we projected coming to fruition with our recently announced $5 million dollar order for multiple state-of-the-art MediCoat systems designed for high-precision, scalable manufacturing in addition to our most recent order of over $2.8 million from another major medical device manufacturer. With a healthy balance sheet, solid backlog and strong customer demand, we remain laser focused on execution and look forward to building on our recent success.”

Steve Harshbarger, CEO & President of Sono-Tek stated, “We continue to see the success of our growth strategies with customers moving into complex large-scale production systems with significantly higher average selling prices “ASPs”. Customer demand and momentum remain strong, and it is validating to see the growing adoption of Sono-Tek’s advanced coating platforms by leading medical device manufacturers worldwide. We are well positioned with our strong balance sheet and backlog to navigate potential short-term demand shifts that may result from changes in tariff policies and clean energy incentives. We remain focused on our long-term growth strategy and look forward to continued revenue growth and profitability over the long term.”

Second Quarter Fiscal 2026 Results

(Narrative compares with prior-year period unless otherwise noted) ($ in thousands)

 Three Months Ended August 31,
 Change
  2025
  2024
 $
 %
Net Sales$5,163  $5,162  1  0% Gross Profit$2,590  $2,516  74  3% Gross Margin 50%
   49%
                   Operating Income$421  $286  135  47% Operating Margin 8%
   6%
                   Net Income$424  $341  83  24% Net Margin 8%
   7%
          Net Sales: $5.163 million, a slight increase from the $5.162 million in the second quarter of fiscal year 2025. This marks the sixth consecutive quarter with sales over $5 million.

Gross Profit: $2.6 million, up 3% from the prior year second quarter of $2.5 million. Gross margin increased to 50% from 49%, mainly due to a favorable product mix of high ASP systems, reflecting further maturation of our product offerings, with reduced costs and favorable warranty expenses in the current period.Operating Income: Increased 47% to $421 thousand compared to $286 thousand in the second quarter of fiscal year 2025, due to an increase in gross profit combined with lower operating expenses.Net Income: Increased 24% to $424 thousand, up from $341 thousand in the second quarter of fiscal year 2025, reflecting a combination of higher gross profit and lower operating expenses.Other Income: Interest and dividend income decreased slightly to $82 thousand for the second quarter of fiscal year 2026 from $85 thousand in the second quarter of fiscal year 2025. Second Quarter Fiscal Year 2026 Product and Market Sales Overview

Product Categories: In-Line Coating Systems (previously referred to as Integrated Coating Systems) sales decreased by $493 thousand, or 24%, to $1.53 million, primarily driven by a customer-requested delivery delay in the clean energy sector. Multi-Axis Coating Systems increased by $99 thousand, or 5%, to $2.03 million. Fluxing sales increased by $46 thousand or 39% to $165 thousand, reflecting increased demand from Asia. OEM sales increased by $189 thousand, or 92%, to $394 thousand driven by strong fluxer OEMs and two new OEM’s. Spare parts, Services and Other sales increased by $160 thousand, or 18% to $1.04 million. During the current reporting period, the Company updated the title of its product category previously referred to as “Integrated Coating Systems” to “In-Line Coating Systems.” We made this change to provide greater clarity in describing this segment of our business. The definition and contents of this category remain unchanged.In-Line Coating Systems include Sono-Tek products that are typically stationary platforms with minimal motion control and may occasionally incorporate a simple axis of movement such as a rotation fixture. These systems are commonly installed over moving substrates such as conveyors or webs, which may be provided either by Sono-Tek or by the customer. They often employ multiple ultrasonic nozzles to provide uniform coverage over larger areas in continuous production environments. In-Line Coating Systems are unlike our Multi-Axis Coating Systems, which commonly utilize XYZ motion platforms or 6+ axis robotic configurations. End Markets: The Medical market increased by 150% y-o-y or $602 thousand to $1.00 million, led by balloon coating systems shipped to the U.S., Europe, and China. Alternative/Clean Energy decreased slightly by 3% y-o-y or $65 thousand, to $2.43 million, supported by a strong clean energy backlog going into FY 2026. The Electronics market declined slightly by 1% y-o-y, down $22 thousand to $1.46 million. The Industrial market declined 68% or $517 thousand to $238 thousand, influenced by a large FY 2025 European glass coating order that did not repeat.
Geography: US/Canada sales decreased 22% y-o-y, or $775 thousand, driven by slowing momentum in the US clean energy industry. Offsetting the US sales decline, sales in Asia increased 153% y-o-y, or $562 thousand, with major growth in China and other parts of Asia. EMEA sales increased 25%, or $288 thousand while Latin American sales were down $74 thousand. First Half Fiscal Year 2026 Overview
(Narrative compares with prior-year period unless otherwise noted) ($ in thousands)

 Six Months Ended August 31, Change  2025   2024  $
 %Net Sales$10,295  $10,193  102  1% Gross Profit$5,254  $4,971  283  6% Gross Margin 51%   49%               Operating Income$905  $524  381  73% Operating Margin 9%   5%               Net Income$909  $672  237  35% Net Margin 9%   7%        Net Sales: $10.30 million, an increase from $10.19 million in the first half of fiscal year 2025.Gross Profit: $5.3 million, up 6% from the first half of fiscal year 2025 of $5 million. Gross margin increased to 51% from 49%, mainly primarily due to product mix and favorable warranty expenses in the current period.Operating Income: Increased 73% to $905 thousand compared to $524 thousand in the first half of fiscal year 2025, due to an increase in gross profit combined with lower operating expenses.Net Income: Increased 35% to $909 thousand, up from $672 thousand in the first half of fiscal year 2025, reflecting a combination of higher gross profit and lower operating expenses.Other Income: Interest and dividend income decreased slightly to $224 thousand for the first half of fiscal year 2026 compared to $228 thousand for the first half of fiscal year 2025. First Half Fiscal Year 2026 Product and Market Sales Overview

Product Categories: In-Line Coating Systems (previously referred to as Integrated Coating Systems) sales increased by $1.82 million, or 65%, to $4.58 million, driven by shipments of six high-ASP systems to a major solar customer totaling $4.42 million. Fluxing sales increased by $64 thousand or 25% driven by strength in Asia. Multi-Axis Coating Systems declined $1.89 million, or 41%, to $2.71 million following a strong FY2025 for semiconductor systems that did not repeat, and slower clean energy activity in FY2026. OEM sales were down slightly by $13 thousand or 2% and Spare Parts, Services and Other sales were up $126 thousand, a 6% increase.
End Markets: The Medical market rose by 44% or $553 thousand, supported by strong balloon coating systems shipped to the U.S., Europe, and China, and increased stent coating activity in Europe. Alternative/Clean Energy rose 19% y-o-y, up $901 thousand, driven by the shipment of six high ASP solar coating systems. The Electronics market declined 21% y-o-y, down $646 thousand following strong FY2025 semiconductor sales, and FY2026 customer timing for similar machines. The Industrial market declined 67% or $711 thousand, influenced by a large FY 2025 European glass coating order that did not repeat.
Geography: US/Canada sales decreased 5% y-o-y, or $324 thousand, driven by slowing momentum in the US clean energy industry. This was offset by increased sales in Asia with 74% growth y-o-y, or $647 thousand, led by strong medical sales in China and strong alternative energy sales in Japan and South Korea. EMEA sales declined slightly, declining $60 thousand and Latin American sales down $160 thousand, due to slow fluxing sales in Mexico. Balance Sheet and Cash Flow Overview

At August 31, 2025, cash, cash equivalents and marketable securities totaled $10.6 million, with no debt, and stockholders’ equity was $18.7 million.

Capital expenditures in the first half of fiscal 2026 were $113K, which were invested in ongoing upgrades to the Sono-Tek’s manufacturing facilities. Sono-Tek anticipates that capital expenditures will total approximately $300k in fiscal year 2026.

Conference Call Information

Sono-Tek will hold a conference call to discuss its second quarter and first half of fiscal year 2026 financial results today, Tuesday, October 14, 2025 at 10:30 am ET. To participate, please call 1-844-481-2752 or 1-412-317-0668 for international callers at least 10 minutes prior to the start of the call and ask to join the Sono-Tek call.

A simultaneous webcast of the call may be accessed through the Company's website, Events & Presentations | Sono-Tek or at https://event.choruscall.com/mediaframe/webcast.html?webcastid=L9LSqRTH

A replay of the call will be available at 1-877-344-7529 or 1-412-317-0088 for international callers, access code 6867548, through October 21, 2025. A replay of the call will also be available on the Company’s website for one year at www.sono-tek.com.

About Sono-Tek

Sono-Tek Corporation (Nasdaq: SOTK) is a global leader in the design and manufacture of ultrasonic coating systems that are shaping industries and driving innovation worldwide. Our ultrasonic coating systems are used to apply thin films onto parts in diverse industries including medical devices, semiconductors, microelectronics, alternative energy, advanced industrial manufacturing, and research and development sectors.

Sono-Tek has a long history of providing advanced coating solutions to the medical device industry, enabling precision coatings for life-saving technologies such as stents, balloons, diagnostic devices, and various drug delivery platforms. At the same time, our expertise in semiconductor and microelectronics applications continues to expand, as customers increasingly turn to Sono-Tek for solutions supporting next-generation chips, displays, and sensors. Alongside these markets, our technologies are also leading the way in next-generation clean energy coatings for fuel cells, carbon capture, advanced solar cells, and various other advanced industrial applications, underscoring the versatility and broad reach of Sono-Tek’s ultrasonic coating platforms.

Our product line is rapidly evolving, transitioning from R&D tools to high-volume production machines with significantly higher average selling prices, showcasing our market leadership and adaptability. Our comprehensive suite of thin film coating solutions and application consulting services ensures unparalleled results for our clients and helps some of the world’s most promising companies achieve technological breakthroughs and bring them to market. The company strategically delivers its products to customers through a network of direct sales personnel, carefully chosen independent distributors, and experienced sales representatives, ensuring efficient market reach across diverse sectors around the globe.

Our growth strategy is focused on leveraging our innovative technologies, proprietary know-how, unique talent and experience, and global reach to further develop microscopic coating technologies that enable better outcomes for our customers’ products and processes. For further information, visit www.sono-tek.com.

Safe Harbor Statement

This news release contains forward looking statements regarding future events and the future performance of Sono-Tek Corporation that involve risks and uncertainties that could cause actual results to differ materially. These “forward-looking statements’ are based on currently available competitive, financial and economic data and our operating plans. They are inherently uncertain, and investors must recognize that events could turn out to be significantly different from our expectations and could cause actual results to differ materially. These factors include, among other considerations, general economic and business conditions, including political, regulatory, tax, competitive and technological developments affecting our operations or the demand for our products; inflationary and supply chain pressures; continued strength of sales to the medical device market; continued private and public funding for the clean energy sector and continued strong demand for Sono-Tek’s suite of thin film coating solutions and application consulting services in the clean energy and other markets; maintenance of order backlog; the imposition of tariffs; timely development and market acceptance of new products and continued customer validation of our coating technologies; adequacy of financing; capacity additions, the ability to enforce patents; maintenance of operating leverage; consummation of order proposals; completion of large orders on schedule and on budget; successful transition from primarily selling ultrasonic nozzles and components to a more complex business providing complete machine solutions and higher value subsystems; and realization of quarterly and annual revenues within the forecasted range of sales guidance. We undertake no obligation to update any forward-looking statement.

For more information:

Sono-Tek Corp.
Stephen J. Bagley
Chief Financial Officer
Ph: (845) 795-2020
[email protected]

Investor Relations
Kirin Smith
PCG Advisory, Inc.
[email protected]

 -FINANCIAL TABLES FOLLOW-

SONO-TEK CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS   August 31,
2025  February 28,
2025   (Unaudited)    ASSETS                 Current Assets:        Cash and cash equivalents $3,832,133  $5,202,361 Marketable securities  6,736,469   6,727,678 Accounts receivable (less allowance of $12,225, respectively)  4,212,354   2,347,764 Inventories  4,152,027   4,474,401 Prepaid expenses and other current assets  188,695   236,261 Total current assets  19,121,678   18,988,465          Land  250,000   250,000 Buildings, equipment, furnishings and leasehold improvements, net  2,413,664   2,610,600 Intangible assets, net  33,529   37,386 Deferred tax asset  1,366,864   1,525,185          TOTAL ASSETS $23,185,735  $23,411,636          LIABILITIES AND STOCKHOLDERS’ EQUITY                 Current Liabilities:        Accounts payable $614,512  $859,483 Accrued expenses  1,852,959   1,718,574 Customer deposits  1,906,629   2,413,195 Income taxes payable  27,813   496,055 Total current liabilities  4,401,913   5,487,307          Deferred tax liability  88,153   132,134 Total liabilities  4,490,066   5,619,441          Commitments and Contingencies (Note 10)                 Stockholders’ Equity        Common stock, $.01 par value; 25,000,000 shares authorized, 15,751,153 issued and 15,707,062 outstanding as of August 31, 2025 and 15,751,153 issued and 15,749,037 outstanding February 28, 2025, respectively  157,512   157,512 Additional paid-in capital  10,163,952   10,018,034 Accumulated earnings  8,533,194   7,624,516 Treasury stock, at cost, 44,091 shares and 2,116 shares, August 31, 2025 and February 28, 2025, respectively  (158,989)  (7,867)Total stockholders’ equity  18,695,669   17,792,195          TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $23,185,735  $23,411,636   See notes to unaudited condensed consolidated financial statements. SONO-TEK CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(Unaudited)   Six Months Ended
August 31,  Three Months Ended
August 31,   2025  2024  2025  2024              Net Sales $10,295,469  $10,192,820  $5,162,696  $5,161,782 Cost of Goods Sold  5,041,218   5,222,236   2,572,959   2,645,685 Gross Profit  5,254,251   4,970,584   2,589,737   2,516,097                  Operating Expenses                Research and product development costs  1,295,748   1,427,303   627,278   695,873 Marketing and selling expenses  1,729,504   1,885,608   871,353   988,418 General and administrative costs  1,324,477   1,133,387   669,952   545,816 Total Operating Expenses  4,349,729   4,446,298   2,168,583   2,230,107                  Operating Income  904,522   524,286   421,154   285,990                  Interest and Dividend Income  223,660   227,730   81,562   85,076 Net unrealized gain on marketable securities  1,570   53,941   23,493   43,580                  Income Before Income Taxes  1,129,752   805,957   526,209   414,646                  Income Tax Expense  221,074   134,435   102,516   73,961                  Net Income $908,678  $671,522  $423,693  $340,685                  Basic Earnings Per Share $0.06  $0.04  $0.03  $0.02                  Diluted Earnings Per Share $0.06  $0.04  $0.03  $0.02                  Weighted Average Shares - Basic  15,727,844   15,750,895   15,721,162   15,750,910 Weighted Average Shares - Diluted  15,740,384   15,771,472   15,731,571   15,768,251  See notes to unaudited condensed consolidated financial statements.  Product Sales

  Three Months Ended
August 31,  Change  Six Months Ended
August 31,  Change   2025  2024  $  %  2025  2024  $  % Fluxing Systems $165,000  $119,000   46,000   39%  $317,000  $253,000   64,000   25% In-Line Coating Systems 1  1,530,000   2,023,000   (493,000)   (24%)  4,584,000   2,770,000   1,814,000   65% Multi-Axis Coating Systems  2,030,000   1,931,000   99,000   5%   2,707,000   4,595,000   (1,888,000)   (41%) OEM Systems  394,000   205,000   189,000   92%   524,000   537,000   (13,000)   (2%) Spare Parts, Services and Other  1,044,000   884,000   160,000   18%   2,164,000   2,038,000   126,000   6% TOTAL $5,163,000  $5,162,000   1,000   0%  $10,296,000  $10,193,000   103,000   1%  During the current reporting period, the Company updated the title of its product category previously referred to as “Integrated Coating Systems” to “In-Line Coating Systems.” This change was made to provide greater clarity in describing this product line of our business. The definition and contents of this category remain unchanged. In-Line Coating Systems include Sono-Tek products that are typically stationary platforms with minimal motion control, and may occasionally incorporate a simple axis of movement such as a rotation fixture. These systems are commonly installed over moving substrates such as conveyors or webs, which may be provided either by Sono-Tek or by the customer. They often employ multiple ultrasonic nozzles to provide uniform coverage over larger areas in continuous production environments. In-Line Coating Systems are unlike our Multi-Axis Coating Systems, which commonly utilize XYZ motion platforms or 6+ axis robotic configurations. Market Sales

  Three Months Ended
August 31,  Change  Six Months Ended
August 31,  Change   2025  2024  $  %  2025  2024  $  % Electronics/Microelectronics $1,455,000  $1,477,000   (22,000)  (1%) $2,399,000  $3,045,000   (646,000)  (21%)Medical  1,004,000   402,000   602,000   150%   1,812,000   1,259,000   553,000   44% Alternative/Clean Energy  2,433,000   2,498,000   (65,000)  (3%)  5,681,000   4,780,000   901,000   19% Emerging R&D and Other  33,000   30,000   3,000   10%   47,000   41,000   6,000   15% Industrial  238,000   755,000   (517,000)  (68%)  357,000   1,068,000   (711,000)  (67%)TOTAL $5,163,000  $5,162,000   1,000   0%  $10,296,000  $10,193,000   103,000   1%   Geographic Sales

  Three Months Ended
August 31,  Change  Six Months Ended
August 31,  Change   2025  2024  $  %  2025  2024  $  % U.S. & Canada $2,720,000  $3,495,000   (775,000)  (22%) $6,263,000  $6,587,000   (324,000)  (5%)Asia Pacific (APAC)  930,000   368,000   562,000   153%   1,527,000   880,000   647,000   74% Europe, Middle East, Asia (EMEA)  1,424,000   1,136,000   288,000   25%   2,321,000   2,381,000   (60,000)  (3%)Latin America  89,000   163,000   (74,000)  (45%)  185,000   345,000   (160,000)  (46%)TOTAL $5,163,000  $5,162,000   1,000   0%  $10,296,000  $10,193,000   103,000   1%  
2025-10-14 11:21 4mo ago
2025-10-14 07:10 4mo ago
New Strong Sell Stocks for Oct. 14th stocknewsapi
AR ATOS BTCS
Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:

Antero Resources (AR - Free Report) is an independent explorer, primarily engaged in the acquisition and development of natural gas, natural gas liquids and oil resources in the Appalachian Basin. The Zacks Consensus Estimate for its current year earnings has been revised almost 25.4 downward over the last 60 days.

BTCS Inc. (BTCS - Free Report) is focused on blockchain infrastructure and technology. The Zacks Consensus Estimate for its current year earnings has been revised almost 23.5% downward over the last 60 days.

Atossa Genetics (ATOS - Free Report)  is a healthcare company focused on the development and marketing of cellular and molecular diagnostic risk assessment products for breast cancer. The Zacks Consensus Estimate for its current year earnings has been revised 8.3% downward over the last 60 days.

View the entire Zacks Rank #5 List.
2025-10-14 11:21 4mo ago
2025-10-14 07:10 4mo ago
GM to take $1.6 billion charge related to EV pullback stocknewsapi
GM
CNBC's Phil LeBeau joins 'Squawk Box' with the latest news from General Motors.
2025-10-14 11:21 4mo ago
2025-10-14 07:11 4mo ago
Bitcoin Bancorp Announces FINRA Completion of Corporate Name Change to Bitcoin Bancorp and New Trading Symbol “BCBC” stocknewsapi
BULT
LAS VEGAS, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Bitcoin Bancorp. (“Bitcoin Bancorp” or the “Company”), formerly Bullet Blockchain, Inc. and trading under the symbol (OTC: BULT), today announced that FINRA has confirmed and completed the Company’s corporate action to change its name to Bitcoin Bancorp, Inc. and its trading symbol to “BCBC.” The Company’s common stock will begin trading on the OTC market under the new symbol BCBC effective at the open of trading on October 15, 2025.

No action is required by our shareholders. Key Highlights:

New Corporate name: From Bullet Blockchain, Inc. to Bitcoin Bancorp, Inc.New Symbol change: From BULT to BCBC, effective 10/15/2025.Shareholder action: No action is required; all existing shares remain valid and tradable.CUSIP: Current CUSIP will remain the same: 12023B103.ISIN: Current ISIN will remain the same: US12023B1035. “Rebranding to Bitcoin Bancorp marks the evolution of our Company into a Bitcoin-native financial services institution with patented Bitcoin ATM technologies, a licensed Bitcoin ATM network, and Bitcoin Treasury management solutions for NASDAQ companies,” said Eric Noveshen, Director of Bitcoin Bancorp. “We envision Bitcoin Bancorp will serve as the bridge between traditional finance and digital asset infrastructure, combining innovation, compliance, and institutional trust.”

Bitcoin Bancorp’s recent moves ensure that the Company remains at the forefront of innovation, offering innovative crypto financial services and building a trusted brand name. Bitcoin Bancorp’s ownership of Bitcoin ATMs and two (2) U.S. patents protecting its Bitcoin ATM technologies forms the backbone of Bitcoin Bancorp’s mission to make Bitcoin accessible, auditable, and seamlessly integrated into the global financial ecosystem.

About Bitcoin Bancorp, Inc.

Headquartered in Las Vegas, Nevada, Bitcoin Bancorp – common stock is publicly traded on the OTC Markets under the symbol (BCBC) – is a diversified digital asset and BaaS company, specializing in blockchain technologies, software development, and Web 3.0. As previously announced, Bitcoin Bancorp, through its wholly owned subsidiary, First Bitcoin Capital LLC, is the owner and exclusive licensor of intellectual property consisting of two (2) Bitcoin ATM patents – U.S. Patent Nos. US9135787B1 and US10332205B1. Bitcoin Bancorp owns Bitcoin ATMs which are operated by licensed third-party operators within the jurisdictions in which they reside. Bitcoin Bancorp is committed to driving the innovations needed to shape the future of digital and blockchain-related platforms through digital technology and decentralized blockchain solutions. Management is dedicated to rapid growth and increasing shareholder value. Bitcoin Bancorp is not licensed as a bank in the U.S. and does not provide banking services. 

Shareholders, potential investors, and others should note that we announce material events and material financial information to our shareholders and the public using our website and the social media addresses listed below, as well as in our OTC Markets’ disclosures, press releases, public conference calls, and webcasts. We also use social media to communicate with our email subscribers and the public about Bitcoin Bancorp, services, and other related information. It is possible that the information we post on social media could be deemed to be material information. Therefore, we encourage shareholders, the media, and others interested in Bitcoin Bancorp to review the information we post on Bitcoin Bancorp’s social media channels listed below. This list may be updated from time to time. 

For investor and general information, please email  [email protected]

Follow us at:Website:https://www.BitcoinBancorp.com/X (f/k/a Twitter):@BULT_stockReddit:https://www.reddit.com/r/BULT/Facebook:https://www.facebook.com/BulletBlockchainInc/Instagram:https://www.instagram.com/bitcoin_bancorp/#LinkedIn:www.linkedin.com/in/bullet-blockchain-inc   Find investor and general information at https://www.otcmarkets.com/stock/BULT/profile

Forward-Looking Statements: 
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements in this press release that are not statements of historical or current fact constitute “forward-looking statements.” Such forward-looking statements involve known and unknown risks, uncertainties, and other unknown factors that could cause the Company's actual operating results to be materially different from any historical results or from any future results expressed or implied by such forward-looking statements. In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors, including (without limitation) general industry and market conditions and growth rates, economic conditions, and governmental and public policy changes. The forward-looking statements included in this press release represent the Company's views as of the date of this press release, and these views could change at some point in the future. However, the Company specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing the Company's views as of any date subsequent to the date of the press release. In addition to statements that explicitly describe these risks and uncertainties, readers are urged to consider statements that contain terms such as “anticipate,” “anticipates,” “believes,” “belief,” “envision,” “expects,” “expect,” “intend,” “plans,” “plans,” “plan,” to be uncertain and forward-looking. 

Contact us: [email protected]

SOURCE: Bitcoin Bancorp, Inc. f/k/a Bullet Blockchain, Inc.
2025-10-14 11:21 4mo ago
2025-10-14 07:13 4mo ago
PotlatchDeltic and Rayonier Announce All-Stock Merger. What It Means for the Timberland Owners. stocknewsapi
PCH RYN
The deal will create a combined company with an enterprise value of more than $8 billion.
2025-10-14 11:21 4mo ago
2025-10-14 07:14 4mo ago
Ecora Resources eyes value unlock as Santa Domingo advances with Orion's Capstone deal stocknewsapi
ECRAF
Ecora Resources PLC (LSE:ECOR, TSX:ECOR, OTCQX:ECRAF) is eyeing valuable new income, highlighting that Orion Resource Partners has agreed a deal with Capstone Copper to acquire a 25% interest in the Santo Domingo project and the Sierra Norte project for up to US$360 million.

Capstone said it is advancing remaining workstreams, and it expects a final investment decision on Santo Domingo in H2 2026.

Ecora retains a 2% net smelter return royalty over certain Santo Domingo tenements, which include the highest copper grade portion of the deposit and is identified to be mined first, according to an updated feasibility study last year.

Ecora said the royalty is expected to generate an average annual royalty entitlement of US$30-to-35million over the first seven years at planned production rates and spot commodity prices.
2025-10-14 11:21 4mo ago
2025-10-14 07:15 4mo ago
PTIR: Palantir Leverage Is Exciting, But Imprudent stocknewsapi
PLTR
Analyst’s Disclosure:I/we have a beneficial long position in the shares of PLTR either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
2025-10-14 11:21 4mo ago
2025-10-14 07:16 4mo ago
Morgan Stanley Raises JOYY (JOYY.US) Target Price from US$40 to US$62 on Signs of Live Streaming Recovery and Attractive Shareholder Returns stocknewsapi
YY
, /PRNewswire/ -- Morgan Stanley has raised its target price for JOYY (JOYY.US) to US$62 from US$40, reflecting improving fundamentals in JOYY's core business, accelerating advertising growth, and attractive shareholder returns. The firm also highlighted JOYY's robust cash position and attractive shareholder return program as key factors offering downside protection.

Live-streaming business may have bottomed out: Morgan Stanley thinks JOYY's live steaming business may have bottomed out since 2Q25, after reporting 1% QoQ growth and positive management comments on revenue growth. The report expects further QoQ improvement in 2H25 and more growth in 2026-2027.

Advertising business to be the main growth driver in 2026 –2027: The report notes that JOYY's advertising business continued its strong revenue momentum in the first half of 2025, following more than 175% year-over-year growth in 2024. Morgan Stanley expects this momentum to persist, forecasting 26% year-over-year growth in 2H25 and 20% in 2026.

Attractive dividends and buybacks of US$300mn annually in 2025-2027: The company previously announced a three-year quarterly dividend policy totaling approximately US$600 million, together with a share repurchase program of up to US$300 million during 2025-2027. In 1H25, JOYY allocated US$135 million to quarterly dividends and share buybacks. Morgan Stanley assumes US$300 million in annual investor returns, including dividends and share buybacks.

SOURCE JOYY Inc.

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+

Newsrooms &

Influencers

9k+

Digital Media

Outlets

270k+

Journalists

Opted In
2025-10-14 11:21 4mo ago
2025-10-14 07:18 4mo ago
Atlas Salt Announces LIFE Private Placement Targeting Gross Proceeds of up to $8 Million stocknewsapi
REMRF
October 14, 2025 07:18 ET

 | Source:

Atlas Salt Inc.

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

ST. GEORGE'S, Newfoundland and Labrador, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Atlas Salt Inc. (“Atlas Salt” or the “Company”) (TSXV: SALT; OTCQB: REMRF; FRA:9D00) announces that it has entered into an agreement with Raymond James Ltd. and Ventum Financial Corp. (collectively, the “Agents”), to act as co-leads and joint bookrunners, in connection with a commercially reasonable efforts private placement offering for up to 10,000,000 common shares of the Company (“Common Shares”) at a price of $0.80 per Common Share (“Offering Price”) for aggregate gross proceeds of up to $8,000,000 (the “Offering”).

The Company has also granted the Agents an option (the “Agents’ Option”) to sell up to an additional 1,500,000 Common Shares for additional gross proceeds of up to $1,200,000, exercisable in whole or in part, any time up to 48 hours prior to the closing of the Offering. The Agents shall be under no obligation, in whole or in part, to exercise the Agents’ Option.

The Company has agreed to pay to the Agents a cash commission equal to 6% of the gross proceeds of the Offering. The Company has also agreed to issue to the Agents that number of compensation options (“Compensation Options”) equal to 6.0% of the aggregate number of Shares issued by the Company under the Offering. Each Compensation Option is exercisable to acquire one Common Share at a price equal to the Offering Price for a period of 24 months from the closing date of the Offering.

Subject to compliance with applicable regulatory requirements and in accordance with National Instrument 45-106 - Prospectus Exemptions (“NI 45-106”), the Offering will be offered for sale to purchasers resident in all of the provinces of Canada with the exception of Québec pursuant to the listed issuer financing exemption under Part 5A of NI 45-106, as amended by Coordinated Blanket Order 45-935 - Exemptions from Certain Conditions of the Listed Issuer Financing Exemption (the “Listed Issuer Financing Exemption”). The securities issuable from the sale of the Offering are expected to be immediately freely tradeable in accordance with applicable Canadian securities legislation if sold to purchasers resident in Canada. The Common Shares may also be sold in offshore jurisdictions and in the United States on a private placement basis pursuant to one or more exemptions from the registration requirements of the United States Securities Act of 1933, as amended (the “U.S. Securities Act”). The minimum amount to be raised in the offering is $5,000,000.

There is an offering document (the “Offering Document”) related to the Offering that can be accessed under the Company's profile at www.sedarplus.ca and on the Company’s website at www.atlassalt.com. Prospective investors should read this Offering Document before making an investment decision.

The net proceeds received from the Offering will be used for civil engineering work related to advancing the Great Atlantic Salt Project towards development and for general corporate and working capital purposes, as further described in the Offering Document.

The Offering is scheduled to close on or about October 21, 2025 (“Closing Date”) or such other date as the Company and the Agents may agree and, in any event, on or before a date not later than 45 days after the date of the news release announcing the Offering. Completion of the Offering is subject to certain conditions including, but not limited to, the receipt of all necessary approvals, including the approval of the TSX Venture Exchange.

Certain insiders of the Company are anticipated to participate in the Offering, and such participation by insiders will constitute a related party transaction as defined in Multilateral Instrument 61-101 - Protection of Minority Security Holders in Special Transactions (“MI 61-101”). The Company intends to rely on exemptions from the formal valuation and minority shareholder requirements provided under sections 5.5(a) and 5.7(1)(a) of MI 61-101 on the basis that neither the fair market value of the securities to be issued under the Offering nor the consideration to be paid by insiders of the Company will exceed 25% of the Company's market capitalization.

This news release does not constitute an offer to sell or a solicitation of an offer to sell any securities in the United States. The securities have not been and will not be registered under the U.S. Securities Act or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.

About Atlas Salt

Atlas Salt is developing Canada’s next salt mine and is committed to responsible and sustainable mining practices. With a focus on innovation and efficiency, the company is poised to make significant contributions to the North American salt market while upholding its values of environmental stewardship and community engagement.

For information, please contact:

Jeff Kilborn, CFO & VP Corporate Development
[email protected]
(709) 275-2009

We seek safe harbour.

Cautionary Statement

Neither the TSX Venture Exchange nor its Regulation Services Provider (as the term is defined in the Policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. This press release includes certain “forward-looking information” and “forward-looking statements” (collectively “forward-looking statements”) within the meaning of applicable Canadian securities legislation. All statements, other than statements of historical fact, included herein, without limitation, statements relating to the future operating or financial performance of the Company, are forward-looking statements. Forward-looking statements are frequently, but not always, identified by words such as “expects”, “anticipates”, “believes”, “intends”, “estimates”, “potential”, “possible”, and similar expressions, or statements that events, conditions, or results “will”, “may”, “could”, or “should” occur or be achieved. Forward-looking statements in this press release relate to the anticipated closing of the Offering; the approval of the TSX Venture Exchange; the filing of the Offering Document; the intended use of proceeds from the Offering. Actual future results may differ materially. There can be no assurance that such statements will prove to be accurate, and actual results and future events could differ materially from those anticipated in such statements. Forward-looking statements reflect the beliefs, opinions and projections on the date the statements are made and are based upon a number of assumptions and estimates that, while considered reasonable by the respective parties, are inherently subject to significant business, technical, economic, and competitive uncertainties and contingencies. Many factors, both known and unknown, could cause actual results, performance or achievements to be materially different from the results, performance or achievements that are or may be expressed or implied by such forward-looking statements and the parties have made assumptions and estimates based on or related to many of these factors. Such factors include, without limitation: the timing, completion and delivery of required permits, supply arrangements and financing. Readers should not place undue reliance on the forward-looking statements and information contained in this news release concerning these times. Except as required by law, the Company does not assume any obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change, except as required by law.
2025-10-14 10:21 4mo ago
2025-10-14 06:00 4mo ago
Solidion Technology Will Avoid Substantially Dilutive Share Sales stocknewsapi
STI
Company Intends to Shun Highly Toxic Financing Structures and May Consider Long-Term or Strategic Partners For Future Capital Needs

, /PRNewswire/ -- Solidion Technology Inc. ("Solidion" or the "Company") (Nasdaq: STI), an advanced battery technology solutions provider, today reaffirmed its commitment to protect shareholder value by avoiding financing structures that could result in substantial dilution to existing investors.

Jaymes Winters, Chief Executive Officer of Solidion Technology, stated:

"Our focus remains on building intrinsic value through the commercialization of our advanced solid-state battery technology. To that end, we intend to avoid financing arrangements that create short-term pressure or excessive dilution. Instead, we are open to proposals from long-term or strategic investors who share our vision for sustainable growth and value creation."

Solidion continues to advance key initiatives aimed at scaling production capacity, securing strategic partnerships, and expanding its customer base across the EV and energy storage sectors. The Company expects to provide further updates on its commercialization roadmap in the coming quarters.

About Solidion Technology, Inc.

Headquartered in Dallas, Texas with pilot production facilities in Dayton, Ohio, Solidion's (NASDAQ: STI) core business includes manufacturing of battery materials and components, as well as development and production of next-generation batteries for energy storage systems, including UPS systems serving the artificial intelligence (AI) data center market and electric vehicles for ground, aerospace, and sea transportation. Solidion holds a portfolio of over 525 patents, covering innovations such as high-capacity, silane gas free and graphene-enabled silicon anodes, biomass-based graphite, advanced lithium-sulfur and lithium-metal technologies.

For more information, please visit www.solidiontech.com or contact Investor Relations.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Solidion Technology Inc., (NASDAQ: STI) (the "Company," "Solidion," "we," "our" or "us") desires to take advantage of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and is including this cautionary statement in connection with this safe harbor legislation. The words "forecasts" "believe," "may," "estimate," "continue," "anticipate," "intend," "should," "plan," "could," "target," "potential," "is likely," "expect" and similar expressions, as they relate to us, are intended to identify forward-looking statements. We undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future developments or otherwise, except as may be required by law.

SOURCE Solidion Technology, Inc.

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+

Newsrooms &

Influencers

9k+

Digital Media

Outlets

270k+

Journalists

Opted In
2025-10-14 10:21 4mo ago
2025-10-14 06:00 4mo ago
Loncor Gold Announces Acquisition by Chengtun Mining for C$261 Million stocknewsapi
LONCF
October 14, 2025 6:00 AM EDT | Source: Loncor Gold Inc.
Toronto, Ontario--(Newsfile Corp. - October 14, 2025) - Loncor Gold Inc. (TSX: LN) (OTCQX: LONCF) (FSE: LO5) ("Loncor" or the "Company") and Chengtun Mining Group Co., Ltd. (SSE: 600711), Ltd, through its wholly-owned subsidiary, Chengtun Gold Ontario Inc. (collectively "Chengtun Mining" or the "Purchaser"), are pleased to announce they have entered into an arrangement agreement (the "Arrangement Agreement"), pursuant to which Chengtun Mining will acquire all the outstanding common shares of Loncor (each, a "Loncor Share"), in exchange for C$1.38 per Loncor Share (the "Consideration") in an all-cash transaction by way of a plan of arrangement (the "Transaction"). The Consideration represents total equity value of approximately C$261 million on a fully diluted basis.

The Consideration represents a premium of approximately 33% to the 30-day volume weighted average trading price ("VWAP") of the Loncor Shares, and a premium of approximately 16% to the closing price of the Loncor Shares as at October 10, 2025 on the Toronto Stock Exchange (the "TSX"). Further details of the Transaction are outlined below.

As part of the Transaction, Loncor shareholders representing approximately 38% of the issued and outstanding Loncor Shares have signed voting support agreements, pursuant to which they have agreed, among other things, to vote their Loncor Shares in favour of the Transaction.

Arnold Kondrat, Executive Chairman of Loncor, commented: "I am pleased to announce that we have entered into an agreement for the sale of the Company, marking a significant achievement for all stakeholders. This Transaction crystallizes the inherent value we have built over 15 years and eliminates future dilution while mitigating commodity, political, and execution risks. The sale delivers a strong outcome for shareholders."

Transaction Highlights

Immediate and significant premium of approximately 33% and 16% to the 30-day VWAP and the closing price of the Loncor Shares, respectively. All-cash offer, providing certainty of value and immediate liquidity to Loncor shareholders. Highly capable counterparty in Chengtun Mining which is principally engaged in trading and mining of new energy metal business internationally. Chengtun Mining's products mainly include copper, cobalt, nickel and gold, and has accumulated extensive operational experience in the Democratic Republic of the Congo.Crystallizes value while removing future dilution, commodity and execution risk for Loncor shareholders. Leverage's Chengtun Mining's strong access to capital and depth of technical and in-country expertise to develop the Imbo project. Transaction Terms

Pursuant to the terms and conditions of the Arrangement Agreement, signed on October 14, 2025, the holders of the issued and outstanding Loncor Shares will receive the Consideration. The Transaction will be carried out by way of court-approved plan of arrangement under the Business Corporations Act (Ontario).

The Arrangement Agreement contains customary reciprocal deal-protection provisions including a non-solicitation covenant and a "fiduciary out" that would allow Loncor to accept a superior proposal as defined in the Arrangement Agreement, subject to a right for Chengtun Mining to match any superior proposal. The Arrangement Agreement also provides for a mutual reciprocal termination fee of C$10 million, payable in certain circumstances.

Pursuant to the Arrangement Agreement, each outstanding Loncor stock option and Loncor common share purchase warrant outstanding at the effective time of the Transaction, will be deemed to be surrendered, assigned and transferred by the holder thereof to Loncor in exchange for a cash payment equal to the amount by which the Consideration exceeds the exercise price of such stock option or warrant, as applicable.

The Arrangement Agreement also provides that the Purchaser will provide to Loncor refundable advances totalling US$3,000,000 within the 60 day period following the date of the Arrangement Agreement. These advances are to be used in connection with the Company's ongoing exploration program at the Adumbi deposit and for general corporate purposes.

Further details of the Arrangement Agreement will be included in a management information circular of Loncor that is expected to be mailed to Loncor shareholders in the coming weeks. A copy of the Arrangement Agreement will be made available on Loncor's SEDAR+ profile at www.sedarplus.ca.

Conditions to Completion

The completion of the Transaction is subject to a number of terms and conditions, including without limitation the following: (i) approval of the Loncor shareholders, as described below; (ii) acceptance of the TSX; (iii) approval of the Ontario Superior Court; and (iv) other standard conditions of closing for a transaction of this nature. There can be no assurance that all of the necessary approvals will be obtained or that all conditions of closing will be satisfied.

The Transaction is subject to the approval at a special meeting of Loncor shareholders (the "Loncor Meeting") by: (a) 66 2/3 percent of the votes cast by Loncor shareholders; and (b) a majority of the votes cast by the Loncor shareholders (excluding the votes cast by persons whose votes may not be included in determining minority approval of a "business combination" in accordance with Multilateral Instrument 61-101 - Protection of Minority Security Holders in Special Transactions).

Transaction Timeline

Subject to certain conditions, including the parties obtaining the requisite regulatory approvals, the Transaction is expected to close not later than Q1 2026. Following completion of the Transaction, the Loncor Shares are expected to be de-listed from the TSX. Loncor will also apply to cease to be a reporting issuer under Canadian securities laws and a registrant with the United States Securities and Exchange Commission (the "SEC").

Voting Support Agreements

Each director and officer of Loncor, and Loncor's largest shareholders, Resolute Mining Ltd, and Arnold Kondrat (Executive Chairman of Loncor), who own approximately 18% and 17%, respectively, of the issued and outstanding Loncor Shares, have entered into a voting support agreement with Chengtun Mining pursuant to which they have agreed to vote their respective Loncor Shares in favour of the Transaction at the Loncor Meeting.

Loncor Board of Directors' and Special Committee Recommendations

After consultation with its financial and legal advisors, and following the unanimous recommendation of a special committee of independent directors (the "Special Committee"), the board of directors of Loncor (the "Loncor Board") unanimously determined the Transaction is fair to Loncor shareholders, is in the best interest of Loncor and approved the entering into of the Transaction. The Loncor Board recommends that Loncor shareholders vote in favour of the Transaction. Stifel Canada provided a fairness opinion to the Special Committee, stating that, as of the date of such opinion and based upon and subject to the assumptions, limitations and qualification stated in such opinion, the Consideration to be received by Loncor shareholders under the Transaction is fair, from a financial point of view, to such Loncor shareholders. The fairness opinion provided by Stifel Canada will be included in the circular mailed to Loncor shareholders.

Advisors and Counsel

Stifel Canada and EB Capital Advisory are acting as financial advisors to Loncor and the Loncor Board. Dickinson Wright LLP are acting as Loncor's legal counsel. Baker McKenzie FenXun acted as international counsel to Chengtun Mining and Dentons Canada LLP acted as Canadian counsel to Chengtun Mining.

About Loncor Gold Inc.

Loncor is a Canadian gold exploration company focused on the Ngayu Greenstone Gold Belt in the northeast of the Democratic Republic of the Congo (the "DRC"). The Loncor team has over two decades of experience of operating in the DRC. Loncor's growing resource base in the Ngayu Belt is focused on the Imbo Project where the Adumbi deposit holds an indicated mineral resource of 1.88 million ounces of gold (28.185 million tonnes grading 2.08 g/t gold), and the Adumbi deposit and two neighbouring deposits hold an inferred mineral resource of 2.090 million ounces of gold (22.508 million tonnes grading 2.89 g/t Au), with 84.68% of these resources being attributable to Loncor. Following a drilling program carried out by the Company at the Adumbi deposit in 2020 and 2021, the Company completed a Preliminary Economic Assessment ("PEA") of the Adumbi deposit and announced the results of the PEA in December 2021.

Additional information with respect to Loncor and its projects can be found on Loncor's website at www.loncor.com.

About Chengtun Mining Group Co., Ltd.

Chengtun Mining specializes in developing new energy metal resources. The company's core operations include mining and refining of energy metals and base metals, with strategic focus on copper, cobalt, nickel for new energy batteries. The company has also identified gold and other precious metals as a key strategic business area for future development. Chengtun owns and operates mines in the Democratic Republic of the Congo, most notably the Kalongwe copper-cobalt mine. Chengtun Mining is publicly listed on the Shanghai Stock Exchange under the ticker 600711.

Cautionary Note Concerning Forward-Looking Information

This press release contains forward-looking information. All statements, other than statements of historical fact, that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future (including, without limitation, statements regarding completion of the terms and conditions of the Transaction, receipt of Loncor shareholder and court approval of the Transaction, the Purchaser advancing funds to the Company, disclosure in the Company's management information circular, the expected closing date of the Transaction, the Company ceasing to be a reporting issuer in Canada and a registrant with the SEC in the United States and the delisting of the Loncor Shares) are forward-looking information. This forward-looking information reflects the current expectations or beliefs of the Company based on information currently available to the Company. Forward-looking information is subject to a number of risks and uncertainties that may cause the actual results of the Company to differ materially from those discussed in the forward-looking information, and even if such actual results are realized or substantially realized, there can be no assurance that they will have the expected consequences to, or effects on the Company. Factors that could cause actual results or events to differ materially from current expectations include, among other things, risks associated with the possibility that the Transaction will not be completed on the terms and conditions, or on the timing, currently contemplated, and that it may not be completed at all, due to a failure to obtain or satisfy, in a timely manner or otherwise, required shareholder, court and regulatory approvals and other conditions of closing necessary to complete the Transaction or for other reasons, the possibility of adverse reactions or changes in business relationships resulting from the announcement or completion of the Transaction, risks relating to the abilities of the parties to satisfy conditions precedent to the Transaction, a third party superior proposal materializing prior to the completion of the Transaction and the other risks disclosed under the heading "Risk Factors" and elsewhere in the Company's annual information form dated March 31, 2025 filed on SEDAR+ at www.sedarplus.ca and EDGAR at www.sec.gov. Forward-looking information speaks only as of the date on which it is provided and, except as may be required by applicable securities laws, the Company disclaims any intent or obligation to update any forward-looking information, whether as a result of new information, future events or results or otherwise. Although the Company believes that the assumptions inherent in the forward-looking information are reasonable, forward-looking information is not a guarantee of future performance and accordingly undue reliance should not be put on such information due to the inherent uncertainty therein.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/270343
2025-10-14 10:21 4mo ago
2025-10-14 06:00 4mo ago
Naughty Ventures Provides Update on High-Grade Rare-Earth Elements Property, Newfoundland and Corporate Update stocknewsapi
SFRIF
Vancouver, British Columbia--(Newsfile Corp. - October 14, 2025) - Naughty Ventures Corp. (CSE: BAD) (OTC Pink: YORKFF) (FSE: 5DE) (the "Company" or "Naughty Ventures") is pleased to provide shareholders with an update on its corporate activities and ongoing projects, including its high-grade rare-earth elements property in Newfoundland. CEO Update Blair Naughty, Chief Executive Officer of Naughty Ventures, reminds shareholders of the Company's holdings in the Bottom Brook Rare-Earth Property ("Bottom Brook Property" or the "Property") located in Newfoundland, Canada.
2025-10-14 10:21 4mo ago
2025-10-14 06:00 4mo ago
Ascletis Completes Denifanstat (ASC40) Pre-NDA Consultation with China National Medical Products Administration stocknewsapi
SGMT
- Denifanstat (ASC40) met all primary, key secondary and secondary efficacy endpoints (ITT analysis) and significantly improved moderate-to-severe acne vulgaris compared with placebo in a Phase III randomized, double-blind, placebo-controlled, multicenter clinical trial. HONG KONG , Oct. 14, 2025 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces today that it recently completed the pre-New Drug Application (NDA) consultation with China National Medical Products Administration (NMPA) for denifanstat (ASC40) for the treatment of moderate-to-severe acne vulgaris and plans to submit an NDA soon.
2025-10-14 10:21 4mo ago
2025-10-14 06:00 4mo ago
Happy Belly Food Group Announces New Franchise Agreement and Real Estate Secured for Heal Wellness in Airdrie, Alberta stocknewsapi
HBFGF
October 14, 2025 6:00 AM EDT | Source: Happy Belly Food Group Inc.
Toronto, Ontario--(Newsfile Corp. - October 14, 2025) - Happy Belly Food Group Inc. (CSE: HBFG) (OTCQB: HBFGF) ("Happy Belly" or the "Company"), a leader in acquiring and scaling emerging food brands across Canada, is pleased to announce the signing of a new franchise agreement and secured real estate for Heal Wellness ("Heal") in Airdrie, Alberta - a thriving and fast-growing community located just north of Calgary. Heal Wellness is a quick-service restaurant ("QSR") specializing in fresh smoothie bowls, açaí bowls, and smoothies.

"With both a franchise agreement and real estate now secured, Airdrie will represent an exciting step forward in our expansion across Alberta," said Sean Black, Chief Executive Officer of Happy Belly. "The city's rapid population growth, strong family demographics, and health-conscious residents make it an ideal market for Heal. This signing reflects the continued confidence our franchise partners have in our scalable, asset-light business model, and further demonstrates the nationwide demand for our wellness-focused brand."

Happy Belly 1

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/6625/270319_063cf4549454f881_002full.jpg

As one of the fastest-growing cities in Canada, Airdrie's proximity to Calgary provides access to a robust consumer base of commuters, families, and young professionals seeking convenient, nutritious, and energizing dining options. Its active, community-driven lifestyle-anchored by local fitness hubs, schools, and sports programs-perfectly complements Heal Wellness' mission to provide better-for-you food that fuels busy lives.

Happy Belly 2

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/6625/270319_063cf4549454f881_003full.jpg

Heal Wellness continues to accelerate its coast-to-coast expansion, solidifying its growing position as Canada's leading smoothie bowl and wellness QSR brand. Founded with a mission to deliver quick, fresh wellness foods that support busy, active lifestyles, Heal Wellness offers a diverse range of smoothie bowls, smoothies, and super-seed grain bowls-all crafted with real fruit and enriched with superfoods such as açaí, pitaya, goji berries, and chia seeds. With 27 locations currently open and over 168 in development, Heal Wellness continues to gain nationwide momentum through consistent franchise growth and strategic real estate execution, contributing to Happy Belly Food Group's total of 626 contractually committed retail franchise locations across its portfolio of emerging brands-including Heal Wellness, Rosie's Burgers, Yolks Breakfast, Via Cibo Italian Street Food, and others-now in various stages of development, construction, and operation nationwide.

"We are just getting started," added Sean Black.

About Heal Wellness Heal Wellness was founded with a passion and mission to provide quick, fresh wellness foods that support a busy and active lifestyle. We currently offer a diverse range of smoothie bowls and smoothies. We take pride in meticulously selecting every superfood ingredient on our menu to fuel the body, including acai smoothie bowls, smoothies, and super-seed grain bowls. Our smoothie bowls are crafted with real fruit and enriched with superfoods like acai, pitaya, goji berries, chia seeds, and more.

FranchisingFor franchising inquiries, please see www.happybellyfg.com/franchise-with-us/ or contact us at [email protected].

About Happy Belly Food GroupHappy Belly Food Group Inc. (CSE: HBFG) (OTCQB: HBFGF) ("Happy Belly" or the "Company") is a leader in acquiring and scaling emerging food brands across Canada.

Happy Belly 3

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/6625/270319_063cf4549454f881_004full.jpg

Sean Black
Chief Executive Officer

Shawn Moniz
Chief Operating Officer

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this press release, which has been prepared by management.

Cautionary Note Regarding Forward-Looking Statements

All statements in this press release, other than statements of historical fact, are "forward-looking information" with respect to the Company within the meaning of applicable securities laws. Forward-Looking information is frequently characterized by words such as "plan", "expect", "project", "intend", "believe", "anticipate", "estimate" and other similar words, or statements that certain events or conditions "may" or "will" occur and include the future performance of Happy Belly and her subsidiaries. Forward-Looking statements are based on the opinions and estimates at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those anticipated in the forward-looking statements. There are uncertainties inherent in forward-looking information, including factors beyond the Company's control. There are no assurances that the business plans for Happy Belly described in this news release will come into effect on the terms or time frame described herein. The Company undertakes no obligation to update forward-looking information if circumstances or management's estimates or opinions should change except as required by law. The reader is cautioned not to place undue reliance on forward-looking statements. For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company's Management's Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted on www.sedarplus.ca.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/270319
2025-10-14 10:21 4mo ago
2025-10-14 06:00 4mo ago
Capitan Silver Corp Intersects 1,541 g/t Silver Equivalent over 1.5 Metres within a Wider Zone of 201.6 g/t Silver Equivalent over 18.3 Metres at the Jesús María Silver Trend stocknewsapi
CAPTF
Drilling Across Cruz de Plata Property Continuing to Deliver High-Grade Results; New Zones Emerging at Depth, Strong Mineralized Continuity Intersected, and More New Targets Identified
October 14, 2025 6:00 AM EDT | Source: Capitan Silver Corp.
Vancouver, British Columbia--(Newsfile Corp. - October 14, 2025) - Capitan Silver Corp. (TSXV: CAPT) ("Capitan" or "the Company") is pleased to report assay results from its recently expanded and fully funded Phase One reverse circulation ("RC") 15,000 metre drill program at its Cruz de Plata silver-gold project, located in Durango, Mexico. The Company is reporting assay results from twelve (12) drillholes.

Highlights:

New high-grade silver mineralization intersected in the extension of the Jesús María veinDrillhole 25-ERRC-20 intersected 1,541 g/t AgEq over 1.5m, within a broader interval of 201.65 g/t AgEq over 18.3mThe mineralization intersected is believed to be the continuation of the Jesús María main vein which has been offset to the north by the Peñoles FaultJesús María vein remains open to the east and at depth, as well as open down plunge of drillhole 25-ERRC-12 (previously released), which returned one of the highest-grade intervals to date at Cruz de Plata:Drillhole 25-ERRC-12 intersected 2,636 g/t Ag over 1.5m, within a wider interval of 1,400 g/t Ag over 4.6m, occurring within a broader zone of 370.2 g/t Ag over 19.8m (See Capitan news release dated September 2, 2025)Peñoles Fault emerging as a new key target: Northwest-striking Peñoles Fault emerging as a high-priority target, with evidence of enhanced mineralization open at depth, especially where the fault intersects east-west trending zones. New high-grade east-west trending zone discovered along the Jesús María silver trendDrillhole 25-ERRC-17 intersected 475.91 g/t AgEq over 1.5m, within a broader zone of 117.69 g/t AgEq over 7.6m proximal to the Peñoles FaultContinued high-grade silver mineralization intersected at the Gully Fault Zone; three (3) distinct zones of mineralization identified:Drillhole JMRC-33Gully Fault: intersected 216.2 g/t AgEq over 13.5m, within a broader interval of 100.7 g/t AgEq over 44.2mJesús María: intersected 803.6 g/t AgEq over 1.5m, within a broader interval of 129.2 g/t AgEq over 22.9mNew Zone: intersected 139.8 g/t AgEq over 3.0m and 128.6 g/t AgEq over 4.6mDrillhole JMRC-25 Gully Fault: intersected 408.4 g/t AgEq over 3.0m, within a broader zone of 112.2 g/t AgEq over 38.1mJesús María: intersected 13.7m of vein zone with two separate 1.5m underground openings with no drill recoveryNew Zone: intersected 358.2 g/t AgEq over 1.5m within 213.1 g/t AgEq over 3m and 276.8 g/t AgEq Drillhole JMRC-26 intersected three (3) high-grade intervals including: Gully Fault: intersected 390.8 g/t AgEq over 1.5m, within a broader interval of 111.9 g/t AgEq over 9.1mJesús María: intersected 502.0 g/t AgEq over 1.5m, and 328.6 g/t AgEq over 1.5m within a broader interval of 238.4 g/t AgEq over 10.7mNew Zone: intersected 100.2 g/t AgEq over 4.6mCatalyst-rich Q4 2025 and Q1 2026: Drilling is ongoing with assays pending for 28 RC drillholesCapitan Silver's CEO Alberto Orozco commented:

"Capitan's 2025 drill program at Cruz de Plata continues to deliver encouraging results; I am very excited by the progress our team has made with regards to intersecting high-grade silver mineralization as well as identifying new zones and targets for further drilling. Cruz de Plata is a robust and rich silver mineralized system - and we are finding that the more we drill, the more mineralization we continue to find."

"I am also pleased to see that the reported drilling has provided further evidence that supports the Company's new geological model - that key radial structures like the Gully Fault and potentially the Peñoles Fault, which are associated with the large intrusion to the north of the Jesús María silver trend - play an important role with respect to the distribution of mineralization at Cruz de Plata.

"Looking ahead, we remain focused on growing the mineralized system at Cruz de Plata and providing our investors and the market with more evidence that we are developing a very compelling new project."

The Silver System at Cruz de Plata Continues to Expand

Fieldwork conducted by the Capitan team continues to increase the footprint of the silver-rich mineralized system at Cruz de Plata, revealing additional structures and zones. Expanded mineralization is evidenced through high-grade hits, like the one returned from drillhole 25-ERRC-20 which intersected the Jesús Maria vein, the potential new zone discovered by drillhole 25-ERRC-17, additional robust results coming from drilling at the Gully Fault Zone, and the identification of a new priority drill target at the Peñoles Fault.

Drilling continues to steadily progress at the Cruz De Plata project, with a total of 51 drillholes completed to date across the Jesús María trend, Gully Fault, as well as new, early-stage targets to the north and east of these known trends (See Figures 1 and 2).

Figure 1. Drill hole map of the Cruz de Plata project showing the location of the holes reported in this release along the Jesús María silver trend with geological units.

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/7373/270341_68ace16194f8a9ec_002full.jpg

Figure 2. Inclined view (Plunge +50, looking North) of Jesús María silver vein.

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/7373/270341_68ace16194f8a9ec_003full.jpg

Jesús María Main Vein Continues

Drilling across the property continues to return high-grade silver results. Surface chip sampling in the vicinity of drillhole 25-ERRC-20 returned moderate to high-grade values. Drill testing returned high-grade silver values, with drillhole 25-ERRC-20 returning very high silver grades with 1,541 g/t AgEq over 1.5m, within a broader interval of 201.65 g/t AgEq over 18.3m. This area appears to be an offset and continuation of the Jesús María vein. Follow-up drilling is planned for this area to extend this new discovery down-dip and along strike.

Potential Discovery of New Zone from Drillhole 25-ERRC-17

A new area of mineralization was tested in between the 200m step-out hole that identified the Jesús María offset to the north and the Jesús María trend to the south (See Figure 1, Plan Map). A total of six (6) holes tested an approximate 250m strike along this trend, with all of them returning silver mineralization ranging from low to high-grade. Best results include 475.91 g/t AgEq over 1.5m, within a wider interval of 117.69 g/t AgEq over 7.6m from drillhole 25-ERRC-17, and 310.37 g/t AgEq over 1.5m from drillhole 25-ERRC-18, respectively. Follow-up drilling is expected for this area, focused on-strike to the west and down-dip of drillhole 25-ERRC-17 proximal to the Peñoles Fault.

Gully Fault Zone Drill Results Reveal Multiple Zones of Silver Mineralization

Additionally, three (3) drillholes were completed at the Jesús María and Gully Fault intersection - drillholes 25-JMRC-25, 25-JMRC-26, and 25-JMRC-33. The purpose of this drilling was to test the continuity of the Gully Fault north of Jesús María, as well as to glean more insights with respect to the orientation of the two mineralization styles. All holes returned near-surface intersections of both Gully Fault and Jesús María-style silver mineralization. In addition, a new zone of mineralization appears to be developing at depth, which is interpreted to be co-located with the Gully Fault, intersecting additional sub-parallel structures to Jesús María in the footwall to the Jesús María zone. Best near-surface results include 803.6 g/t AgEq over 1.5m, within a broader interval of 129.2 g/t AgEq over 22.9m in drillhole 25-JMRC-33 (Jesús María vein), and 502.0 g/t AgEq over 1.5m in drillhole 25-JMRC-26.

Several new gold-silver and polymetallic (gold-silver-lead-zinc) zones were also intersected in the footwall to the Jesús María zone, representing a new target to be followed up on (see Table 1 and Figures 1 and 2). These zones have shown some continuity along strike to the west and up-dip but require further investigation. This new zone appears to trend roughly parallel to the Jesús María vein, remains open at depth and to the east, and may or may not come to surface. Most notably, parts of this zone appear to carry higher gold tenors, compared to both the Jesús María Zone and Gully Fault Zone, and may represent a new style of mineralization beginning to emerge. The best intersections from this area include 358.2 g/t AgEq over 1.5m within 213.1 g/t AgEq over 3m in drillhole 25-JMRC-25, 276.8 g/t AgEq over 1.5m within 108.9 g/t AgEq over 4.6m in drillhole 25-JMRC-25, 100.2 g/t AgEq over 4.6m in drillhole 25-JMRC-26, and 139.8 g/t AgEq over 3.0m and 128.6 g/t AgEq over 4.6m in drillhole 25-JMRC-33 (See Table 1).

New Geological Interpretation: Enhanced Mineralization at the Peñoles Fault

Recent drilling as well as surface mapping at the Cruz de Plata project has revealed that a major northwest-trending structure known as the Peñoles Fault appears to be an important feature in the potential distribution of high-grade silver-gold mineralization across the central portion of the property (See Figures 1 and 2). This has been identified as a priority follow-up target.

Table 1. Drill results

Hole IDFrom (m)To
(m)Interval
(m)Ag Eq Rec (g/t)Ag
(ppm)Au
(ppm)Pb
(%)Zn
(%)ZONE25-ERRC-11interval3.012.29.151.9748.470.080.010.02
interval16.821.34.693.0050.730.640.010.03
including18.319.81.5178.576.41.530.020.02
interval36.639.63.042.4139.900.060.010.01
interval51.862.510.794.0793.370.070.020.03
including51.853.31.5347.33349.000.210.090.06
interval80.897.516.864.7155.050.100.100.09
interval102.1112.810.736.1431.790.050.030.06
interval141.7146.34.625.5820.530.020.050.10
25-ERRC-13No significant mineralization25-ERRC-14interval117.3120.43.036.9634.050.050.000.04
interval131.1137.26.128.1522.230.100.000.01
25-ERRC-15interval42.745.73.067.8766.600.060.000.03
interval108.2112.84.650.9451.370.030.000.02
25-ERRC-16interval131.064132.61.5275.6170.000.120.010.03
25-ERRC-17interval132.6140.27.6117.69108.380.220.010.02
including138.7140.21.5475.91451.000.730.030.04
interval166.1170.74.655.9638.600.270.010.02
including167.6169.21.5102.874.30.460.010.02
interval175.3179.84.637.7218.470.280.010.02
interval189.0190.51.552.2936.700.240.010.02
25-ERRC-18interval35.136.61.5112.42114.400.050.010.04
interval53.354.91.543.7340.400.080.000.02
interval114.3115.81.5310.37324.000.050.030.04
interval134.1135.61.560.7256.700.060.010.08
25-ERRC-19interval54.956.41.525.0018.300.100.000.02
interval108.2109.71.564.1765.700.030.000.01
interval155.4157.01.530.1619.600.170.000.00
25-ERRC-20interval13.732.018.3201.65200.280.170.030.03
including18.322.44.6688.8709.80.250.090.05
including18.319.81.51,541.031,599.000.430.210.07
including19.821.31.5369.09375.000.200.050.05
interval45.747.21.528.6821.100.110.020.02
25-JMRC-25Interval10.748.838.1112.293.40.2530.070.15Gully FaultIncluding19.822.93408.4371.50.5730.490.18Interval56.459.4368.732.10.2490.50.22Jesús María Vein (13.7m)
6162.51.5OPEN UNDEGROUND WORKING / NO RECOVERYInterval62.565.53162.252.30.2570.542.36
65.567.11.5OPEN UNDEGROUND WORKING / NO RECOVERYInterval67.170.13213.1820.2891.112.5NewIncluding67.168.61.5358.2142.80.4071.894.2Interval109.7114.34.6108.161.60.1710.60.63NewIncluding109.7111.31.5276.8165.600.381.451.59Interval126.5138.712.241.313.20.2710.10.22New25-JMRC-26Interval24.433.59.1111.9101.80.0850.190.15Gully FaultIncluding25.927.41.5390.83770.1040.640.33Interval61.071.610.7238.4117.10.551.521.42Jesús María VeinIncluding67.168.61.5502.0278.00.315.571.85Including70.171.61.5328.6106.61.552.211.76Interval80.886.96.150.213.90.0770.280.71NewInterval149.4155.46.192.419.90.9380.130.16NewIncluding149.4153.94.6100.218.071.090.130.1425-JMRC-33Interval13.757.944.2100.765.320.520.040.08Gully Faultincluding25.939.613.5216.2142.011.120.080.1including27.429.01.5315.1310.000.280.050.10including36.638.11.5301.0155.802.160.080.10interval50.357.97.685.161.70.330.040.1including54.956.41.5151.2102.20.700.050.16Interval68.691.422.9129.267.150.370.620.68Jesús María Veinincluding85.389.94.6374.1234.40.612.141.53including86.988.41.5803.6523.001.214.343.15Interval125.0128.03.0139.869.350.510.640.64NewInterval141.7146.34.680.225.800.280.480.69NewInterval152.4157.04.6128.649.700.490.680.86NewInterval173.7178.34.633.14.530.410.000.01NewMetal Recovery: Ag 94%, Au 86%, Pb 93.5%, Zn 92%

AgEq considers Ag, Au, Pb and Zn and calculated as follows: AgEq = Ag g/t + (80x Au g/t) + (0.003 x Pb g/t) + (0.0037 x Zn g/t). High grades have not been capped. Capitan Silver field samples are sent to the Bureau Veritas Lab in Durango, Mexico for prep. RC Drill samples have been analysed using the following codes: MA300, 4-acid digestion, multi-element analysis (Vancouver Lab). Au is analyzed using Fire Assay (FA430, Durango Lab). Overlimit (>200 ppm Ag) assays utilize method MA370, with gravimetric utilized for any overlimit thereafter. QAQC: Capitan Silver maintains a rigorous QAQC program and inserts multiple standards, blanks and duplicates into the sample stream at regular intervals. Check Assays are performed at SGS laboratories in Durango, Mexico.

Qualified Person

The scientific and technical data contained in this news release pertaining to the Cruz de Plata project was reviewed and approved by Marc Idziszek, P.Geo, a non-independent qualified person to Capitan Silver, who is responsible for ensuring that the technical information provided in this news release is accurate and who acts as a "qualified person" under National Instrument 43-101 Standards of Disclosure for Mineral Projects.

About Capitan Silver Corp.

Capitan Silver is defining a new high-grade silver system at its Cruz de Plata project, located in the heart of Mexico's primary silver belt. The Company is led by a proven and accomplished management team that has previously advanced three projects into production, on time and on budget. The Company has been diligent in maintaining a tight share structure and has one of the tightest share structures among its peer group, with the top three shareholders owning over 38% of the Company's share capital. Capitan Silver is fully funded and actively drilling at its Cruz de Plata silver project.

ON BEHALF OF CAPITAN SILVER CORP.

"Alberto Orozco"

Alberto Orozco, CEO

For Additional Information Contact:

DISCLAIMER FOR FORWARD-LOOKING INFORMATION

Certain statements in this press release may be considered forward-looking information. These statements can be identified by the use of forward-looking terminology (e.g., "expect", "estimates", "intends", "anticipates", "believes", "plans"). Such information involves known and unknown risks -- including the availability of funds, the results of financing and exploration activities, the interpretation of exploration results and other geological data, or unanticipated costs and expenses and other risks identified by Capitan in its public securities filings that may cause actual events to differ materially from current expectations. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/270341
2025-10-14 10:21 4mo ago
2025-10-14 06:00 4mo ago
Disney has considered a co-CEO structure to replace Bob Iger. Its history may make that a bad idea stocknewsapi
DIS
As 2025 enters its final months, Disney inches closer to the announcement the entire entertainment industry has been waiting for — who will take over for Bob Iger as the company's next CEO.

Disney has publicly stated it will name Iger's successor in early 2026. Two internal candidates stand out as the most likely contenders: Disney Entertainment co-chairman Dana Walden and Disney Experiences chairman Josh D'Amaro. Walden brings decades of Hollywood expertise; D'Amaro worked in consumer products before his elevation in the theme parks division all the way up to running the unit when its previous leader, Bob Chapek, was named Disney CEO in 2020.

Given Walden's and D'Amaro's complementary skill sets — and given recent momentum behind co-CEO appointments both in media and beyond — the Disney board could opt to select both to jointly replace Iger.

It's a strategy rival Netflix has similarly — and effectively — used since 2020, when Reed Hastings named Ted Sarandos his co-CEO. Three years later, Hastings relinquished that post and moved on to become the company's executive chairman, elevating Greg Peters into his spot as co-CEO.

Netflix's success has contributed to a recent co-CEO wave. Last month, Spotify named Alex Norstrom and Gustav Soderstrom as co-CEOs to replace founder Daniel Ek; Oracle named Clay Magouyrk and Mike Sicilia to jointly lead the company; and Comcast tapped president Mike Cavanagh to join longtime CEO Brian Roberts in the chief role.

But while a duel CEO structure may superficially make sense for Disney, company insiders and corporate governance experts warn there are considerations specific to the Mouse House that would make such a dynamic unwise.

The Netflix strategyLast year, Iger called Sarandos and asked him about Netflix's co-CEO model. That call was first reported by the Wall Street Journal in November, and CNBC can confirm it took place, according to people familiar with the matter.

Sarandos and co-CEO Peters have different areas of passion, according to people familiar with Netflix's leadership styles, who asked to remain unnamed because the details are private. That's allowed the two leaders to make decisions without stepping on each other's toes. If Sarandos and Peters disagree on something, they work it out by deferring to the leader who is more passionate about the answer. That typically means Sarandos wins out if it's a content or creative decision, and Peters triumphs if the decision is more product- or technology-based. A Netflix spokesperson declined to comment.

If there's a grey area, the co-CEOs can always fall back on Hastings, the company's co-founder and CEO of 25 years. Peters and Sarandos worked together under Hastings for many years. That comfort level — and Netflix's famously un-hierarchical corporate culture — have helped maintain a dual CEO structure without turf wars and while serving shareholders, Sarandos told Iger, according to the people familiar.

Since Peters stepped in as co-CEO in January 2023, Netflix shares have gained about 275%.

Disney's choiceAt first glance, Walden and D'Amaro present a similar dynamic to Sarandos and Peters. Walden's expertise is Hollywood, and D'Amaro's is parks and consumer products. Iger could theoretically advance to the executive chairman role, keeping him around in a similar fashion to Hastings.

Selecting both Walden and D'Amaro as Iger's long-awaited successor may allow Disney to keep both leaders at the company. If the board chooses one over the other, Disney risks losing a top executive who may want a chance to be CEO elsewhere. This happened to Disney in 2020, when streaming chief Kevin Mayer departed the company to become TikTok's CEO after he was passed over for Chapek.

But a Disney co-CEO arrangement also comes with a number of red flags that don't exist at other companies.

First, if Iger sticks around on the board, some employees — and external partners — may still view him as a CEO. That could undercut the power-sharing structure of two CEOs, especially given Iger's reputation for wanting to remain the company's No. 1 leader.

While Hastings has turned his attention to hobbies like skiing since giving up his CEO role, Iger has developed a reputation for wanting to hang around as Disney's head honcho. He's five times pushed backed retirement to remain at the helm, and he came back to replace Chapek in 2022 after hand-picking him as his replacement.

Second, during Chapek's tenure, Iger didn't fully give up his operational responsibilities right away, choosing to direct the company's "creative endeavors" for more than a year. That led to an ugly power-sharing situation between Iger and Chapek, as CNBC detailed in 2023. Even if Walden and D'Amaro have different domain strengths, choosing a co-CEO model after suffering through a recent time period where control lines were blurred may be a case of failing to learn from one's mistakes.

Third, Walden and D'Amaro haven't worked together as long as Peters and Sarandos (or other co-leader arrangements with long-term success, such as CAA's co-chairman arrangement with Bryan Lourd, Richard Lovett and Kevin Huvane). Walden did work in a co-chair arrangement with Gary Newman at Fox for many years running Fox TV, proving she's capable of succeeding in such an arrangement, but it's unclear if she'd relish the opportunity to go back to a pairing.

Fourth, Disney's corporate culture is famously political. The company has had several tortured succession processes with Iger and Disney's former CEO Michael Eisner. While Netflix is largely untouched by M&A, Disney is an amalgam of many acquisitions and units over the years, including ABC, ESPN, Fox, Pixar, Marvel and Lucasfilm. That's brought employees from many different cultures together, rather than breeding a unified corporate mindset from its founding.

"It wouldn't work for Disney," a senior media executive told CNBC privately. "There would be so much backbiting. That's how it's always been there."

A Disney spokesperson declined to comment.

Netflix vs. traditionOn top of all of that, traditional corporate governance experts have broadly dismissed a co-CEO setup as suboptimal.

About 1.2% of companies in the Russell 3000 index have employed a co-CEO structure at any given time in recent years, The Wall Street Journal reported last month, citing data from Equilar.

"When you create two sources of authority in an organization, that's never good," said Charles Elson, founding director of the Weinberg Center for Corporate Governance at the University of Delaware, in an interview. "Two in charge means no one is in charge."

Still, there are mitigating factors that can make a co-CEO arrangement more palatable, Elson said. Having Hastings as executive chairman is likely important for Netflix because he can act as a de-facto tiebreaker in a co-CEO arrangement.

Similarly, a co-CEO structure can work if it's clearly done for more-drawn-out succession planning, such as Comcast's decision to elevate Cavanagh to co-CEO alongside Roberts, said Elson.

When push comes to shove, Hastings and Roberts can make the deciding calls on the biggest decisions, Elson said. Roberts is Comcast's controlling shareholder. Oracle similarly has a controlling shareholder in co-founder Larry Ellison.

While Iger could play a tie-breaking role for Disney as executive chairman, he isn't a founder of the company and owns less than 1% of shares outstanding. That gives him less skin in the game for the Disney's future than someone like Roberts or Ellison, noted Elson.

Selecting just one CEO may be a leap of faith for the Disney board, but it's better than setting up instability, said Elson.

"Inevitably, one CEO dominates and the other one goes away," he said. "That's the nature of humanity."

Disclosure: Comcast is the parent company of NBCUniversal, which owns CNBC. Versant would become the new parent company of CNBC upon Comcast's planned spinoff of Versant.
2025-10-14 10:21 4mo ago
2025-10-14 06:00 4mo ago
M&S share rise as chairman Archie Norman's contract extended stocknewsapi
MAKSY
Marks and Spencer Group PLC (LSE:MKS) shares are rose 1% after the retailer's board of directors extended chairman Archie Norman's tenure to a potential 12 years. 

The former Asda and Kingfisher boss joined the clothing and food retailer in 2017 and will reach the "comply or explain" nine-year point next September.

A three-year extension has been agreed, subject to an annual review by a committee of independent directors and no major change of circumstances, with his appointment also requiring approval at the annual shareholder meeting, as normal. 

After carrying out a consultation with shareholders, executives and advisers, the board unanimously backed Norman's continuation, citing "widespread support across the shareholder base".

Senior independent director Fiona Dawson said Norman "has been an exceptional chair, steering an effective, engaged board and putting in place a highly capable leadership team under Stuart Machin which is transforming M&S and building a stronger, better business.

"There remains much to do, and Archie's deep knowledge of the business, drive and unique experience will be invaluable as we move to the next phase of the Reshaping for Growth plan." 

Analyst Clive Black at house broker Shore Capital said it was "good news" that was "very warmly" welcomed.,

"We sense that M&S shareholders will both share a collective sigh of relief and express pleasure that the board and CEO, Stuart Machin et al, will continue to benefit from Mr Norman's immense experience, fabulous insight, and questioning mind, making for a uniquely talented individual.

"Whilst those of a rather prescriptive process bent may splutter, we firmly believe that this is good for all stakeholders in M&S in the here and now and further out too, and so we applaud Ms Dawson and the Board for their bravery and commonsense."
2025-10-14 10:21 4mo ago
2025-10-14 06:01 4mo ago
Target Announces Limited-time Collection with Woolrich, Blending Iconic Heritage and Trend-forward Style stocknewsapi
TGT
The collection of 100-plus items with the outdoor lifestyle brand spans men's and women's apparel and accessories, home, outdoor gear and food and beverage, starting at $2 and with most items under $40

Woolrich x Target includes the retailer's largest-ever men's capsule in a limited-time offering

For the first time, the retailer will offer three Woolrich x Target items ahead of the launch, exclusively for members of the retailer's paid membership program Target Circle 360

, /PRNewswire/ -- Target Corporation (NYSE: TGT) today announced the launch of a limited-time collection with Woolrich, the iconic outdoor lifestyle brand known for its signature buffalo check. Woolrich x Target launches Oct. 18 in select Target stores and on Target.com, featuring more than 100 reinvented classics that blend Woolrich's heritage of outdoor craftsmanship with modern style across men's and women's apparel, home, outdoor gear and food and beverage.

Woolrich x Target

The collaboration brings together two design-driven brands, offering a fashion-forward collection that reflects today's cultural shift toward outdoor living and adventure. It includes Target's largest men's capsule ever in a limited-time offering, alongside a broad range of women's styles and lifestyle pieces, with standouts like the Women's Buffalo Check Melton Jacket and Adult Printed Landscape Zip-Up Fleece Jacket. Designed to blend style and function and taking inspiration from the growing urban adventure movement, the assortment leans into modern trends with prices starting at $2, and most items under $40. Explore the lookbook for the full collection.

"Woolrich x Target is all about fashion meeting function to help consumers embrace the outdoors in style," said Jill Sando, executive vice president and chief merchandising officer, apparel & accessories, home and hardlines, Target. "From the Quilted Sheep Tote Bag to the Buffalo Check Outdoor Wearable Throw, to the amazing inflatable kayak, and so much more, I love how Target and Woolrich have worked together to create something that's fun and affordable."

Building on two legacies 
Known as "the original outdoor clothing company," Woolrich has been outfitting adventurers since 1830, with a legacy rooted in durability, craftsmanship and iconic style. From outfitting Arctic expeditions to becoming a staple in streetwear, Woolrich has inspired generations of open-air wanderers and urban explorers alike.

Meanwhile, Target's leadership as a brand has long been driven by great design, built through decades of investment in owned brands, national brands and partnerships to deliver on-trend design and affordable style. For over 25 years, Target has partnered with trendsetting designers — nearly 200 to date — and expanded into unexpected categories such as beauty, home, food and more, evolving its strategy with cultural and social trends.

The Woolrich x Target collaboration builds on both legacies and celebrates the joy of outdoor living and versatility of adventure-ready fashion, with pieces like the Buffalo Check Outdoor Wearable Throw and Men's Mid-Rise Straight Fit Cargo Pant that blend style and function while surprising with unexpected details. The Woolrich archives provided early inspiration for the team, who incorporated original details, prints and artwork into many Woolrich x Target items. Target guests will find archival Woolrich designs alongside unique additions that include an inflatable kayak, binoculars, mindfulness journals, a new home assortment, plus new and exclusive food and beverage items from Peet's Coffee and Kodiak Cakes — all designed to bring joy and adventure into everyday life.

"For nearly two centuries, Woolrich has been synonymous with authentic American outdoor exploring, crafting products built on a legacy of heritage," said Heekyun Kim, Woolrich's creative director. "This collaboration with Target represents an exciting opportunity to introduce our iconic designs, like our legendary buffalo check, to a new generation of explorers. We are proud to create a collection that honors our archives while making the Woolrich spirit of adventure accessible to all."

Early access on three exclusive items for Target Circle 360 members
For the first time, the retailer will offer three Woolrich x Target items ahead of the launch — the Patchwork Plaid Throw Blanket, Sheep Shaped Throw Pillow and Sheep Print Beanie — exclusively for members of the retailer's paid membership program Target Circle 360. The items will be available for purchase on Target.com Oct. 14-16, while supplies last, before the collection launches Oct. 18 — and are not included in the main collection.

An adventure-fueled campaign and shopping experience
To celebrate the launch, Target will debut an "Adventure Is Wherever You Are" marketing campaign shot in New York City by the retailer's in-house team and featuring style influencer Lauren Wolfe and singer-songwriter David Kushner. The campaign captures the playful, optimistic spirit of the collection, showing how the collection fits seamlessly into everyday moments of exploration, style and self-expression.

The retailer will craft the shopping experience in the same adventurous spirit. Select stores will feature a dedicated Woolrich x Target shopping experience that immerses guests in a world of buffalo check and invites them to explore the collection's cozy textures. On Target.com and the Target app, guests will be greeted with joyful touches that evoke fall and highlight the collection. Target is also making shopping the collection fast and easy with same-day pickup and same-day delivery so guests can grab their gear and get adventuring*.1

The Woolrich x Target collection is the latest example of Target's commitment to its continued legacy of design partnerships that make quality style and design accessible to all.

About Target
Minneapolis-based Target Corporation (NYSE: TGT) serves guests at nearly 2,000 stores and at Target.com, with the purpose of helping all families discover the joy of everyday life. Since 1946, Target has given 5% of its profit to communities, which today equals millions of dollars a week. Additional company information can be found by visiting the corporate website and press center.

1 Availability for same-day services will vary based on location and time.

SOURCE Target Corporation

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+

Newsrooms &

Influencers

9k+

Digital Media

Outlets

270k+

Journalists

Opted In
2025-10-14 10:21 4mo ago
2025-10-14 06:02 4mo ago
Q3 2025 Earnings Preview: Earnings Season Begins With High Hopes And Key Tests For Banks stocknewsapi
BAC C CRCL CRWV JPM NVDA WFC
SummaryEarnings season gets underway this week, with reports from major banks providing the first look at corporate performance.The technology sector is expected to be the standout performer with over 20% projected earnings growth, driven by the ongoing "AI arms race"Sectors that rely on lower-end consumer spending are expected to see earnings decline as shoppers become more "value-conscious" Alistair Berg/DigitalVision via Getty Images

Earnings season kicks into high gear this week, with the big banks unofficially firing the starting gun on Tuesday. As the season begins, major U.S. indices are at record levels, even amidst a government shutdown, creating a dynamic

Recommended For You
2025-10-14 10:21 4mo ago
2025-10-14 06:02 4mo ago
Vodafone reveals cause of massive internet blackout amid calls for compensation stocknewsapi
VOD
Vodafone has said a massive blackout in its internet coverage yesterday was not caused by a cyber attack.

The issues have now been fully resolved, according to the company, after hundreds of thousands of people reported their wifi, 4G and 5G connections dropping out.

"On Monday afternoon, for a short time, the Vodafone network had an issue affecting broadband, 4G and 5G services," said a Vodafone spokesperson.

"This was triggered by a non-malicious software issue with one of our vendor partners which has now been resolved, and the network has fully recovered.

"We apologise for any inconvenience this caused our customers."

As well as internet connections, Vodafone's app, website and customer services were also down.

At its peak, more than 130,000 people reported problems to the internet status checker Downdetector.

More on Vodafone

Vodafone internet services down for thousands of users

UK biggest phone network created as Three-Vodafone merger gets conditional approval

Vodafone and Three merger could get green light, says UK's competition watchdog

Image:
Vodafone users were shown an error message when trying to access the internet provider's app

Vodafone users contacted Sky News and posted on social media to find out if compensation would be given to affected customers.

"We all better get some compensation or I'll be cancelling my contract," said one X user.

"Are they paying any compensation to those affected?" asked a Sky News reader. "This outage must have had major effects on ordinary people/business."

Read more technology news:
Warning China poses 'highly sophisticated' cyber threat to UK
Got a pair of AirPods? There's more to them than meets the eye
SpaceX enjoys successful Starship rocket launch test

According to Sabrina Hoque, a telecoms expert at Uswitch, customers could be entitled to compensation of £9.76 for each calendar day their broadband doesn't work - but only if it is down for more than two days.

"Ofcom advises that compensation for mobile signal outages is 'dependent on the circumstances'," she said, "but in extreme cases, where repairs take much longer, you may be entitled to an additional refund or account credit."

Considering the outage only lasted a few hours for most people, they may not be entitled to claim.

However, Melanie Pizzey, chief executive of the Global Payroll Alliance, said the company could now face "a wave of compensation claims ... particularly if financial losses or missed deadlines can be directly linked to the downtime."

One X user warned that last night, scammers pretending to be from Vodafone had called and directed him to download an app in order to receive compensation.

"Who knows how many people they [are] scamming as we speak?" he said.
2025-10-14 10:21 4mo ago
2025-10-14 06:05 4mo ago
CNFinance Holdings Limited Regains Compliance with NYSE ADS Trading Price Requirement stocknewsapi
CNF
, /PRNewswire/ -- CNFinance Holdings Limited (NYSE: CNF) ("CNFinance" or the "Company"), a leading home equity loan service provider in China, today announced that it has regained compliance with the New York Stock Exchange ("NYSE") continued listing standard for minimum share price under Section 802.01C of the NYSE Listed Company Manual ("Price Criteria").

As announced on April 18, 2025, CNFinance was notified by NYSE on April 7, 2025, that the Company was not in compliance with the Price Criteria, as the average closing price of the Company's American depositary shares ("ADSs") was less than US$1.00 over thirty (30) trading-day period. NYSE provided the Company with a cure period of six (6) months following receipt of the notification to regain compliance with NYSE continued listing standards.

As part of its efforts to regain compliance with the Price Criteria, the Company changed the ratio of its ADSs to its Class A ordinary shares, par value US$0.0001 per share, from the current ratio of one (1) ADS to twenty (20) Class A ordinary shares to a new ratio of one (1) ADS to two hundred (200) Class A ordinary shares. The change became effective on September 5, 2025.

On October 1, 2025, the Company received a notification letter from NYSE that the Company's stock price was above the NYSE's minimum requirement of US$1.00 based on a thirty (30)-trading day average ended September 30, 2025. Accordingly, the Company has regained compliance with the Price Criteria, and will continue to be traded on the NYSE .

About CNFinance Holdings Limited

CNFinance Holdings Limited (NYSE: CNF) ("CNFinance" or the "Company") is a leading home equity loan service provider in China. CNFinance, through its operating subsidiaries in China, conducts business by connecting demands and supplies through collaborating with sales partners and trust companies under the trust lending model, and sales partners, local channel partners and commercial banks under the commercial bank partnership model. Sales partners and local channel partners are responsible for recommending micro- and small-enterprise ("MSE") owners with financing needs to the Company and the Company introduces eligible borrowers to licensed financial institutions with sufficient funding sources including trust companies and commercial banks who will then conduct their own risk assessments and make credit decisions. The Company's primary target borrower segment is MSE owners who own real properties in Tier 1 and Tier 2 cities and other major cities in China. The Company's risk mitigation mechanism is embedded in the design of its loan products, supported by an integrated online and offline process focusing on risks of both borrowers and collateral and further enhanced by effective post-loan management procedures.

SOURCE CNFinance Holdings Limited

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+

Newsrooms &

Influencers

9k+

Digital Media

Outlets

270k+

Journalists

Opted In
2025-10-14 10:21 4mo ago
2025-10-14 06:05 4mo ago
Domino's Pizza® Announces Third Quarter 2025 Financial Results stocknewsapi
DPZ
Global retail sales growth (excluding foreign currency impact) of 6.3%

U.S. same store sales growth of 5.2%

 International same store sales growth (excluding foreign currency impact) of 1.7%

Global net store growth of 214, including 29 net store openings in the U.S. and 185 net store openings internationally

Income from operations increased 12.2%; excluding the $0.8 million positive impact of foreign currency exchange rates on international franchise royalty revenues, income from operations increased 11.8%

, /PRNewswire/ -- Domino's Pizza, Inc. (Nasdaq: DPZ), the largest pizza company in the world, announced results for the third quarter of 2025.

"I am incredibly proud of how our team and franchise system is bringing our Hungry for MORE strategy to life and delivering best in class results," said Russell Weiner, Domino's Chief Executive Officer. "In the U.S., we drove positive order counts behind our Best Deal Ever promotion and stuffed crust pizza product innovation for the third quarter. This resulted in another quarter of strong growth in both our delivery and carryout businesses. Seeing our strategy being executed at such a high level gives me the confidence that we will continue to win and take QSR pizza market share around the world in 2025 and beyond. We have never had more tools to drive long-term value creation for our franchisees and shareholders."

Third Quarter 2025 Operational and Financial Highlights (Unaudited):

The tables below outline certain statistical measures utilized by the Company to analyze its performance, as well as key financial results. This historical data is not necessarily indicative of results to be expected for any future period. Refer to Comments on Regulation G below for additional details, including definitions of these statistical measures and certain reconciliations.

Third Quarter

Three Fiscal Quarters

2025

2024

2025

2024

Global retail sales: (in millions of U.S. dollars)

U.S. stores

$

2,320.4

$

2,168.4

$

6,896.8

$

6,602.5

International stores

2,375.8

2,223.6

6,933.5

6,581.9

Total

$

4,696.2

$

4,392.0

$

13,830.3

$

13,184.4

Third Quarter

Three Fiscal Quarters

2025

2024

2025

2024

Global retail sales growth:
   (versus prior year period, excluding foreign currency impact)

U.S. stores

+ 7.0 %

+ 5.1 %

+ 4.5 %

+ 6.6 %

International stores

+ 5.7 %

+ 5.1 %

+ 6.6 %

+ 6.5 %

Total

+ 6.3 %

+ 5.1 %

+ 5.5 %

+ 6.5 %

Same store sales growth:
   (versus prior year period)

U.S. Company-owned stores

+ 3.4 %

+ 3.1 %

+ 1.0 %

+ 5.4 %

U.S. franchise stores

+ 5.3 %

+ 3.0 %

+ 2.7 %

+ 4.4 %

U.S. stores

+ 5.2 %

+ 3.0 %

+ 2.7 %

+ 4.5 %

International stores (excluding foreign currency impact)

+ 1.7 %

+ 0.8 %

+ 2.5 %

+ 1.1 %

U.S. Company-
owned Stores

U.S. Franchise
Stores

Total
U.S. Stores

International
Stores

Total

Third quarter of 2025 store counts:

Store count at June 15, 2025

258

6,803

7,061

14,475

21,536

Openings

2

28

30

220

250

Closings



(1)

(1)

(35)

(36)

Store count at September 7, 2025

260

6,830

7,090

14,660

21,750

Third quarter 2025 net store growth

2

27

29

185

214

Trailing four quarters net store growth

3

157

160

588

748

Third Quarter

Three Fiscal Quarters

(In millions, except percentages, percentage points, per
share data and leverage ratio)

2025

2024

Increase/
(Decrease)

2025

2024

Increase/
(Decrease)

Total revenues

$1,147.1

$1,080.1

+ 6.2 %

$3,404.3

$3,262.5

+ 4.3 %

U.S. Company-owned store gross margin

16.3 %

16.8 %

(0.5) pp

16.0 %

17.3 %

(1.3) pp

Supply chain gross margin

11.3 %

10.6 %

+ 0.7 pp

11.6 %

11.0 %

+ 0.6 pp

Income from operations

$223.2

$198.8

+ 12.2 %

$658.3

$605.3

+ 8.7 %

Net income

$139.3

$146.9

(5.2) %

$420.1

$414.7

+ 1.3 %

Diluted earnings per share

$4.08

$4.19

(2.6) %

$12.22

$11.80

+ 3.6 %

Leverage ratio

4.5x

4.9x

(0.4)x

Net cash provided by operating activities

$552.3

$446.9

+ 23.6 %

Capital expenditures

(56.7)

(70.8)

(19.9) %

Free cash flow

$495.6

$376.1

+ 31.8 %

Revenues increased $66.9 million, or 6.2%, in the third quarter of 2025 as compared to the third quarter of 2024, primarily due to higher supply chain revenues and higher U.S. franchise royalties and fees and advertising revenues. The increase in supply chain revenues was primarily attributable to higher order volumes, as well as an increase in the Company's food basket pricing to stores, which increased 3.3% during the third quarter of 2025 as compared to the third quarter of 2024. These increases were partially offset by a shift in the relative mix of products sold by the Company and the transition of the Company's equipment and supplies business to a third-party supplier. The increases in U.S. franchise royalties and fees and advertising revenues were driven primarily by same store sales growth and net store growth during the trailing four quarters.
U.S. Company-owned store gross margin decreased 0.5 percentage points in the third quarter of 2025 as compared to the third quarter of 2024, primarily due to the increase in the Company's food basket pricing to stores, as well as higher wage rates, and was partially offset by higher sales leverage.
Supply chain gross margin increased 0.7 percentage points in the third quarter of 2025 as compared to the third quarter of 2024, primarily due to procurement productivity, partially offset by the increase in the cost of the Company's food basket.
Income from operations increased $24.3 million, or 12.2%, in the third quarter of 2025 as compared to the third quarter of 2024. Excluding the positive impact of foreign currency exchange rates on international franchise royalty revenues of $0.8 million, income from operations increased $23.5 million, or 11.8%, in the third quarter of 2025 as compared to the third quarter of 2024. The increase in income from operations was primarily due to higher U.S. franchise royalties and fees and gross margin dollar growth within supply chain.
Net income decreased $7.6 million, or 5.2%, in the third quarter of 2025 as compared to the third quarter of 2024, primarily due to an unfavorable change of $29.2 million in the pre-tax unrealized losses and gains associated with the Company's investment in DPC Dash Ltd. To a lesser extent, an increase in the provision for income taxes also contributed to the decrease in net income. The effective tax rate increased to 22.3% in the third quarter of 2025 as compared to 20.4% in the third quarter of 2024 resulting in an increase in the provision for income taxes of $2.2 million. These decreases were partially offset by higher income from operations as discussed above.
Diluted EPS was $4.08 in the third quarter of 2025 as compared to $4.19 in the third quarter of 2024, representing an $0.11, or 2.6%, decrease. The decrease in diluted EPS in the third quarter of 2025 as compared to the third quarter of 2024 was driven by lower net income, partially offset by a lower weighted average diluted share count resulting from the Company's share repurchases during the trailing four quarters.
Net cash provided by operating activities was $552.3 million in the three fiscal quarters of 2025 as compared to $446.9 million in the three fiscal quarters of 2024. The Company spent $56.7 million on capital expenditures in the three fiscal quarters of 2025 as compared to $70.8 million in the three fiscal quarters of 2024, resulting in free cash flow of $495.6 million in the three fiscal quarters of 2025 as compared to $376.1 million in the three fiscal quarters of 2024. The increase in free cash flow was a result of the positive impact of changes in operating assets and liabilities, higher net income excluding non-cash operating activities, the timing and amount of advertising activities, as well as lower investments in capital expenditures.

Quarterly Dividend

Subsequent to the end of the third quarter of 2025, on October 7, 2025, the Company's Board of Directors declared a $1.74 per share quarterly dividend on its outstanding common stock for shareholders of record as of December 15, 2025, to be paid on December 26, 2025.

Share Repurchases

During the third quarter of 2025, the Company repurchased and retired 165,778 shares of common stock for a total of $74.7 million. During the three fiscal quarters of 2025, the Company repurchased and retired 596,754 shares of common stock for a total of $274.7 million. As of September 7, 2025, the Company had a total remaining authorized amount for share repurchases of $539.7 million.

2025 Refinancing

On September 5, 2025, the Company completed a previously announced $1.00 billion refinancing transaction, including the issuance by certain of its subsidiaries of $500.0 million of 4.930% fixed rate senior secured notes with an anticipated term of five years and $500.0 million of 5.217% fixed rate senior secured notes with an anticipated term of seven years (collectively, the "2025 Notes").

The proceeds from the 2025 Notes, as well as $160.0 million of the Company's unrestricted cash and cash equivalents, were used to (i) repay the remaining $742.0 million in outstanding principal under the Company's 2015 ten-year notes and the remaining $402.7 million in outstanding principal under the Company's 2018 7.5-year notes, (ii) prefund a portion of the interest payable on the 2025 Notes and (iii) capitalize $15.4 million for financing costs. Additionally, certain of the Company's subsidiaries also issued a new $320.0 million variable funding note facility, which was undrawn on the closing date, and the Company's previous variable funding note facilities were canceled. For additional information related to this refinancing transaction, refer to the Company's Current Report on Form 8-K filed on September 8, 2025 and the Company's Form 10-Q for the quarter ended September 7, 2025.

Comments on Regulation G

In addition to the GAAP financial measures set forth in this press release, the Company has included non-GAAP financial measures within the meaning of Regulation G, including free cash flow, income from operations, excluding foreign currency impact and Consolidated Adjusted EBITDA. The Company has also included metrics such as global retail sales, global retail sales growth (excluding foreign currency impact), same store sales growth, net store growth, food basket pricing change, impact of changes in foreign currency exchange rates on international franchise royalty revenues and the leverage ratio, which are commonly used statistical measures in the quick-service restaurant industry that are important to understanding Company performance.

The Company uses "global retail sales," a statistical measure, to refer to total worldwide retail sales at Company-owned and franchise stores. The Company believes global retail sales information is useful in analyzing revenues because franchisees pay royalties and advertising fees that are based on a percentage of franchise retail sales. The Company reviews comparable industry global retail sales information to assess business trends and to track the growth of the Domino's Pizza brand and believes they are indicative of the financial health of the Company's franchisee base. In addition, supply chain revenues are directly impacted by changes in franchise retail sales in the U.S. and Canada. As a result, sales by Domino's franchisees have a direct effect on the Company's profitability. Retail sales for franchise stores are reported to the Company by its franchisees and are not included in Company revenues. "Global retail sales growth" is calculated as the change of U.S. Dollar global retail sales against the comparable period of the prior year. "Global retail sales growth, excluding foreign currency impact" is calculated as the change of international local currency global retail sales against the comparable period of the prior year. Changes in global retail sales growth, excluding foreign currency impact, are primarily driven by same store sales growth and net store growth.

The Company uses "same store sales growth," a statistical measure, which is calculated by including only retail sales from stores that also had sales in the comparable weeks of both periods. International same store sales growth is calculated similarly to U.S. same store sales growth. Changes in international same store sales are reported excluding foreign currency impacts, which reflect changes in international local currency sales. Same store sales growth for transferred stores is reflected in their current classification.

The Company uses "net store growth," a statistical measure, which is calculated by netting gross store openings with gross store closures during the period. Transfers between Company-owned stores and franchised stores are excluded from the calculation of net store growth.

The Company uses "food basket pricing change," a statistical measure, which is calculated as the percentage change of the food basket (including both food and cardboard products) purchased by an average U.S. store (based on average weekly unit sales) from U.S. supply chain centers against the comparable period of the prior year. The Company believes that the food basket pricing change is important to investors and other interested persons to understand the Company's performance. As food basket prices fluctuate, revenues, cost of sales and gross margin percentages in the Company's supply chain segment also fluctuate. Additionally, cost of sales, gross margins and gross margin percentages for the Company's U.S. Company-owned stores also fluctuate.

The Company uses "free cash flow," which is calculated as net cash provided by operating activities, less capital expenditures, both as reported under GAAP. The most directly comparable financial measure calculated and presented in accordance with GAAP is net cash provided by operating activities. The Company believes that the free cash flow measure is important to investors and other interested persons, and that such persons benefit from having a measure which communicates how much cash flow is available for working capital needs or to be used for repurchasing debt, making acquisitions, repurchasing common stock or paying dividends.

The Company uses "income from operations, excluding foreign currency impact," which is calculated as income from operations as reported under GAAP, less the "impact of changes in foreign currency exchange rates on international franchise royalty revenues," a statistical measure. The most directly comparable financial measure calculated and presented in accordance with GAAP is income from operations. The impact of changes in foreign currency exchange rates on international franchise royalty revenues is calculated as the difference in international franchise royalty revenues resulting from translating current period local currency results to U.S. dollars at current period exchange rates as compared to prior period exchange rates. The Company believes that the impact of changes in foreign currency exchange rates on international franchise royalty revenues is important to investors and other interested persons to understand the Company's international royalty revenues given the significant variability in those revenues and that can be driven by changes in foreign currency exchanges rates. International franchise royalty revenues do not have a cost of sales component, so changes in these revenues have a direct impact on income from operations.

The Company uses "Consolidated Adjusted EBITDA," which is calculated as Segment Income as defined by the Company under Accounting Standards Codification 280, Segment Reporting, less corporate administrative costs that have not been allocated to a reportable segment including labor, computer expenses, professional fees, travel and entertainment, rent, insurance and other corporate administrative costs. Consolidated Adjusted EBITDA is defined in the base indenture governing the Company's securitized debt. The Company uses Consolidated Adjusted EBITDA to determine future business objectives and targets and for long-range planning, as well as to evaluate total Company operating performance for the purposes of determining certain variable performance-based compensation. The Company believes Consolidated Adjusted EBITDA is a reliable barometer for the overall success of the Company. It is also used to calculate the leverage ratio (defined below), and other ratios defined in the indenture governing the Company's securitized debt. As such, Consolidated Adjusted EBITDA is important to investors and other interested persons to understand the financial performance of the Company, and to assess the ability of the Company to meet its financial obligations.

The Company uses the "leverage ratio1," which is calculated as the Company's securitized debt related to its fixed-rate notes and borrowings under its variable funding notes, divided by Consolidated Adjusted EBITDA on a trailing four quarters basis. The Company has historically operated with a leverage ratio between four and six times. The Company reviews its leverage ratio on at least a quarterly basis and believes its leverage ratio is important to investors and other interested persons to understand the capital structure of the Company, and to assess the ability of the Company to meet its financial obligations.

The reconciliation of the leverage ratio for the third quarters of 2025 and 2024 is as follows below.

September 7,
2025

September 8,
2024

2015 Ten-Year Notes

$



$

742,000

2017 Ten-Year Notes

940,000

940,000

2018 7.5-Year Notes



402,688

2018 9.25-Year Notes

379,000

379,000

2019 Ten-Year Notes

648,000

648,000

2021 7.5-Year Notes

826,625

826,625

2021 Ten-Year Notes

972,500

972,500

2025 Five-Year Notes

500,000



2025 Seven-Year Notes

500,000



Total fixed-rate notes

$

4,766,125

$

4,910,813

Segment Income - third quarter of 2025 and 2024

$

273,771

$

252,117

Segment Income - second quarter of 2025 and 2024

273,758

253,565

Segment Income - first quarter of 2025 and 2024

268,417

260,016

Segment Income - fourth quarter of 2024 and 2023

340,968

327,098

Segment Income - trailing four quarters

$

1,156,914

$

1,092,796

General and administrative - other - third quarter of 2025 and 2024

$

(19,771)

$

(22,839)

General and administrative - other - second quarter of 2025 and 2024

(20,925)

(26,165)

General and administrative - other - first quarter of 2025 and 2024

(27,313)

(18,173)

General and administrative - other - fourth quarter of 2024 and 2023

(27,818)

(32,498)

General and administrative - other - trailing four quarters

$

(95,827)

$

(99,675)

Consolidated Adjusted EBITDA - trailing four quarters

$

1,061,087

$

993,121

Leverage ratio

4.5

x

4.9

x

(1)

The Company also calculates and reviews its Senior Leverage Ratio and Holdco Leverage Ratio as defined in the indenture governing the Company's securitized debt.

Conference Call Information

The Company will file its Quarterly Report on Form 10-Q today. As previously announced, Domino's Pizza, Inc. will hold a conference call today at 8:30 a.m. (Eastern) to review its third quarter 2025 financial results. The webcast is available at ir.dominos.com and will be archived for one year.

About Domino's Pizza®

Founded in 1960, Domino's Pizza is the largest pizza company in the world, with a significant business in both delivery and carryout. It ranks among the world's top public restaurant brands with a global enterprise of more than 21,700 stores in over 90 markets. Domino's had global retail sales of over $19.7 billion in the trailing four quarters ended September 7, 2025. Its system is comprised of independent franchise owners who accounted for 99% of Domino's stores as of the end of the third quarter of 2025. In the U.S., Domino's generated more than 85% of U.S. retail sales in 2024 via digital channels and has developed many innovative ordering platforms.

Order – dominos.com
Company Info – biz.dominos.com
Media Assets – media.dominos.com

Please visit our Investor Relations website at ir.dominos.com to view news, announcements, earnings releases, investor presentations and conference webcasts.

SAFE HARBOR STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995:

This press release contains various forward-looking statements about the Company within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Act") that are based on current management expectations that involve substantial risks and uncertainties which could cause actual results to differ materially from the results expressed in, or implied by, these forward-looking statements. The following cautionary statements are being made pursuant to the provisions of the Act and with the intention of obtaining the benefits of the "safe harbor" provisions of the Act. You can identify forward-looking statements by the use of words such as "anticipates," "believes," "could," "should," "estimates," "expects," "intends," "may," "will," "plans," "predicts," "projects," "seeks," "approximately," "potential," "outlook" and similar terms and phrases that concern our strategy, plans or intentions, including references to assumptions. These forward-looking statements address various matters including information concerning future results of operations and business strategy, our anticipated profitability, estimates in same store sales growth, store growth and the growth of our U.S. and international business in general, our ability to service our indebtedness, our future cash flows, our operating performance, trends in our business and other descriptions of future events reflect the Company's expectations based upon currently available information and data. While we believe these expectations and projections are based on reasonable assumptions, such forward-looking statements are inherently subject to risks, uncertainties and assumptions. Important factors that could cause actual results to differ materially from our expectations are more fully described in our filings with the Securities and Exchange Commission, including under the section headed "Risk Factors" in our Annual Report on Form 10-K for the fiscal year ended December 29, 2024. Actual results may differ materially from those expressed or implied in the forward-looking statements as a result of various factors, including but not limited to: our substantial indebtedness as a result of our recapitalization transactions and our ability to incur additional indebtedness or refinance or renegotiate key terms of that indebtedness in the future; the impact a downgrade in our credit rating may have on our business, financial condition and results of operations; our future financial performance and our ability to pay principal and interest on our indebtedness; the strength of our brand, including our ability to compete in the U.S. and internationally in our intensely competitive industry, including the food service and food delivery markets; our ability to successfully implement our growth strategy, including through our participation in the third-party order aggregation marketplace; labor shortages or changes in operating expenses resulting from increases in prices of food (particularly cheese), fuel and other commodity costs, labor, utilities, insurance, employee benefits and other operating costs or negative economic conditions; the effectiveness of our advertising, operations and promotional initiatives; shortages, interruptions or disruptions in the supply or delivery of fresh food products and store equipment; the additional risks our international operations subject us to, which may differ in each country in which we and our franchisees do business; our ability and that of our franchisees to successfully operate in the current and future credit environment; the impact of social media or a boycott on our business, brand and reputation; the impact of new or improved technologies and alternative methods of delivery on consumer behavior; new product, digital ordering and concept developments by us, and other food-industry competitors; our ability to maintain good relationships with and attract new franchisees, and franchisees' ability to successfully manage their operations without negatively impacting our royalty payments and fees or our brand's reputation; our ability to successfully implement cost-saving strategies; changes in the level of consumer spending given general economic conditions, including interest rates, energy prices and consumer confidence or negative economic conditions in general; our ability and that of our franchisees to open new restaurants and keep existing restaurants in operation and maintain demand for new stores; the impact that widespread illness, health epidemics or general health concerns, severe weather conditions and natural disasters may have on our business and the economies of the countries where we operate; changes in foreign currency exchange rates; changes in income tax rates; our ability to retain or replace our executive officers and other key members of management and our ability to adequately staff our stores and supply chain centers with qualified personnel; our ability to find and/or retain suitable real estate for our stores and supply chain centers; changes in government legislation and regulations, including changes in laws and regulations regarding information privacy, payment methods, advertising and consumer protection and social media; adverse legal judgments or settlements; food-borne illness or contamination of products or food tampering or other events that may impact our reputation; data breaches, power loss, technological failures, user error or other cyber risks threatening us or our franchisees; the impact that environmental, social and governance matters may have on our business and reputation; the effect of war, terrorism, catastrophic events, other geopolitical or reputational considerations or climate change; our ability to pay dividends and repurchase shares; changes in consumer tastes, spending and traffic patterns and demographic trends; changes in accounting policies; and adequacy of our insurance coverage. In light of these risks, uncertainties and assumptions, the forward-looking events discussed in this press release might not occur. All forward-looking statements speak only as of the date of this press release and should be evaluated with an understanding of their inherent uncertainty. Except as required under federal securities laws and the rules and regulations of the Securities and Exchange Commission, or other applicable law, we will not undertake, and specifically disclaim, any obligation to publicly update or revise any forward-looking statements to reflect events or circumstances arising after the date of this press release, whether as a result of new information, future events or otherwise. You are cautioned not to place undue reliance on the forward-looking statements included in this press release or that may be made elsewhere from time to time by, or on behalf of, us. All forward-looking statements attributable to us are expressly qualified by these cautionary statements.

TABLES TO FOLLOW

Domino's Pizza, Inc. and Subsidiaries

Condensed Consolidated Statements of Income

(Unaudited)

Fiscal Quarter Ended

September 7,
2025

% of
Total
Revenues

September 8,
2024

% of
Total
Revenues

(In thousands, except share and per share data)

Revenues:

U.S. Company-owned stores

$

82,749

$

89,173

U.S. franchise royalties and fees

157,155

144,074

Supply chain

696,959

651,314

International franchise royalties and fees

78,549

74,633

U.S. franchise advertising

131,642

120,925

Total revenues

1,147,054

100.0

%

1,080,119

100.0

%

Cost of sales:

U.S. Company-owned stores

69,258

74,205

Supply chain

617,894

582,167

Total cost of sales

687,152

59.9

%

656,372

60.8

%

Gross margin

459,902

40.1

%

423,747

39.2

%

General and administrative

105,092

9.1

%

103,991

9.6

%

U.S. franchise advertising

131,642

11.5

%

120,925

11.2

%

Income from operations

223,168

19.5

%

198,831

18.4

%

Other (expense) income

(3,017)

(0.3)

%

26,172

2.4

%

Interest expense, net

(40,952)

(3.6)

%

(40,387)

(3.7)

%

Income before provision for income taxes

179,199

15.6

%

184,616

17.1

%

Provision for income taxes

39,880

3.5

%

37,692

3.5

%

Net income

$

139,319

12.1

%

$

146,924

13.6

%

Earnings per share:

Common stock – diluted

$

4.08

$

4.19

Weighted average diluted shares

34,146,418

35,039,408

Domino's Pizza, Inc. and Subsidiaries

Condensed Consolidated Statements of Income

(Unaudited)

Three Fiscal Quarters Ended

September 7,
2025

% of
Total
Revenues

September 8,
2024

% of
Total
Revenues

(In thousands, except share and per share data)

Revenues:

U.S. Company-owned stores

$

266,803

$

274,086

U.S. franchise royalties and fees

464,416

442,168

Supply chain

2,053,945

1,969,772

International franchise royalties and fees

231,272

220,295

U.S. franchise advertising

387,818

356,181

Total revenues

3,404,254

100.0

%

3,262,502

100.0

%

Cost of sales:

U.S. Company-owned stores

224,242

226,722

Supply chain

1,815,993

1,753,132

Total cost of sales

2,040,235

59.9

%

1,979,854

60.7

%

Gross margin

1,364,019

40.1

%

1,282,648

39.3

%

General and administrative

321,777

9.5

%

320,962

9.8

%

U.S. franchise advertising

387,818

11.4

%

356,181

10.9

%

Refranchising (gain) loss

(3,883)

(0.1)

%

158

0.0

%

Income from operations

658,307

19.3

%

605,347

18.6

%

Other income

5,036

0.2

%

18,871

0.6

%

Interest expense, net

(123,411)

(3.6)

%

(122,996)

(3.8)

%

Income before provision for income taxes

539,932

15.9

%

501,222

15.4

%

Provision for income taxes

119,871

3.6

%

86,496

2.7

%

Net income

$

420,061

12.3

%

$

414,726

12.7

%

Earnings per share:

Common stock – diluted

$

12.22

$

11.80

Weighted average diluted shares

34,366,396

35,145,732

Domino's Pizza, Inc. and Subsidiaries
Condensed Consolidated Balance Sheets
(Unaudited)

September 7,
2025

December 29,
2024

(In thousands)

Assets

Current assets:

Cash and cash equivalents

$

139,728

$

186,126

Restricted cash and cash equivalents

202,501

195,370

Accounts receivable, net

277,175

309,104

Inventories

71,155

70,919

Prepaid expenses and other

41,349

40,363

Advertising fund assets, restricted

135,826

103,396

Total current assets

867,734

905,278

Property, plant and equipment, net

290,653

301,179

Operating lease right-of-use assets

223,540

210,302

Investment in DPC Dash

43,650

82,699

Other assets

234,700

237,555

Total assets

$

1,660,277

$

1,737,013

Liabilities and stockholders' deficit

Current liabilities:

Current portion of long-term debt

$

5,521

$

1,149,679

Accounts payable

113,071

85,898

Operating lease liabilities

45,163

39,920

Advertising fund liabilities

132,705

101,567

Other accrued liabilities

242,693

235,398

Total current liabilities

539,153

1,612,462

Long-term liabilities:

Long-term debt, less current portion

4,810,274

3,825,659

Operating lease liabilities

190,757

181,983

Other accrued liabilities

82,052

79,200

Total long-term liabilities

5,083,083

4,086,842

Total stockholders' deficit

(3,961,959)

(3,962,291)

Total liabilities and stockholders' deficit

$

1,660,277

$

1,737,013

Domino's Pizza, Inc. and Subsidiaries

Condensed Consolidated Statements of Cash Flows

(Unaudited)

Three Fiscal Quarters Ended

September 7,
2025

September 8,
2024

(In thousands)

Cash flows from operating activities:

Net income

$

420,061

$

414,726

Adjustments to reconcile net income to net cash provided by operating activities:

Depreciation and amortization

61,128

60,974

Refranchising (gain) loss

(3,883)

158

Loss on sale/disposal of assets

703

501

Amortization of debt issuance costs

3,768

3,685

Provision (benefit) for deferred income taxes

9,255

(7,524)

Non-cash equity-based compensation expense

31,681

31,541

Excess tax benefits from equity-based compensation

(2,751)

(21,609)

(Benefit) provision for losses on accounts and notes receivable

(49)

250

Unrealized and realized gain on investments, net

(5,036)

(18,871)

Changes in operating assets and liabilities

10,242

(18,968)

Changes in advertising fund assets and liabilities, restricted

27,137

2,016

Net cash provided by operating activities

552,256

446,879

Cash flows from investing activities:

Capital expenditures

(56,667)

(70,801)

Sale of investments

44,085



Proceeds from sale of assets

8,458

73

Other

(1,939)

(1,167)

Net cash used in investing activities

(6,063)

(71,895)

Cash flows from financing activities:

Proceeds from issuance of long-term debt

1,000,000



Repayments of long-term debt and finance lease obligations

(1,147,773)

(15,947)

Proceeds from exercise of stock options

12,882

34,669

Purchases of common stock

(277,698)

(214,999)

Tax payments for restricted stock upon vesting

(10,862)

(10,706)

Payments of common stock dividends and equivalents

(119,503)

(106,015)

Cash paid for financing costs

(15,287)



Net cash used in financing activities

(558,241)

(312,998)

Effect of exchange rate changes on cash

1,487

(589)

Change in cash and cash equivalents, restricted cash and cash equivalents

(10,561)

61,397

Cash and cash equivalents, beginning of period

186,126

114,098

Restricted cash and cash equivalents, beginning of period

195,370

200,870

Cash and cash equivalents included in advertising fund assets, restricted,
   beginning of period

80,928

88,165

Cash and cash equivalents, restricted cash and cash equivalents and
   cash and cash equivalents included in advertising fund assets, restricted,
   beginning of period

462,424

403,133

Cash and cash equivalents, end of period

139,728

189,084

Restricted cash and cash equivalents, end of period

202,501

185,439

Cash and cash equivalents included in advertising fund assets, restricted, end of period

109,634

90,007

Cash and cash equivalents, restricted cash and cash equivalents and cash and
   cash equivalents included in advertising fund assets, restricted, end of period

$

451,863

$

464,530

SOURCE Domino's Pizza, Inc.

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+

Newsrooms &

Influencers

9k+

Digital Media

Outlets

270k+

Journalists

Opted In
2025-10-14 10:21 4mo ago
2025-10-14 06:05 4mo ago
PacBio Announces Major Advances for Revio and Vega to Lower Genome Cost and Expand Multiomic Capabilities stocknewsapi
PACB
New SPRQ-Nx chemistry designed to deliver the most complete view of the genome for less than $300 at scale

October 14, 2025 06:05 ET

 | Source:

PacBio

MENLO PARK, Calif., Oct. 14, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), developer of the world's most advanced sequencing technologies, today announced innovations to its Revio and Vega platforms designed to lower sequencing costs, add new multiomic capabilities, and expand support for regulated research environments.

The advancements center on new SPRQ-Nx sequencing chemistry and consumables, which are designed to deliver PacBio’s most affordable HiFi genome to date. Customers operating at scale could see as much as a 40% reduction from current costs, down to a price of less than $300 per genome. Additional improvements include 5hmC detection for epigenetic profiling and 21 CFR Part 11 compliance features for Vega. These updates reflect PacBio’s continued investment in making its highly accurate long-read sequencing solutions accessible at scale for population genomics, clinical research, and production-scale environments.

Beta testing of SPRQ-Nx chemistry on the higher throughput Revio is expected to begin in November 2025, with full commercial availability planned in 2026. Beta participants will be able to purchase 384 genomes of sequencing reagents for approximately $250 per genome. At launch, Revio systems running SPRQ-Nx will produce complete, multiomic native long-read genomes at the lowest cost in the market. PacBio intends to achieve these cost savings by enabling multiple runs per SMRT Cell while maintaining output per run, which will improve efficiency, reduce waste, and preserve PacBio’s hallmark accuracy and data richness.

“With lower sequencing costs, deeper biological insights, and new capabilities for clinical research and production-scale labs, we are delivering on our goal to make HiFi sequencing accessible for every genome and every lab,” said Christian Henry, President and Chief Executive Officer of PacBio. “From early discussions with customers, we’re seeing funding for projects at a larger scale than we’ve seen in the past. Our new pricing will allow researchers to apply the richness of HiFi data to many applications requiring more genomes, especially those leveraging large sample numbers to build robust AI models.”

Vega, PacBio’s benchtop system, will integrate SPRQ-Nx chemistry and 5hmC detection capabilities in 2026. Vega will also add rapid two- and four-hour sequencing runs, designed for high-demand applications such as plasmid and targeted sequencing. These upgrades will include secure authentication and audit logging features to support 21 CFR Part 11 compliance for labs operating under regulated conditions.

“Long reads are essential for population genomics because they reveal variants, phasing, methylation, and complex regions that other methods often miss,” said Michael Schatz, Bloomberg Distinguished Professor at Johns Hopkins University. “With Revio’s multi-use SMRT Cells driving down sequencing costs, long-read data will be foundational to the next generation of population studies, enabling deeper discovery and greater representation across diverse populations.” With the increased demand for HiFi data in large-scale, multi-year population studies, PacBio plans to provide to long-term support for the Revio and Vega platforms through 2032.

Interested customers can register for early-access to SPRQ-Nx through PacBio’s updated Technology Page, or visit booth #919 at ASHG 2025 for more details.

For more information about PacBio, visit: https://www.pacb.com

About PacBio

PacBio (NASDAQ: PACB) is a premier life science technology company that designs, develops, and manufactures advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. Our products and technologies, which include our HiFi long-read sequencing, address solutions across a broad set of research applications including human germline sequencing, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. For more information, please visit www.pacb.com and follow @PacBio. 

PacBio products are provided for Research Use Only. Not for use in diagnostic procedures. 

Forward Looking Statements

This press release may contain “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and the U.S. Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact are forward-looking statements, including statements relating to the uses, advantages, and benefits or expected uses, advantages or benefits of using, PacBio products or technologies; price, affordability and cost reductions; complete, multiomic genomes at the lowest cost native long-read genome in the market at launch for systems running SPRQ-Nx; expected dates and time frames of product and product feature availability; completeness of the genome and views thereof; expanded multiomic and epigenetic capabilities; regulatory compliance features; beta testing anticipated availability; efficiency; waste reduction; expected larger customer project scales and AI modeling; commitment to long-term product support through 2032; and other future events. You should not place undue reliance on forward-looking statements because they are subject to assumptions, risks, and uncertainties and could cause actual outcomes and results to differ materially from currently anticipated results, including, challenges inherent in commercializing new products; potential manufacturing, performance and quality issues; unexpected cost and tariff increases; regulatory requirements; and third-party claims alleging infringement of patents and proprietary rights or seeking to invalidate PacBio's patents or proprietary rights. Additional factors that could materially affect actual results can be found in PacBio's most recent filings with the Securities and Exchange Commission, including PacBio's most recent reports on Forms 8-K, 10-K, and 10-Q, and include those listed under the caption "Risk Factors." These forward-looking statements are based on current expectations and speak only as of the date hereof; except as required by law, PacBio disclaims any obligation to revise or update these forward-looking statements to reflect events or circumstances in the future, even if new information becomes available.

Contacts

Investors:
Jim Gibson: [email protected] or [email protected]

Media:
[email protected]
2025-10-14 10:21 4mo ago
2025-10-14 06:05 4mo ago
Trump's Tylenol claims limit M&A options for parent company Kenvue stocknewsapi
KVUE
SummaryCompaniesKenvue faces investor pressure amid strategic review, leadership changes and litigation riskTrump administration position on Tylenol erased $10 billion in market valuePotential sale or spin-off of Kenvue's skin health is on the tableOct 14 (Reuters) - Tylenol maker Kenvue

(KVUE.N), opens new tab was already having a painful year before U.S. President Donald Trump and his health secretary got involved.

Activist investor Starboard Value took aim at the company about a year ago, forcing the Band-Aid and Benadryl maker to settle a potentially costly and time-consuming fight by naming the hedge fund's CEO, Jeffrey Smith, and two other directors to the board in March.

Sign up here.

Other unhappy investors weren't mollified by the board refreshment, including Daniel Loeb's hedge fund Third Point, which quietly built its own stake in April.

In mid-July, Kenvue's board ousted its CEO after already replacing its chief financial officer and launched a strategic review of its operations, which sources say could include a sale or breakup of the company that had been spun off from healthcare conglomerate Johnson & Johnson

(JNJ.N), opens new tab in 2023.

Then news leaked on September 5 of a report that Health Secretary Robert F. Kennedy, Jr. planned to release linking its popular painkiller Tylenol to autism, driving shares down 9% that day.

AUTISM CLAIMSArguably the biggest blow came on September 22, when Trump told people to stop taking Tylenol. Flanked by Kennedy at a rare Roosevelt Room press conference, he told America: "It's not good."

The Food and Drug Administration, part of Kennedy's Department of Health and Human Services, that same day said it was slapping a

new warning, opens new tab on Tylenol labels reflecting safety concerns that its active ingredient, acetaminophen, could cause attention-deficit/hyperactivity disorder and autism in children whose mothers took it during pregnancy. That claim was refuted by influential medical groups and dismissed in federal court for its lack of scientific evidence.

The Trump administration's statements have cost Kenvue some $10 billion in market value and prompted investors to steer clear of the company, for now, analysts and investors said.

The presidential spotlight created a public relations firestorm for Kenvue, which has a market value of roughly $30 billion. It could create new legal dangers and complicate any strategic plans for the company, which also owns Neutrogena, Listerine and Zyrtec among several popular household products.

Kenvue declined to comment.

Plaintiffs are appealing a federal judge's 2024 dismissal of lawsuits bundled into multi-district litigation that alleged Tylenol or generic versions caused autism. The judge ruled that they failed to support their conclusions with scientific evidence.

"In 25 years or so doing this work, I’ve never seen the president, the HHS secretary, and the FDA commissioner join hands in common cause with the plaintiffs’ bar and use the bully pulpit of the White House to promote the interests of a legal case,” said Bob Chlopak, managing partner at Vision360 Partners, a firm that specializes in crisis communications.

COMPLICATING STRATEGIC OPTIONSKenvue's strategic review committee is considering a broad range of options, including a sale of the company or sale or spin-off of its struggling skin health & beauty unit, which contains household brands like Neutrogena, Aveeno and Clean & Clear, people familiar with the company's thinking said.

Finding a buyer for the full company would be much harder now with several dealmakers saying the company is “unsellable” until all Tylenol claims are resolved because buyers would worry about litigation risk and a prolonged drop in sales at one of the biggest brands.

“In our view, the company’s current structure makes (a full sale) unlikely, but a more focused OTC and skin care business could eventually become a target,” a July HSBC research note said.

Other consumer giants including Kellogg and Kraft Heinz

(KHC.O), opens new tab have opted for separation to create more streamlined businesses. Last month, Kraft Heinz announced it will separate into two independent, publicly traded companies: Global Taste Elevation and North American Grocery.

There is already interest in Neutrogena and Aveeno, sources said, but so far Kenvue has only been willing to part with its non-core skin health & beauty brands.

The skin health & beauty unit could be worth $6 billion to $9 billion, analysts say, despite the segment's falling revenue. That's a large bite for any company or private equity firm, but some have turnaround ideas for brands like Neutrogena, which Kenvue has poured advertising dollars into this year, sources said.

Neutrogena has struggled to win over Gen Z consumers and lost market share to competitors like L'Oreal's CeraVe, which in 2021 usurped the title of the No. 1 recommended skin care brand by dermatologists.

LEGAL CHALLENGES AHEADIf Kenvue were to sell or spin the skin health & beauty unit, the remaining company might be worse off without profitable segments to balance potential losses from its Tylenol litigation.

Ashley Keller, who represents families in the class action dismissed last year, submitted the Trump administration's latest actions as supporting evidence in an appeal before the 2nd U.S. Circuit Court of Appeals in Manhattan.

Kenvue could face substantial damages if the appeals court sides with plaintiffs, worrying investors.

The appellate court is using a legal standard that allows it to overturn the dismissal only if the panel of judges finds the prior ruling to be "plain error," unreasonable, or "completely out of bounds," lawyers and analysts said.

A ruling is expected by the end of March.

The solution to the Tylenol problem might just be time, analysts said, but board committees typically try to wrap up strategic reviews in a matter of months.

Reporting by Abigail Summerville and Svea Herbst-Bayliss in New York; Editing by Dawn Kopecki and Bill Berkrot

Our Standards: The Thomson Reuters Trust Principles., opens new tab

Abigail is on the M&A team and writes about consumer and retail deals. She joined Reuters in 2022 from Debtwire where she covered leveraged finance and the primary debt market for three years. Previously, her work has appeared in the Wall Street Journal, CNBC and the Boston Business Journal. She majored in business journalism at Washington and Lee University.
2025-10-14 10:21 4mo ago
2025-10-14 06:06 4mo ago
InnovAge (INNV) Surges 8.6%: Is This an Indication of Further Gains? stocknewsapi
INNV
InnovAge Holding Corp. (INNV - Free Report) shares ended the last trading session 8.6% higher at $5.55. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 12.3% gain over the past four weeks.

InnovAge Holding Corp. scored a strong price increase, on investors’ optimism surrounding its impending fiscal 2026 first-quarter financial results, which is expected to release next month. The Zacks Consensus Estimate for the first quarter revenue suggests a growth of 9.6% year over year, while earnings are projected to jump 125%. Building on a strong fiscal 2025 performance, InnovAge is likely to maintain its momentum this year through continued financial discipline, clinical performance and compliance execution.

This company is expected to post quarterly earnings of $0.01 per share in its upcoming report, which represents a year-over-year change of +125%. Revenues are expected to be $224.83 million, up 9.6% from the year-ago quarter.

While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.

For InnovAge, the consensus EPS estimate for the quarter has been revised 100% higher over the last 30 days to the current level. And a positive trend in earnings estimate revision usually translates into price appreciation. So, make sure to keep an eye on INNV going forward to see if this recent jump can turn into more strength down the road.

The stock currently carries a Zacks Rank #2 (Buy). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>

InnovAge belongs to the Zacks Medical Services industry. Another stock from the same industry, GeneDx Holdings Corp. (WGS - Free Report) , closed the last trading session 0.7% lower at $120.87. Over the past month, WGS has returned -1.8%.

GENEDX HOLDINGS' consensus EPS estimate for the upcoming report has changed -4.7% over the past month to $0.28. Compared to the company's year-ago EPS, this represents a change of +600%. GENEDX HOLDINGS currently boasts a Zacks Rank of #3 (Hold).